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ABSTRACT  
AMICA SIMMONS YON:The Influence of Spirituality on Medication Adherence and Blood 
Pressure Among Older Adults With Hypertension 
(Under the direction of Mary T. Roth McClurg) 
 
 Despite the effectiveness of pharmacological therapies, medication nonadherence is 
prevalent among older adults with chronic disease. Established correlates of adherence 
(e.g., access, race/ethnicity, education) do not fully explain the differences in adherence. 
This study examines whether spirituality contributes to older adults’ medication adherence 
and blood pressure, as well as the indirect pathways by which spirituality may be linked to 
self-reported adherence behavior, with social support and active coping as putative 
mediators.  
A cross-sectional analysis was performed on data from surveys on spirituality, social 
support, active coping, and adherence behavior administered to a convenience sample of 
Black and White hypertensive, older adults (> 65 years) visiting senior community centers in 
North Carolina, along with demographic characteristics and blood pressure measurements.  
Multivariate logistic and linear regressions were used to examine the relationship 
between spirituality and self-reported medication adherence and blood pressure, 
respectively, after adjusting for the psychosocial and demographic characteristics. 
Results revealed that perceived spiritual intensity and active spiritual health locus of 
control (SHLC) were significantly and positively associated with medication adherence. The 
psychosocial variables were significantly related to both perceived spirituality and 
medication adherence but were not significant mediators. High spirituality and active SHLC 
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beliefs were also significantly related to lower systolic and diastolic blood pressures after 
controlling for adherence and the psychosocial and demographic variables. 
These findings highlight the importance of spirituality in adherence behavior and 
health outcomes for some older adults with chronic disease. Better understanding of the 
mechanisms and role of spirituality in medication-taking behavior and health outcomes will 
aid researchers and health professionals in the development of culturally sensitive and 
patient-centered interventions to improve medication adherence and cardiovascular 
outcomes.  
  
v 
 
 
 
 
 
ACKNOWLEDGEMENTS 
 
 
There are so many people to thank for helping me to reach this goal. But first, I have 
to thank Jesus Christ, my Lord and Savior, for granting me the privilege of glorifying Him in 
my pharmacy profession, my research and educational experience. I am humbled by His 
faithfulness and love for me. I, Amica Simmons Yon, PharmD, PhD, am nothing without Him. 
It is promised in God’s Word that He “who began a good work in [me] will carry it on to 
completion until the day of Jesus Christ” (Philippians 1:6). I speak it, believe it and know that 
my latter days will be even more prosperous than today—only because I reverence, glorify 
and have faith in Him. He will do what He said He would do. I love you, Lord! 
Thanks to Mary T. Roth McClurg, my advisor for our experience through this 
process. We learned a lot along the way and I know that it has made each of us better 
people. Thank you also to Betsy, Jaya, Morris and Hayden for your support and direction, 
which have helped me to strive to be a great researcher. I thank each of you for the time you 
invested and the advice you provided: your mentorship has been invaluable. I also extend 
thanks to my spirituality and health research mentors: Harold Koenig, Cheryl Holt and Lisa 
Lewis. You all have inspired me in so many ways, especially as I strive to magnify the 
intangible with respect for its importance to the people we serve. Much love and thanks also 
go to Catherine Zimmer for her statistical assistance throughout this project. Not only did 
she serve as my statistician, she was also a friend and counselor every Monday morning—I 
love you. To my NRSA faculty and colleagues, thank you for your input, guidance and 
financial support. To my editor, Kay Robin Alexander, thank you for your expertise and 
patience and for helping me meet all my deadlines.  
  
vi 
To Mommy and Daddy, and my sisters and brother—I can never put into words how 
you all have embraced, encouraged and kept emphasizing the Word of God to me. Because 
of this, I made it through. My educational success is also yours! To my church families, 
Church at the Park and Disciple of Grace Ministries, you have had monumental impact on 
my family and life—I will never let you down, as I will continue to share the gospel in 
whatever I do. To a host of friends—Carla White, Anne Beaubrun, Latoya Griffin, Deidre 
Washington, Melissa Butler, Stacie Duesetzina, to name just a few—thank you for sharing in 
the late nights, tears, frustrations etc. but still pushing me forward!   
Finally, thank you to my husband, best friend and boyfriend for life, Pastor Raphael 
L. Yon. Your love, encouragement, support and smile mean the world to me. Thank you for 
dancing with my soul through the good and bad times, the tears, late nights and heartaches.  
Thank you for believing in me when I had lost all hope! Most of all, thank you for loving and 
taking care of our babies during all the days and nights that I was not there. And to my 
precious angels, Seth and Faith, your smiles, hugs, love and patience through all this makes 
a grown woman cry. I love you so much! Please know in your hearts that this was all for you, 
my handsome son and beautiful daughter, the next God-fearing, intelligent and magnificent 
leaders of this nation. Just remember, you can do all things through Christ who strengthens 
you…always put Him first!  Know that Mommy loves you, but God loves you more. 
   
  
vii 
 
TABLE OF CONTENTS 
 
CHAPTER 1:  INTRODUCTION ............................................................................................. 1 
OVERVIEW ............................................................................................................................................ 1 
Definition of Spirituality ................................................................................................................... 2 
SPECIFIC AIMS ...................................................................................................................................... 6 
CHAPTER 2: BACKGROUND AND SIGNIFICANCE ............................................................ 9 
PREVALENCE OF PRESCRIPTION DRUG USE ........................................................................................... 9 
MEDICATION ADHERENCE ...................................................................................................................... 9 
Adherence in Vulnerable Populations .......................................................................................... 10 
Adherence to Hypertension Medications ...................................................................................... 11 
Factors Associated with Medication Nonadherence .................................................................... 12 
SPIRITUALITY: IMPORTANT PERSONAL/CULTURAL BELIEFS .................................................................... 14 
SPIRITUALITY, HEALTH BEHAVIORS, AND MEDICATION ADHERENCE ....................................................... 14 
SPIRITUALITY AND HEALTH .................................................................................................................. 17 
Mortality ........................................................................................................................................ 18 
Physical and Mental Health .......................................................................................................... 18 
Cardiovascular Disease ................................................................................................................ 19 
SPIRITUALITY AND HYPERTENSION ....................................................................................................... 20 
NEGATIVE EFFECTS OF SPIRITUALITY ON HEALTH ................................................................................. 21 
SUMMARY ........................................................................................................................................... 23 
CONCEPTUAL MODEL .......................................................................................................................... 25 
MECHANISMS OF SPIRITUALITY: SOCIAL SUPPORT AND ACTIVE COPING ................................................ 26 
CHAPTER 3: METHODS ...................................................................................................... 31 
OVERVIEW .......................................................................................................................................... 31 
  
viii 
AIM 1 METHODS (PILOT STUDY) .......................................................................................................... 31 
Description of Parent Study .......................................................................................................... 31 
Setting ........................................................................................................................................... 33 
Patient Eligibility and Recruitment ................................................................................................ 33 
Description of Measures ............................................................................................................... 38 
Measures ...................................................................................................................................... 38 
Data Collected and Variables ....................................................................................................... 44 
AIM 1 ANALYSIS .................................................................................................................................. 50 
Overview ....................................................................................................................................... 50 
Statistical Analyses ....................................................................................................................... 51 
Overview ....................................................................................................................................... 53 
Descriptive Data: Characteristics of Hypertensive Patients ......................................................... 53 
Internal Consistency of Spiritual Measures .................................................................................. 59 
Logistic Regression Models .......................................................................................................... 60 
Estimated Sample Sizes ............................................................................................................... 62 
Selection of Spiritual Measure(s) for Aims 2 & 3 .......................................................................... 64 
Summary of Other Study Findings ............................................................................................... 68 
Conclusion .................................................................................................................................... 71 
AIMS 2 & 3 METHODS .......................................................................................................................... 72 
Overview ....................................................................................................................................... 73 
Study Setting ................................................................................................................................ 73 
Participant Eligibility and Recruitment/Enrollment ........................................................................ 75 
Data Collected and Variables ....................................................................................................... 80 
AIM 2 ANALYSIS .................................................................................................................................. 88 
Descriptive Data and Bivariate Analysis ....................................................................................... 89 
Logistic Regression Analysis ........................................................................................................ 89 
AIM 2A ANALYSIS: SECONDARY AIM ..................................................................................................... 91 
Mediation Analysis ........................................................................................................................ 92 
  
ix 
AIM 3 ANALYSIS .................................................................................................................................. 97 
CHAPTER 4. RESULTS OF AIMS 2 & 3 ............................................................................. 98 
AIM 2 RESULTS ................................................................................................................................... 98 
Overview ....................................................................................................................................... 98 
Participant Characteristics ............................................................................................................ 98 
Adherence Characteristics ......................................................................................................... 104 
Spirituality Characteristics .......................................................................................................... 109 
AIM 2 LOGISTIC REGRESSION RESULTS ............................................................................................. 121 
Overview ..................................................................................................................................... 121 
Effects of Self-ranking of Spirituality on Adherence ................................................................... 121 
Effects of Active Spiritual Health Locus of Control on Adherence ............................................. 123 
AIM 2A: MEDIATION ANALYSIS RESULTS ............................................................................................. 127 
Overview ..................................................................................................................................... 127 
Analysis of Social Support and Active Coping as Mediators of Self-ranking of Spirituality ........ 127 
AIM 3 RESULTS ................................................................................................................................. 132 
Overview ..................................................................................................................................... 132 
OLS Regression Results ............................................................................................................ 132 
CHAPTER 5: DISCUSSION ............................................................................................... 137 
SUMMARY OF FINDINGS ..................................................................................................................... 137 
Spirituality and Medication Adherence (Aim 2) .......................................................................... 137 
Mediation Analysis: Social Support & Active Coping (Aim 2a) ................................................... 141 
Spirituality and Blood Pressure (Aim 3) ...................................................................................... 142 
LIMITATIONS ..................................................................................................................................... 143 
STRENGTHS ...................................................................................................................................... 146 
IMPLICATIONS FOR FUTURE RESEARCH AND PRACTICE ....................................................................... 148 
CONCLUSION .................................................................................................................................... 150 
APPENDICES ..................................................................................................................... 151 
  
x 
APPENDIX 1. DUKE UNIVERSITY RELIGION INDEX (DUREL) USED IN AIM 1 ........................................... 152 
APPENDIX 2.  SPIRITUAL HEALTH LOCUS OF CONTROL SCALE (SHLCS) .............................................. 153 
APPENDIX 3.  SELF-RANKING OF SPIRITUALITY .................................................................................... 155 
APPENDIX 4.  JOHN HENRYISM ACTIVE COPING SCALE (JHAC12)....................................................... 157 
APPENDIX 5.  TANGIBLE, INFORMATIONAL, EMOTIONAL SOCIAL SUPPORT SURVEY (ADAPTED TIES) ..... 158 
APPENDIX 6.  MORISKY COMPLIANCE ASSESSMENT SCALE (4-ITEM) .................................................... 159 
APPENDIX 7. DEMOGRAPHIC QUESTIONNAIRE .................................................................................... 160 
APPENDIX 8.  MORISKY MEDICATION ADHERENCE SCALE (MMAS 8-ITEM)........................................... 163 
APPENDIX 9.  VISUAL ANALOG SCALE FOR MEDICATION ADHERENCE .................................................. 164 
APPENDIX 10.  TANGIBLE, INFORMATIONAL, EMOTIONAL SOCIAL SUPPORT SURVEY ............................. 165 
APPENDIX 11.  STUDY FLYER ADVERTISEMENT ................................................................................... 167 
APPENDIX 12.  REFERRAL LIST FORM ................................................................................................ 168 
APPENDIX 13.  TELEPHONE SCRIPT USED FOR RECRUITMENT ............................................................. 169 
APPENDIX 14.  BLOOD PRESSURE MEASUREMENT PROTOCOL ............................................................ 172 
REFERENCES .................................................................................................................... 180 
 
 
 
 
 
 
 
 
 
 
 
  
xi 
LIST OF TABLES 
TABLE 1. OUTLINE OF MEASURES ADMINISTERED AT BASELINE ............................. 38 
TABLE 2. VARIABLES USED IN AIM 1 .............................................................................. 45 
TABLE 3. CHARACTERISTICS OF HYPERTENSIVE PATIENTS (N = 62)  
 IN AIM 1 .............................................................................................................. 55 
TABLE 4. SPIRITUAL CHARACTERISTICS OF PATIENTS (N = 62) IN AIM 1 ................. 56 
TABLE 5. MEDICATION ADHERENCE (MORISKY SCORE OF 4 = ADHERENT)  
 BY SPIRITUAL VARIABLES AND CHARACTERISTICS OF PATIENTS 
 WITH HYPERTENSION (N = 62) IN AIM 1 ......................................................... 58 
TABLE 6. RELIABILITY OF SPIRITUALITY MEASURES (CRONBACH’S ∂)  
 USED IN AIM 1 ................................................................................................... 60 
 
TABLE 7. ADJUSTED LOGISTIC REGRESSION MODELS FOR MEDICATION 
ADHERENCE AND ESTIMATED SAMPLE SIZE ............................................... 63 
TABLE 8. SUMMARY OF CRITERIA FOR SELECTING SPIRITUAL MEASURE  
 TO USE IN AIMS 2 AND 3 .................................................................................. 64 
TABLE 9. RECRUITMENT/ENROLLMENT SCHEDULE FOR THE SENIOR  
 CENTERS ........................................................................................................... 78 
TABLE 10. VARIABLES USED IN AIMS 2 AND 3 ................................................................ 82 
TABLE 11. STANDARDIZING EQUATIONS USED IN THE SOBEL TEST FOR  
 PARTIAL MEDIATION ........................................................................................ 96 
 
TABLE 12. PARTICIPANT CHARACTERISTICS IN TOTAL SAMPLE (N = 170) ..............  102 
 
TABLE 13. CHARACTERISTICS OF PARTICIPANTS BY RACE IN TOTAL  
 SAMPLE (N = 170) ...........................................................................................  103 
 
TABLE 14. SELF-REPORTED MEDICATION ADHERENCE CHARACTERISTICS  
 BY OTHER DEMOGRAPHIC, HYPERTENSION, ACTIVE COPING,  
 AND SOCIAL SUPPORT CHARACTERISTICS (N =  170) .............................  108 
 
TABLE 15. SELF-RANKING OF SPIRITUALITY CHARACTERISTICS BY OTHER 
DEMOGRAPHIC, HYPERTENSION, ACTIVE COPING, AND SOCIAL 
SUPPORT CHARACTERISTICS (N = 170) .....................................................  113 
 
TABLE 16. ACTIVE SPIRITUAL HEALTH LOCUS OF CONTROL (SHLC) 
CHARACTERISTICS BY OTHER DEMOGRAPHIC, HYPERTENSION,  
 ACTIVE COPING, AND SOCIAL SUPPORT  
  
xii 
 CHARACTERISTICS (N = 170) .......................................................................  117 
 
TABLE 17. CORRELATION MATRIX ASSESSING RELATIONSHIPS AMONG 
INDEPENDENT VARIABLES PREDICTING SELF-REPORTED  
 MEDICATION ADHERENCE TO ANTI-HYPERTENSIVE(S) ..........................  119 
 
TABLE 18. VARIANCE INFLATION FACTOR (VIF) AND TOLERANCE (1/VIF)  
 VALUES FOR INDEPENDENT VARIABLES USED IN REGRESSION 
ANALYSES PREDICTING ADHERENCE ......................................................... 120 
 
TABLE 19. BIVARIATE AND MULTIVARIATE EFFECTS OF SPIRITUALITY ON  
 SELF-REPORTED MEDICATION ADHERENCE IN HYPERTENSIVE  
 OLDER ADULTS (N = 170) ..............................................................................  125 
 
TABLE 20. BIVARIATE AND MULTIVARIATE EFFECTS OF ACTIVE SPIRITUAL  
 HEALTH LOCUS OF CONTROL (SHLC) ON SELF-REPORTED  
 MEDICATION ADHERENCE IN HYPERTENSIVE OLDER ADULTS  
 (N =  70) ...........................................................................................................  126 
 
TABLE 21. BIVARIATE AND MULTIVARIATE EFFECTS OF SELF-RANKING OF 
SPIRITUALITY ON SYSTOLIC AND DIASTOLIC BLOOD PRESSUR  
 IN HYPERTENSIVE OLDER ADULTS (N = 170) ............................................  135 
 
TABLE 22. BIVARIATE AND MULTIVARIATE EFFECTS OF ACTIVE SPIRITUAL 
 HEALTH LOCUS OF CONTROL ON SYSTOLIC AND DIASTOLIC  
 BLOOD PRESSURE IN HYPERTENSIVE OLDER ADULTS (N = 170) ..........  136 
  
xiii 
LIST OF FIGURES 
FIGURE 1. CONCEPTUAL MODEL OF SPIRITUALITY AND MEDICATION 
 ADHERENCE FOR AFRICAN AMERICANS DIAGNOSED WITH 
 HYPERTENSION (LEWIS & OGEDEGBE, 2008) ...........................................  29 
FIGURE 2. CONCEPTUAL MODEL OF THE PRESENT STUDY ...................................... 30 
FIGURE 3.   DIAGRAM OF SINGLE-STEP MULTIPLE MEDIATION MODEL ..................... 95 
FIGURE 4. HISTOGRAM OF SELF-REPORTED MEDICATION ADHERENCE 
 SCORES (N = 70) .........................................................................................  105 
FIGURE 5. SELF-RANKING OF SPIRITUALITY CHARACTERISTICS (N = 170) ..........  110 
FIGURE 6. HISTOGRAM OF ACTIVE SPIRITUAL HEALTH LOCUS OF  
 CONTROL (SHLC) SCORES (N = 170) ........................................................  115 
 
FIGURE 7.   INFORMAL TEST OF SOCIAL SUPPORT AND ACTIVE 
 COPING AS MEDIATORS ............................................................................. 129 
FIGURE 8. MODEL OF SOBEL TEST OF MEDIATION ................................................... 131 
 
 
  
xiv 
 
 
PREAMBLE 
Despite the effectiveness of pharmacological therapies upon hypertension, 
medication nonadherence is prevalent among older adults, whose adherence can be 
influenced by numerous factors including income, health literacy, medication cost, 
race/ethnicity, and regimen complexity. These established correlates of adherence do not 
exhaust its variance, however, and inconsistent results have been reported in the literature. 
Although spirituality has been associated with improved physical and mental health, and 
some positive lifestyle behaviors, its role in medication adherence has not been well studied. 
This study seeks to address this gap by determining whether spirituality, via its known 
associations with social support and active coping, contributes to older adults’ medication 
adherence and thus to lower blood pressure. 
This dissertation is organized around three primary research aims, which are 
described in detail in Chapter 1. Chapter 2 includes a review of the literature on spirituality 
and adherence, other relevant literature on spirituality and health, and two recognized 
attributes of spirituality: social support and active coping. The conceptual model that guides 
this research is also described in Chapter 2. Chapter 3 details the research methods 
describing the study setting, participant eligibility, the study data, measurements, and 
analysis by aim, as well as the methods and results for Aim 1, which served as a pilot study. 
Chapter 4 presents the study results for aims 2 and 3. Finally, Chapter 5 summarizes the 
major findings of the present study and discusses their implications as well as possible 
directions for future research.
  
 
 
 
 
 
Chapter 1 
INTRODUCTION 
Overview 
Medication adherence is a major public health challenge. The World Health 
Organization (WHO) reports that adherence to long-term therapy for chronic diseases in 
developed countries averages about 50%.1 The consequences of nonadherence include 
poorer health outcomes, severe adverse events (e.g., hospitalizations and death), and 
increased health care expenditures.1-3 These consequences are particularly evident in 
chronic conditions such as hypertension, diabetes, heart failure, and multiple co-morbidities 
in which pharmacological therapy is the foundation for optimal disease management.4-6 
Nonadherence is a tremendous problem in the United States, where more than half of 
Americans report not taking their prescribed medications as instructed7,8 and studies have 
shown that poor medication adherence accounts for approximately 125,000 deaths annually 
(342 per day) and 28% of all emergency room visits.2,9-13 
Adherence can especially be challenging in older adults, who may be prescribed 
multiple medications for their chronic conditions. Across different disease states and 
definitions of adherence, it is estimated that up to 70% of chronically ill older adults do not 
adhere to their prescribed regimens.5,14-20 As Americans continue to live to more advanced 
ages, live with multiple chronic conditions, and rely on more medications for disease control, 
it becomes necessary to recognize and understand factors that contribute to medication-
taking behaviors in order to optimally encourage therapeutic adherence. 
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A review of the literature reveals several factors that may be associated with 
nonadherence, including age, race/ethnicity, income, education, health literacy, access/cost, 
and others.9,21,22 However, these factors do not fully explain the variance in adherence and 
there are “relatively few consistent predictors” in the literature.21,23 Therefore, adherence 
research has been broadening its focus to other patient-level factors (e.g., personal and 
cultural beliefs about disease) that influence medication-taking behaviors.24-26 
Definition of Spirituality 
No agreement has been reached in the literature on the exact definition of the terms 
spirituality and religiosity. However, scholars from a wide range of disciplines do agree that 
these constructs share overlapping meanings; in addition, they so frequently appear 
together in medical literature that they are written as a combined term (religiosity/spirituality, 
or R/S) .24,27,28 Spirituality is often described as the broader term—that is, as being more 
universal, more inclusive, and at times less offensive (because it has been less stigmatized 
by institutionalization).29-32 Spirituality is often equated with traditional religious practices and 
beliefs, although it is considered to be more encompassing and personal.29,31 It comprises 
feelings of connection to others and the search for meaning and purpose in life beyond the 
corporeal.33 Spirituality is often considered a personal phenomenon, meaning that spiritual 
people have, and cultivate within themselves, an intimate connection or relationship with a 
higher power or sacred entity. 
In essence, spirituality relates to the subjective, individualized experience of 
transcendence. In this way it differs from religion, which is usually viewed as a societal 
phenomenon or institutionalized expression and is commonly defined as an organized 
system of beliefs and practices that involve and determine the collective spiritual 
experiences of a group of people.32,35 Thus, religiosity (or religious involvement) refers to the 
degree of participation or commitment to these organized beliefs and practices.30,34-36 The 
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vast majority of Americans are said to not distinguish between spirituality and religiosity, 
especially in certain regions (e.g., the Southeast).24,30 This dissociation may be due to the 
popular perception that spirituality is rooted in an established religious tradition or belief 
system; in any case, religion is one way that people experience or express spirituality. 
Although spirituality is viewed more broadly and defined less strictly than religiosity, 
scholars tend to agree that these two constructs share very similar characteristics that 
involve the quest for life’s meaning and purpose, transcendence of the present and/or 
ordinary, connection with other people and with a Divine power, and specific values and 
behaviors.25,32,34,35 Because spirituality and religiosity are considered more alike than 
different, and with the goal of remaining consistent with the spirituality and health literature, 
in the present study the term spirituality will be used to connote both spiritual and religious 
practices and beliefs. Spirituality in the present study is defined as the personal quest for 
understanding ultimate questions about life and events, about meaning, and about 
relationship with the sacred or transcendent; these aims may or may not involve religious 
practices and beliefs. The term “religiosity” will be used in reference to previous research 
that has differentiated it from spirituality and/or has specifically used the term religiosity. 
Because spiritual traditions and beliefs may affect the decisions individuals make 
about their health, illnesses, and treatment choices, research on spirituality and health has 
begun to garner more attention and researchers have become more interested in the ways 
that spirituality impacts health.25,34,37-43 The majority of past research on spiritual 
characteristics, including religious involvement, has shown positive relationships between 
spirituality and health outcomes.24,29,30,34,44,45 However, the positive cast of this literature may 
have resulted from author or publication bias.  
The majority of studies examining various aspects of spirituality (mostly in terms of 
religiosity) in relation to health have been cross-sectional and unable to differentiate cause 
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and effect; however, research also suggests that the patterns seen in these cross-sectional 
studies have also been observed in prospective studies and in studies that have compared 
secular to spiritually based interventions.40,46-52 For example, Strawbridge and colleagues 
found in their 28-year prospective study of more than 5000 adults that weekly religious 
service attendance decreased the relative risk of dying during follow-up by 36% (relative 
hazard = 0.64; 95% CI 0.53–0.77).46 This association between attendance and mortality 
remained statistically significant even after adjusting for health conditions, body mass index 
(BMI), social connections, and health practices (e.g., smoking, exercise, alcohol 
consumption). After adjusting for similar control variables, Koenig and colleagues found 
similar effects on survival in a six-year study of 4000 older adults (relative hazard = 0.72; p < 
0.001).53  
Affirmation of the notion that spirituality positively influences health outcomes has 
varied. Reactions have ranged from cynical skepticism to supportive advocacy (i.e., when 
researchers contend that spirituality has health-promoting effects).41,54 Some researchers 
remain skeptical because the majority of past studies have focused on religious involvement 
(usually worship service attendance) to the exclusion of other factors or dimensions such as 
self-perceptions of spirituality, agnosticism, and spiritual well-being. For example, some 
studies have suggested that individuals who struggle with their faith may be at higher risk for 
certain emotional and physical health challenges.55-58 In addition, several of these studies 
were clouded or confounded by pre-existing mental health disorders (e.g., depression, 
PTSD) within the study populations. Doubt also stems from the fact that most studies have 
not been designed to test conceptual models or theory. For all of these reasons, the 
mechanisms that underlie the positive associations found in some studies, but not in others, 
are not well understood.41    
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Although there is support for the premise that spirituality positively influences health 
outcomes and behaviors, little research has examined the role of spirituality in medication 
adherence. Nonetheless, understanding the role of spirituality in medication adherence is 
important because it may help explain some of the positive associations that have been 
observed between spirituality and health. To date, there have been limited studies 
examining the relationship between spirituality and medication adherence in community-
dwelling older adults with hypertension. Past research is mostly comprised of small 
qualitative studies that have only suggested or implied that aspects of spirituality may 
facilitate medication management and adherence in chronic diseases such as 
hypertension.43,59-61 For example, qualitative results of a recent study that involved in-depth 
interviews with 21 older African American women suggested that they perceive spirituality as 
a positive resource that helps them adhere to their antihypertensive medication regimens.59 
If spiritual beliefs do in fact affect the decisions that a significant number of older patients 
make about their health and behavior choices, it is critical that health care providers listen 
and recognize all aspects of their patients' lives.  
A better understanding of these issues is likely to guide the development of 
interventions to improve or maintain adherence—which would ultimately improve health 
outcomes. In addition, understanding whether a patient’s spirituality functions as an 
enhancement of or barrier to adherence may lead to care that is more patient-centered and 
culturally appropriate; in any case, it will foster better patient-provider communication around 
disease management. More-specific interventions could also be targeted to high-risk 
patients and community groups whose adherence to prescribed therapies is challenged.   
The objective of this study was to assess the influence of older adults’ spiritual 
characteristics on self-reported medication adherence and blood pressure. In addition, to 
explore the mechanisms by which spirituality might influence adherence, social support and 
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active coping were assessed as possible mediators in the pathway between spirituality and 
self-reported adherence. This study is a cross-sectional analysis of data collected from 
questionnaires administered to older adults with hypertension. Its specific aims are 
described in more detail below.  
Specific Aims 
Aim 1: To assess three spiritual measures and select the measure (based on internal 
consistency, association with adherence and sample size efficiency) to test the 
hypothesis that spirituality is positively associated with medication adherence. 
Aim 2: To examine the relationship between spirituality and self-reported medication 
adherence among community-dwelling older adults with hypertension. 
Hypothesis 2:  
 Older adults who report high spirituality versus those who report low spirituality 
are more likely to report being adherent to their anti-hypertensive medication(s).  
 Older adults with high active spiritual health locus of control (SHLC) beliefs 
versus those with low active SHLC are more likely to report being adherent to 
their anti-hypertensive medication(s).  
Aim 2a: To examine the relationships among spirituality, social support, active 
coping, and self-reported medication adherence in community-dwelling older adults 
with hypertension.  
Hypothesis 2a: 
 Spirituality is positively associated with self-reported medication adherence, 
and this association is mediated through social support and active coping. 
Aim 3:  To examine the relationship between spirituality and blood pressure among 
community-dwelling, older adults with hypertension. 
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 Hypothesis 3: 
 Older adults who report high spirituality will have lower systolic and diastolic 
blood pressures compared to older adults who report low spirituality. 
Aim 1, the pilot study, involved a cross-sectional study of 62 hypertensive older 
adults who had already been recruited into a larger study (hereafter, the parent study). A 
series of questionnaires about spiritual characteristics (i.e., organized religiosity, non-
organized religiosity, spiritual health locus of control beliefs, and self-reported level of 
spirituality) that may influence medication adherence was administered to this group. The 
goal of Aim 1 was to select the spiritual measure(s) to be used in Aims 2 and 3 for 
hypothesis testing. Selection of one or more suitable spiritual measures to examine in 
relation to medication adherence included examining scale reliability; assessing the 
observed effect sizes (odds ratios); and estimating sufficient sample sizes to efficiently and 
feasibly test associations between the spiritual variables and medication adherence. 
Relevance of the spiritual measure to the study population was also considered.  
The next part of this project was to design and conduct a larger study (aims 2 and 3), 
based on the results of Aim 1. Aims 2 and 3 were to 1) test the hypothesis that high 
spirituality leads to greater medication adherence among older adults with hypertension; 2) 
examine the relationships among spirituality, social support, active coping, and medication 
adherence—that is, to test whether social support and active coping mediate the 
relationship between spirituality and adherence; and 3) to examine the relationship between 
spirituality and blood pressure.   
Data for this project was derived from two main sources: questionnaires 
administered to a sample of older adult patients enrolled in the parent study, at Chatham 
  
8 
Crossing Medical Center in Chapel Hill, North Carolina (Aim 1), and questionnaires 
administered to a convenience sample of community-dwelling older adults with hypertension 
at local senior centers (aims 2 and 3) in the Research Triangle Park region of North 
Carolina. Logistic regression methods were used to examine the relationships between 
spirituality and medication adherence in aims 1 and 2, and OLS regression was used to 
examine the effect of spirituality on blood pressure in Aim 3.  
  
 
 
 
 
Chapter 2 
BACKGROUND AND SIGNIFICANCE 
 
Prevalence of Prescription Drug Use  
 Medications are the most common and one of the most important health care 
interventions to prevent disease, morbidity, and mortality.21 According to recent data from 
the U.S. Department of Health and Human Services (DHHS), 50% of all Americans take at 
least one prescription medication and 10% use five or more.62 In 2008, over $234 billion was 
spent in the United States for prescription drugs. Data for 2007–2008 also reveal that more 
than 76% of Americans age 60 and older used two or more prescription drugs in any given 
month and that 37% had used five or more in the preceding month.62  
Medication Adherence 
Medication adherence is generally defined as the extent to which an individual’s 
medication-taking behavior corresponds to prescribed recommendations from a health care 
provider.1,12 Despite the availability of effective medical therapies for chronic disease and 
specific interventions to improve adherence, medication adherence rates remain low—by 
some estimates, between 50% and 60%.21,63 However, according to different definitions of 
adherence, the literature contains estimated rates of medication nonadherence from 40% to 
93% across various chronic diseases.64-67 The problem is so severe that in 1998, poor 
adherence to therapeutic and beneficial medication regimens was described as the world’s 
“other drug problem” in The New York Times.68  
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Evidence also reveals that poor adherence to medication regimens accounts for 
preventable worsening of disease, hospitalizations, death, and increased health care costs 
in the United States.3,69-79 According to a recent New England Healthcare Institute (NEHI) 
study, the estimated cost of nonadherence to the U.S. health care system is $290 billion 
annually, which translates to 13% of the nation’s total health care expenditures.78  
Adherence in Vulnerable Populations 
Poor adherence to prescribed therapy is a significant healthcare issue for vulnerable 
population groups, especially minorities and the elderly.80 Many older adults are not only 
diagnosed with multiple chronic conditions but also have to manage complex medication 
regimens prescribed by various physicians. Therefore, the consequences of medication 
nonadherence and/or adverse drug events can be serious or life-threatening. Nonadherence 
accounts for more than 10% of older adult hospital admissions,11 nearly 25% of nursing 
home admissions, and 20% of preventable adverse drug events among older persons in 
ambulatory settings,12 and results in thousands of preventable deaths annually.9 As noted by 
the American Society on Aging and the American Society of Consultant Pharmacists 
Foundation, “…of all age groups, older persons with chronic diseases and conditions benefit 
the most from taking medications, and risk the most from failing to take them properly.”81   
Racial differences in medication adherence have also been reported among the 
elderly, with Blacks tending to be less adherent.82,83 Researchers recently found that 
medication-related problems (6.2 vs. 4.9; p < 0.01) and higher rates of nonadherence (68% 
vs. 42%; p < 0.01) were more prevalent in older Black, community-dwelling adults than in 
Whites, despite the fact that Whites used more medications (11.6 vs. 9.7; p < 0.01).84 In 
another study of Medicare enrollees, researchers found that Blacks were more likely than 
Whites to report “not always following physician instructions on how to take medications” 
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(adjusted OR = 1.60; 95% CI 0.74–3.42), which may reflect differences in patients’ attitudes 
or lay health beliefs that, in turn, influence their medication decisions.85  
 Researchers have also noted that even when controlling for access barriers to 
medications, Blacks remain more likely to be nonadherent than Whites.66,80,82,86 For 
examples, racial/ethnic differences in medication adherence are reported within the 
veterans’ healthcare system despite equal access and cost.87-92 This discrepancy indicates 
that poor adherence is more than a problem of access to services or cost of medications, 
which are two of the most-cited reasons for nonadherence in the literature. Findings of racial 
differences in medication adherence have profound implications for health disparities, 
especially because lower adherence often contributes to significant disparities in chronic 
disease outcomes. 
Adherence to Hypertension Medications 
 Hypertension affects approximately 75 million Americans (1 of every 3).93,94 Data from 
the Framingham Heart Study95 suggest normotensive individuals at age 55 have a 90% 
lifetime risk of developing hypertension. Moreover, hypertension increases patients’ risk of 
heart disease and stroke (the first and third leading causes of death in the U.S., 
respectively).93,96 In 2010, researchers estimated that high blood pressure alone results in 
more than $76 billion nationwide in direct and indirect health care services costs.96  
 Although persistent adherence to prescribed antihypertensive medication regimens is 
essential to reduce the risks of stroke, cardiovascular disease, renal disease, and even 
death, medication adherence is low among hypertensive patients regardless of their race or 
ethnic background.60 Only about half of patients who are being treated for hypertension 
actually have their blood pressure under control.96,97 Furthermore, researchers report that 
only 50% of patients for whom medication therapy has been initiated persist with this 
treatment after one year.98,99 Risk factors of hypertension, such as age and comorbid 
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conditions, pose an excess risk to cardiovascular morbidity and mortality, a relationship that 
emphasizes the importance of persistent adherence in vulnerable populations.   
Low antihypertensive medication adherence has been proposed as an important 
barrier to achieving hypertension control and reducing morbidity and mortality in older 
adults. Most large clinical trials, such as the Systolic Hypertension in the Elderly Program 
(SHEP) have reported improvements in blood pressure control and patient outcomes, in 
both community and ambulatory care settings, with adherence to prescribed medications.100 
These and other trials have associated antihypertensive drug therapy with a 35%–45% 
reduction in stroke incidence, myocardial infarction reduction of 20%–25%, and heart failure 
reduction of more than 50%.95   
As the U.S. population continues to age, the prevalence of hypertension will increase 
and many more people will be prescribed and required to take anti-hypertensive 
medications.  Persistent adherence is the cornerstone for control and for reducing morbidity 
and mortality. Therefore, it is crucial to understand the factors that affect adherence and to 
institute a variety of proactive and responsive strategies that help older adults with 
hypertension to improve and maintain medication adherence.   
Factors Associated with Medication Nonadherence  
 Since the 1970s, literature on medication adherence has grown substantially.101 In 
general, medication adherence is believed to be a multidimensional phenomenon. The 
WHO has grouped relevant factors into five dimensions: (1) social and economic, (2) health 
care system-related, (3) condition-related, (4) therapy-related, and (5) patient-related.1 
Particularly in older populations, the most frequently examined potential determinants of 
adherence include variables related to sociodemographics, health status, medications, and 
prescribers.101,102 The literature also suggests specific patient-related factors (e.g., 
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involvement with their care, disease knowledge, beliefs and attitudes about their chronic 
illness and treatment) may also be associated with adherence.1,14,63,102,103  
   Although studies associated adherence with an array of sociodemographic 
characteristics, links have typically been modest and findings have been 
inconsistent.21,101,104,105 For example, researchers recently examined the correlates of 
medication adherence among older adults and found little consensus regarding the 
sociodemographic and medication-related variables that are associated with adherence in 
this population,101 but also concluded that individual choices and beliefs regarding health 
and treatment may be stronger determinants. 
 Some researchers have suggested that nonadherence to antihypertensive medications 
is influenced by a complex set of factors beyond the health care system and general 
sociodemographics.22,66,106-109 For example, Steiner and colleagues104 conducted a 
retrospective cohort study of more than 100,000 hypertensive patients in which they 
attempted to develop clinical prediction rules for adherence based on a combination of 
sociodemographic and clinical patient characteristics. Multivariate logistic models based on 
the study’s predictors, however, could not accurately discriminate adherent from 
nonadherent individuals (C statistic indice range 0.56–0.61); as a result, these researchers 
concluded that health providers should not rely only upon their patients’ sociodemographic 
or clinical characteristics to predict which ones will be adherent.104 Overall, the numerous 
factors that have been shown to influence patients’ adherence to antihypertensive therapies 
have not fully explained variances in adherence; moreover, most of the study findings have 
been modest.8,101,110 
 Some studies have indicated that psychosocial and cultural beliefs may be important 
contributors to medication adherence and blood pressure control,100,109,111,112 and have 
suggested their further investigation.26,60,111,113,114 Accordingly, more research is being 
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conducted to understand the effects of personal and/or cultural beliefs on adherence 
behavior and to help understand different adherence rates among various groups of 
hypertensive patients.26,112,115,116  Such research is warranted, given that the U.S. population 
is not only growing older and showing an increased prevalence of hypertension but it is also 
becoming more racially, ethnically, and culturally diverse.   
Spirituality: Important Personal/Cultural Beliefs 
Spirituality has been identified as an important personal and/or cultural belief in many 
communities. It is an important part of the lives of most Americans; recent surveys have 
estimated that more than 90% (including older adults and the medically ill) claim to believe 
in God or some higher power and to value such beliefs.117,118 For some, spirituality plays a 
prominent role and affects every aspect of life––including health.24,26,29,39,113,116,119,120 The 
following sections present a  review of relevant literature on spirituality and health outcomes 
and behaviors. In addition, a conceptual framework through which to assess the general 
impact of spirituality on medication adherence in hypertension is presented. This literature 
review and conceptual framework form the basis for the generated hypotheses of the 
present study. 
Spirituality, Health Behaviors, and Medication Adherence 
 Research suggests that spirituality is an important variable that can both influence and 
explain health behaviors.34,38,47,121-123 For example, spiritual involvement has been 
associated with health-promoting behaviors such as physical activity or exercise, proper 
nutrition, improved communication with health providers and caregivers, lower smoking and 
alcohol prevalence, greater use of preventive services, and medical treatment 
compliance.34,123-130 These associations have been observed across race/ethnic 
backgrounds and the age spectrum from adolescents to older adults.131-135 Religious 
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affiliation/involvement and frequency of religious service attendance have been the most 
frequently examined spiritual variables; however, the positive associations between these 
characteristics and various behaviors probably stem from the notion that religious beliefs 
and practices condemn risky or unhealthy actions and instead provide behavioral guidelines 
that “reduce self-destructive tendencies.”38 
 Spiritual transcendence and well-being have also been examined in relation to health-
promoting behaviors.122,136,137 Greater physical activity, exercise adherence, better 
diet/nutrition regimes, and significantly improved weight loss have been shown to be 
successful in several faith-based behavioral interventions.138-145 Researchers suggest that 
community interventions at church level, where consistent support and reinforcement can be 
found, have a reasonable chance of influencing the health of vulnerable populations at high 
risk for cardiovascular disease.141 
 Most people with chronic diseases are required to take medications on a daily basis, 
which makes adherence one of the most important health behaviors. Nonetheless, 
medication adherence has been less studied in relation to spirituality and, despite evidence 
that spirituality has a positive effect on various health outcomes, investigations of direct links 
between spirituality and medication-taking behavior are scarce. Numerous studies and 
systematic reviews have suggested, however, that personal beliefs and cultural factors, 
including spirituality, are important in relation to adherence for patients with chronic illnesses 
and have concluded that these factors warrant further investigation.26,59,146,147 For example, 
researchers have found that faith and reliance on God frequently helped members of a 
focus group of 28 older adults to manage and cope with chronic illnesses.147 That spirituality 
and close ties to religious organizations strengthen patients’ coping ability, increase their 
compliance with health care visits, and even increase their compliance with treatment 
recommendations have also been suggested.148-150 Research that indicates an association 
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between spirituality and adherence is scant, however, and mostly found in the HIV literature. 
For prevalent chronic diseases such as diabetes and hypertension, few studies have been 
done; most of these have been small-scale and qualitative and have indicated only a 
possible relationship between spirituality and medication adherence. Only a small number of 
studies suggest that spirituality may enhance medication adherence in some patients with 
chronic diseases such as diabetes and hypertension. Most of these were qualitative, 
conducted in minority populations, and stemmed from church-based interventions designed 
to promote healthy lifestyle behaviors. Spirituality has been suggested to possibly play a role 
in medication adherence among patients diagnosed with hypertension.26,151-153 It has also 
been indicated that spirituality influences patients’ thoughts about hypertension, how they 
manage the disease, and how they follow medication recommendations.26,60,66,151   
In a qualitative study of 20 hypertensive black Americans, the majority of participants 
were found to use their religious beliefs as protective, control, and coping mechanisms in 
their disease management.151 Informants attributed their hypertension to ”God’s plan,” a 
conclusion that enhanced their own sense of personal control because they believed that 
God would  provide the necessary means to handle their situation (e.g., “God created 
doctors”, "God has the medication there for me").151 The authors of this study suggested 
further investigation into the relationship between spirituality and medication use and stated 
that whether different dimensions of spirituality are associated with different levels of 
medication compliance behavior should be determined.151 In a more recent qualitative study, 
researchers assessed the role of spirituality in self-management practices among 
community-dwelling older women (age > 65–96 years).43 Their informants reported using a 
combination of spiritual and traditional methods as therapeutic approaches to manage their 
chronic illnesses and that their spirituality guided them in what allopathic therapies to use. 
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Respondents also reported the importance of spirituality in empowering them to practice 
health-promoting activities. 
 Although evidence from other small qualitative studies also indicates that spirituality 
positively influences treatment preferences and how some patients therapeutically manage 
their chronic diseases, these have mostly been conducted in the Black population.108,113,154-
159 However, these exploratory qualitative studies (as well as the more abundant HIV 
literature) represent the first stages of inquiry into the links between spirituality and self-
management (particularly medication adherence) in chronic illness. The relationship and 
potential benefits of spirituality to medication-taking behavior requires further study. 
Spirituality and Health 
Although a direct relationship between spirituality and medication adherence has not 
been found, links between spirituality/religiosity and health (e.g., that spiritual beliefs and 
practices may improve general health, benefit specific health outcomes, and facilitate 
health-promoting behaviors in some patients) have been much more firmly established. The 
current increase of interest in the association between spirituality and health and health 
behaviors among lay and research communities is largely due to scientific evidence of 
positive associations.24,34,41,124,160-163 To date, more than 1200 studies have examined clinical 
and epidemiological relationships between spirituality and health and at least two-thirds 
have found significant positive associations.24,29,37,39,55,149,163,164 However, most of these 
studies concern positive associations between religiosity and improved deleterious health 
outcomes;44,165 whereas other researchers attribute the positive and protective affects that 
spirituality exerts on health simply to lifestyle changes.34,37 The following sections describe 
some of the associations found between spirituality and health.  
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Mortality 
For many years, researchers have attempted to demonstrate the importance of 
spirituality in long life and decreased mortality rates.162,166,167 It has often been revealed that 
spiritual or religious involvement is inversely related to mortality. Such studies, which include 
both cross-sectional and large longitudinal designs,34,46,53,166,168-172 most often use the 
spiritual variable of religious service attendance.162 Other variables include membership in a 
religious congregation, self-reported spirituality or religiosity, frequency of prayer or 
meditation, spiritual well-being (particularly strong senses of meaning/purpose, inner peace, 
and faith)124 and living within a religious or spiritual community.34,162 Inverse relationships 
have been found between spirituality and mortality even after controlling for demographics, 
socioeconomic status, health status, and health behavior variables.34,166,170 Overall, the 
assessment of spiritual factors in mortality research has resulted in significant results that 
show a favorable effect of spirituality on survival.163  
Physical and Mental Health 
Research has also linked spirituality to physical and psychological well-being along 
with other health-related outcomes.39,40,173,174 Such connections seem to be stronger in older 
patients and patients with severe, terminal, or chronic illnesses.33,175 As in the spirituality and 
mortality research, most of these studies have used measures of religiosity or religious 
involvement; fewer have used other measures of spirituality. This gap has been attributed to 
a greater consensus by researchers about how to define and measure religious 
involvement.29,34   
Some psychiatric researchers claim that spirituality plays a role and is positively 
linked to mental health. Studies of different racial/ethnic populations, in different settings and 
age groups, have shown that spirituality (mostly in the form of religious involvement) is 
related to lower rates of depression, anxiety, suicide, and psychotic disorders.34,38,126,176 
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Since the early 1970s, the number of empirical studies examining the relationship between 
spirituality and mental health has increased dramatically; most have found significantly lower 
rates of depressive symptoms and disorders, improved courses of depression, and less 
anxiety among subjects who identify as spiritual or religious.34,39,127,177,178 These studies, 
which have included longitudinal and randomized control trials, have revealed that a higher 
baseline of spirituality or religiosity predicts fewer depression symptoms and faster 
remission of symptoms at follow-up compared to control participants and recipients of 
secular therapies.38,176 People with chronic and terminal illnesses have reported that their 
spirituality not only mitigates feelings of fear, worthlessness, and hopelessness, but also 
replaces such feelings with a clearer understanding of meaning and increased strength to 
deal with the demands of their health condition(s).164 The general conclusion of well-
conducted scientific investigations into the relationship between spirituality and mental 
health is that higher levels of spiritual involvement and self-rated spirituality positively impact 
psychological well-being.34,38,176 
Cardiovascular Disease 
Spirituality has also been studied in patients with cardiovascular disease,121 the 
leading cause of death in the United States.179 Because adults with heart disease face 
complex physical, psychological, and social stressors resulting from a decrease in general 
well-being and loss of physical functioning,180 qualitative and quantitative research has 
noted that spirituality is important to patients with a range of cardiovascular diseases and 
that these individuals tend to incorporate their spirituality into their disease coping and 
management.37,40,121,164,181 Several observational studies have demonstrated positive 
impacts of numerous expressions of spirituality (e.g., religious involvement, as sense of 
hope, inner peace, feelings of strength, and overall spiritual well-being) on the health 
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outcomes of cardiovascular patients, including adjustment to diagnosis and progression of 
disease.182-185   
Spirituality and Hypertension 
Spirituality has been shown to be important to hypertensive patients, and some 
patients have indicated that they use their spirituality for coping and disease 
management.115 After adjusting for age, ethnicity, sex, education, functional status, BMI, and 
previous blood pressures, spiritual involvement has been specifically associated with lower 
blood pressure and hypertension.34,174,186-190 Because most of these studies have been 
observational, which means that causality cannot be inferred, researchers have posed 
explanations for their positive findings (e.g., the promotion of health-related behaviors, the 
healthful psychosocial effects of spiritual practice, and the beneficial psychodynamics of 
belief systems and faith).189,191 
 For example, preliminary findings from one study192 indicate that religious and spiritual 
participation and practice are beneficial to blood pressure. In the Jackson Heart Study,187,188 
researchers examined the prevalence, awareness, treatment, and control of hypertension 
among 5302 Black participants aged 21 to 94 years and ascertained, in a sub-analysis, 
associations among organized and non-organized religion, religious coping, and daily 
spiritual experiences and participants’ blood pressure.192 Findings revealed that participants 
with more religious activities and participation had significantly lower diastolic and systolic 
blood pressure (77.8 vs. 84.7 mmHg and 137.2 vs. 149.5 mmHg, respectively) after 
adjusting for demographic, sociocultural, and psychological variables. Interestingly, these 
researchers noted that the link between spirituality and blood pressure remained consistent 
even though religious and spiritual subjects were more likely to have higher BMI scores and 
were less likely to take their medications as directed.187,192 Researchers also found that 
people who engaged in religious activities had lower levels of cortisol (a biological marker of 
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stress).192 This finding is similar to others that have linked spirituality to better lipid 
profiles,191,193 glucose control,194,195 and immune function.33,186,191,196,197   
Negative Effects of Spirituality on Health 
There is also a smaller body of literature that has related spirituality (especially 
religious involvement) to negative physical and mental health outcomes or found no 
association between spirituality and improved physical and mental health.34,37,39,54,149,162,198,199 
Such outcomes have also included negative coping behaviors and inappropriate use of 
health services. For example, particularly among older adults, mental health disorders often 
remain undetected (and, therefore, untreated) when people feel that their mental health is 
“unworthy of professional help.”200,201 Older adults who frame and view mental health issues 
as evidence of personal weakness, failure, and spiritual inadequacy also tend to have 
issues with access to and utilization of medical health treatment and services.200,202 Some 
reports indicate spiritual beliefs and practices—particularly in the context of religiosity—can 
negatively affect patients’ health outcomes (e.g., increased anxiety and guilt, lower self-
esteem, and greater psychological distress).56,58,203-205    
More germane to the focus of the present study is research that has found negative 
or no associations between spirituality and blood pressure or hypertension. For example, in 
a longitudinal study (Fitchett et al., 2009) of the relationship between daily spiritual 
experiences (DSES; e.g., a feeling connection to God or transcendent, inner peace) and 
systolic blood pressure and hypertension among 1658 Black and White middle-aged 
women206 DSES neither provided protective effects on blood pressure nor was associated 
with hypertensive status (OR = 0.90, 95% CI 0.42–1.93; OR = 1.03, 95% CI 0.52–2.06, 
respectively). Studies of similar relationships have found negative or no associations 
between spirituality and blood pressure or hypertension.127,195,207,208 Medication adherence 
was not examined or adjusted for, however, in favor of examining the influence of religious 
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affiliation (i.e., service attendance) on blood pressure rather than any broader aspects of 
spirituality. These limitations, and the inconsistent findings about blood pressure, support 
the premise of the current study. 
For some individuals, leading a spiritual life or maintaining a spiritual orientation can 
involve interpersonal struggles and/or struggles with God or the Divine that may have 
important implications for their health and overall well-being.149 Several empirical studies 
have related spiritual struggles to poorer quality of health and longer hospitalizations, as well 
as higher rates of mortality, psychological distress, and suicide.56-58,149,209 Pargament and 
colleagues’ (2001), two-year longitudinal cohort study of 596 patients aged 55 years or older 
who were receiving medical inpatient services at a hospital and VA medical center56 
assessed patients’ positive religious coping and religious struggles in relation to their 
mortality and found that religious struggle was associated with greater risk of mortality (RR 
for death, 1.06; p = 0.02), particularly for patients who “wondered whether God had 
abandoned” them and those who “questioned God’s love” for them (RR for death, 1.28 and 
1.22, respectively). In this study, the magnitude of the effects associated with religious 
struggle was relatively small (from 6% to 10% increased risk of mortality) but remained 
significant even after controlling for demographics and physical and mental health 
variables.56 In another study of medically ill hospitalized older adults, indicators of religious 
struggle (e.g., anger toward God, feeling punished by God) were associated with poorer 
health indicators including number of medical diagnoses (Std. β, 0.15; p < 0.001), ADL 
impairment (Std. β, 0.12; p < 0.01), and cognitive function (Std. β, -0.10; p < 0.01). Results 
of this study also significantly related negative religious coping methods with greater 
depression and lower quality of life.203     
It has been suggested that certain belief systems or spiritual practices may adversely 
affect a person’s health by encouraging avoidance or discontinuance of allopathic 
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treatments, failure to seek medical care, and avoidance of effective preventive health 
measures such as immunizations and blood transfusions.34,39,210 Other people may not 
comply with medical recommendations because they believe that a higher power has 
caused their disease, or that illness in general is the result of bad behavior.211-213 Because 
such convictions can influence self-efficacy or willingness to adhere to chronic disease 
management, these findings cannot be negated in general and especially not for people 
who experience spiritual/religious struggles in relation to their health and behavior or who 
are members of faith groups that hold fatalistic views of health, life, and death. Similarly, 
individuals who rely on faith alone for their healing or endorse prayer as a medical substitute 
experience higher levels of negative outcomes for most chronic diseases.214-217   
The few empirical studies that have indicated certain forms of spirituality negatively 
impact health have mostly focused on religiosity; been conducted on mental health, 
hospitalized, and/or terminally ill patients (as opposed to community-dwelling adults); and 
have not provided sufficient evidence of spirituality’s relationship to medication adherence in 
chronic disease. This information strongly influenced the research focus, population of 
interest, and hypotheses of the present study; moreover, it affirms the necessity of 
extending prior research into the relationship between spirituality and health as well as the 
importance of being mindful of potentially negative findings.  
Summary 
 Medication adherence is a serious public health issue that is extremely challenging in 
older adults with chronic disease. Personal and cultural beliefs may play a role in adherence 
to medications. Spirituality, an important personal/cultural factor in many communities, is 
especially expressed in patients with chronic illnesses. A summary of the literature indicates 
support for the positive effects of spirituality upon health and health behaviors, ranging from 
positively impacting mortality to serving as a resource in chronic disease management. 
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However, negative associations have also been found between spirituality and health, and 
these findings must be considered—especially in light of the possibility of publishing bias 
toward positive findings. 
 Research has clearly shown that many patients rely on a spiritual framework to guide 
them in making decisions, understanding their health condition(s), and increasing their self-
efficacy and coping skills when dealing with chronic disease.26,34,60,158 Given the major issues 
with medication nonadherence in chronic illness, however, it is important for researchers 
and health providers to be cognizant of the role spirituality may play in medication-taking 
behaviors and patients’ adherence or nonadherence to prescribed therapies. As a 
background factor, spirituality has been largely overlooked in prior studies of medication 
adherence, particularly in older adults. This gap is evidenced by the dearth of research on 
the role of spirituality in adherence rates, although the positive associations that have been 
found between spirituality and health outcomes may have resulted from the greater 
adherence of spiritual patients. In order to clarify these relationships in older patients with 
chronic diseases, it is important for clinicians and researchers to understand which aspects 
of spirituality predict better medication adherence or function as barriers.   
Less specifically, recognition and clarification of how spirituality influences 
medication-taking behaviors among older adults with chronic disease(s) is an important part 
of providing patient-centered and culturally appropriate care. For these reasons, the present 
study sought to examine the influence of a range of spiritual dimensions on self-reported 
medication adherence in older adults with hypertension. To our knowledge, this is one of the 
first quantitative studies to examine this relationship in this population. Its findings can not 
only be used to further our understanding of the influence of spirituality on adherence, and 
the beliefs that patients consider important in their health behaviors, they also may help 
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researchers design future studies to further clarify the relationship among spirituality, 
adherence, and chronic disease control.  
Conceptual Model 
 The conceptual model for this doctoral project was adapted from an innovative 
conceptual model proposed by Lewis and Ogedegbe (2008) of possible mechanisms by 
which spirituality may increase medication adherence and decrease blood pressure in 
hypertensive African Americans (Figure 1).26 Although it focuses on spirituality qualified as 
uniquely African American, its developers emphasized that the influence of spirituality on 
adherence may also operate in other minority populations as well as Whites.26 This model is 
largely based on data from small qualitative studies that have suggested a positive 
relationship between spirituality and medication adherence in African Americans. The model 
is also based upon systematic reviews of adherence research that have suggested personal 
beliefs about hypertension and its treatments influence how African Americans manage and 
follow medical recommendations.26,66,108,154-156,218,219 The model includes three dimensions of 
African American spirituality (faith in a transcendent force; relationships with God, others, 
and self; and transformation and consolation) that may work together or independently to 
influence medication adherence in African Americans. The first dimension, faith in a 
transcendent force or higher power, provides direction and guidance for maintaining health, 
which in turn helps patients make positive decisions about adherence to prescribed 
medications. The second dimension (relationships with God, others, and self) involves the 
notion that such relationships provide increased social support that in turn increases self-
efficacy to overcome barriers associated with medication adherence. The third dimension 
(transformation and consolation) provides strength to actively cope with disease and the 
barriers associated with adherence. 
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Mechanisms of Spirituality: Social Support and Active Coping 
 In the literature, there are several mechanisms of spirituality that may help explain its 
positive impacts on health and health behaviors. In particular, social support and active 
coping have been suggested to facilitate the importance and benefits of spirituality in health 
and health-promoting behaviors.26,61,79,99,167,220-222 Some researchers have found that spiritual 
beliefs and practices tend to improve social support and coping skills across many chronic 
diseases, especially in vulnerable populations.43,119,151,194,221,223,224  
The link between spirituality and social support appears in studies that have 
significantly related measures of spirituality to larger social networks and to 
tangible/instrumental and emotional support.225-228 Social support has also been shown to 
mediate the relationships between a number of spiritual dimensions and health outcomes 
(e.g., lower psychological distress, increased life satisfaction, improved quality of life, 
enhanced coping, reduced levels of pain, and lower rates of mortality).169,226,229 It is generally 
accepted that spiritual participation, especially public spiritual involvement, can facilitate 
social support by providing avenues for increased social contact and development of close 
social bonds outside the nuclear family. Particularly in older adults, researchers have 
observed that spiritual/religious involvement often provides a close network of family, 
friends, and others with similar values and experiences who provide support in times of 
stress and during decision making about health.223 These support networks have been 
found to offer positive assistance that facilitates or promotes healthy lifestyle behaviors, 
protects health, and aids recovery from illness in older adults.228 
Social support has also been associated with medication adherence in older adults 
with chronic illnesses.108,230-234 A study of Medicare enrollees with histories of hypertension 
revealed perceived social support to be associated both with following physician instructions 
on how to take medications and not forgetting to take medications (adjusted OR = 0.51; 95% 
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CI, 0.35–0.76).85 Other studies have found similar associations across various health 
conditions,11,67,235 which suggests that the involvement of others in providing knowledge, 
offering reminders, and giving other types of support may help to overcome barriers to 
medication adherence.85 
Active coping, another proposed mechanism by which spirituality positively impacts 
health in chronically ill people,229,236-240 refers to the strategies whereby “individuals accept 
and actively attempt to deal with” their illness and other stressors related to health 
problems.224,240 It is generally accepted that active coping, in contrast to avoidant or 
maladaptive coping, is the most adaptive response to stress; as such, it includes strategies 
such as problem solving, planning, and seeking emotional and tangible/instrumental 
support.224 Active coping is primarily perceived as positive because it involves effectively 
reframing stressful situations (e.g., health challenges) to lessen the impact of stressors.241-243 
Active coping has also been associated with patient adherence to treatment across 
numerous health conditions.244-247 Patients with multiple chronic conditions must balance 
many priorities and make daily decisions about illness management; these tasks become 
even more complicated for older adults who suffer from multiple health conditions that may 
interrupt normal routines, diminishes finances, affects psychological well-being, and even 
creates situations of dependency.34,43,45 In the face of such obstacles, not only do many 
people rely on their spiritual beliefs but they also tend to cope more effectively than those 
without spiritual beliefs.38,43,243,248-250   
 Studies have shown spiritual beliefs and practices to be significantly and positively 
correlated with active coping, even after controlling for health status and demographic 
variables.224,240,251,252 A survey of 330 hospitalized medical patients aged 60 and over 
revealed that 90% reported using religion to cope, at least to a moderate extent,253 and that 
more than 40% indicated their religious faith was the most important factor that enabled 
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them to cope.253 Chronically ill patients with greater reliance on spiritual beliefs are more 
likely to use an active coping style in which they accept their illness and try to deal with it 
positively and purposefully.39,226 
Because social support and active coping have been shown to be attributes of 
spirituality and also to influence health outcomes and behaviors,39,224,226 it is important to 
investigate whether social support and active coping are mechanisms through which 
spirituality influences medication adherence. For this reason, another aim of the present 
study is to examine whether social support and active coping mediate the relationship 
between spirituality and medication adherence in the target population. 
 Although Lewis and Ogedgbe (2008) noted that their conceptual framework is a 
complex paradigm that warrants additional study, its use in the present study is appropriate 
as a way to clarify whether aspects of spirituality positively influence adherence. Figure 2 
presents an adapted version of this framework as the basic conceptual model of the present 
study, whose interest and primary objective was to examine characteristics of spirituality 
(i.e., organized and non-organized religious activity, spiritual health locus of control beliefs, 
and self-ranking of spirituality) and their possible relationships to medication adherence. 
These spiritual characteristics, which were chosen in an effort capture the dimensions of 
spirituality described by Lewis and Ogedegbe, include the premise that spirituality may 
increase patients’ social support and active coping that function as resources for 
overcoming some barriers (e.g., limited personal control over chronic illness) associated with 
medication adherence. Spirituality may work in conjunction with these two attributes to 
influence adherence, or it may have a more proximal or direct impact. For the purposes of 
clarification, the present study also sought to explore the effect of spirituality on blood 
pressure after adjusting for self-reported adherence, social support, and active coping as 
potentially confounding and/or explanatory variables. Given that the conceptualization of 
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spirituality may be similar across races/ethnicities, both Whites and Blacks were included as 
subjects in the present study. 
 
 
 
 
 
 
 
Figure 1. Conceptual Model of Spirituality and Medication Adherence for African 
Americans Diagnosed with Hypertension (Lewis & Ogedegbe, 2008) 
 
Adapted from; Lewis, L and Ogedegbe, G. Understanding the Nature and Role of Spirituality in 
Relation to Medication Adherence; Holistic Nursing Practice, Sept/Oct 2008. 
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Figure 2. Conceptual Model of the Present Study 
 
Adapted from Lewis, L and Ogedegbe, G. (2008) Understanding the nature and role of spirituality in 
relation to medication adherence. Holistic Nursing Practice, Sept/Oct 2008. 
 
 
  
 
 
 
 
CHAPTER 3 
METHODS 
Overview 
  The present study examined the influence of spirituality on medication adherence 
and blood pressure in community-dwelling White and Black older adults with hypertension in 
a two-phase process. The first phase (Aim 1) involved a pilot study of a sub-sample of 
hypertensive patients (N = 62) who were already enrolled in a larger study (i.e., the parent 
study). The performance of three spiritual/religious measures were examined in relation to 
medication adherence. Enacting the first aim involved selecting the spiritual measure(s) to 
be used for hypothesis testing (Aims 2 and 3). Selection of the spiritual measure(s) for the 
project’s second phase consisted of examining their reliability, comparing their observed 
effect sizes, and estimating sample sizes in order to sufficiently power the larger study. 
Description of the methods for each phase is presented below as follows: the results of 
Aim1 (the pilot study), and then the methods and results of aims 2 and 3.  
Aim 1 Methods (Pilot Study) 
Aim 1: To assess three spiritual measures and select the measure (based on internal 
consistency, association with adherence and sample size efficiency) to test the 
hypothesis that spirituality is positively associated with medication adherence. 
Description of Parent Study  
 Data for Aim 1 (the pilot study) was collected as part of an ongoing parent study 
conducted by researchers at the UNC-Eshelman School of Pharmacy (Effects of a 
Medication Management Program on the Quality of Medication Use in Older Adults, IRB 
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Study #10-0874). Aim 1 was conducted using 62 hypertensive patients selected from the 73 
participants in the parent study, which was a prospective, longitudinal study of the feasibility 
and effectiveness of a clinical pharmacist-led medication management program in improving 
the quality of medication use in Black and White older adults. In the parent study, patients 
were seen three times (baseline, 3, and 6 months) at a community-based, academically 
affiliated clinic, by one of two study pharmacists. As per the parent study protocol, baseline 
assessment consisted of meeting with a research assistant and a subsequent interview with 
the assigned clinical pharmacist. During the baseline assessment visit, the research 
assistant (RA) collected self-reported information on the participants’ demographics, health 
literacy, functional status, and medication management. Following this assessment, patients 
met with the study pharmacist who collected detailed information about medical history, 
current health status, medications, and adherence behavior and also provided medication 
management services.  
 For the purposes of the present study, three measures were added to the parent 
study at the baseline assessment and collected by the RA in order to explicate the 
significance of spirituality and/or religiosity in the study subjects and the relationship of these 
qualities to subjects’ medication adherence. The additional measures were the Duke 
University Religion Index (DUREL), the Spiritual Health Locus of Control Scale (SHLCS), 
and a one-item measure of overall self-ranking of spirituality (or spiritual intensity) which was 
administered along with a newly developed survey. These measures were chosen to 
capture relevant dimensions (i.e., faith in a transcendent force, relationship with God, and 
transformation and consolation) of spirituality described in the framework of the present 
study (Figure 1).26 Scale brevity and cultural appropriateness were strong considerations in 
the selection these measures, in part because many of the spirituality measures in the 
literature contain up to 150 items and because many of the older people in the geographical 
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region (Southeast United States) from which the sample population was drawn experience 
spirituality within the context of religion or religious beliefs. 
 Two additional measures were added to the parent study in order to assess social 
support and active coping as depicted in the conceptual model (Figure 2): an adapted 
version of the Tangible, Informational, Emotional and Social Support (TIES) survey and the 
John Henry Active Coping scale (JHAC12). These were added to report the distribution of 
responses given by participants in the pilot study and to assess the approximate time 
required to complete all the questionnaires. All five of the additional measures are presented 
in the appendices of this dissertation.   
Setting 
The setting for the pilot study was Chatham Crossing Medical Center, a community-
based outpatient physician practice affiliated with the University of North Carolina at Chapel 
Hill and serviced by the UNC Health Care system that provides medical care to a diverse 
population of adults and children with chronic medical conditions and special needs. 
Available services, which include preventive health care, chronic health management, 
same-day sick care, and minor procedures, are provided by seven physicians who 
specialize in Internal Medicine and Pediatrics and serve on the faculty of the UNC 
Department of Medicine and Pediatrics. Approximately one-third of the older adults serviced 
at Chatham Crossing are Medicare-eligible (> 65 years of age).   
Patient Eligibility and Recruitment 
  Patients in the parent study were eligible to participate in the pilot study if they met 
the following criteria: (1) racially identified as Black or White, (2) aged 65 years or older, (3) 
taking at least five medications (prescription, nonprescription, and/or herbal), (4) living 
independently in the community without a terminal illness, (5) English-speaking, and (6) 
under the care of a primary care provider (attending physician or mid-level practitioner) at 
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Chatham Crossing Medical Center. Eligibility criteria for five medications or more was based 
upon verified evidence of older adults’ higher risk of adverse drug events, patient errors and 
nonadherence.254-256 Individuals with cognitive impairments (e.g., dementia or mental 
function deficit) were included in the study with appropriate proxy consent. Patients were 
excluded if they were non-English-speaking, non-community-dwelling, children, pregnant, 
terminally ill, or if their primary care provider at Chatham Crossing was a resident in training 
in the UNC healthcare system.  
 Participants were recruited from referrals by primary care providers at the Chatham 
Crossing Medical Center (as per the enrollment protocol of the parent study). Providers at 
the clinic were given an overview of the parent study and a list of eligibility criteria and asked 
to generate a list of patients who they felt could benefit from medication therapy 
management services; they also referred participants to the medication management 
program based on patient need and medication complexity. Providers who generated lists of 
potential participants left the completed referral forms for the study team in a designated box 
at the clinic at the beginning of the study and at any time during enrollment that they 
identified potential participants. At the end of the enrollment period of the parent study, 
physicians had referred 139 patients for the medication management program; of these, 73 
were eligible and agreed to participate.  
  All referred patients were entered into the study database, which tracked everything 
from the point of referral through enrollment. Using WebCIS (the UNC Health Care System 
electronic medical record database), the RA verified that referred patients met study 
eligibility criteria. Next, eligible patients were mailed a letter from their provider at Chatham 
Crossing that informed them of the study as well as a forthcoming phone call from study 
personnel at the UNC Eshelman School of Pharmacy. A total of three calls were made 
within one week of the mailing date of the invitation letter; after three with no response, an 
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individual was considered to be unreachable.  When the RA was able to contact an eligible 
individual by phone, s/he described the study in greater detail, confirmed eligibility criteria, 
and invited participation. At the time of the call, patients were at liberty to decline 
participation in the study.  If the patient expressed interest in participating, the RA arranged 
a meeting with the RA and a clinical pharmacist at the clinic for consent and baseline 
assessment.  
Baseline Study Visit 
The baseline assessment comprised meeting with the RA and then being 
interviewed by the clinical pharmacist. All interviews were conducted in a designated private 
examination room at Chatham Crossing Medical Center. 
Visit with the RA 
At the beginning of the initial meeting, the RA described the study and explained the 
informed consent document. After the individual or proxy provided written, informed consent, 
the RA administered a series of measures (Table 1) that included patient demographics, 
health literacy, functional status, spirituality, social support, and active coping. 
The RA collected demographic information (e.g., age, marital status, gender, 
race/ethnicity, education, primary health care provider, and specialist physicians) from the 
patient and/or proxy using the demographic questionnaire designed for the parent study and 
then asked patients to complete the following self-report surveys/questionnaires: 
 Duke University Religion Index (DUREL)257 (Appendix 1) 
 Spiritual Health Locus of Control Scale (SHLCS)258 (Appendix 2) 
 Self-Ranking of Spirituality259 (Appendix 3) 
 John Henryism Active Coping Scale (JHAC12)260 (Appendix 4) 
 Tangible, Informational, Emotional Social Support Survey (adapted version of 
TIES)261 (Appendix 5) 
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Prior to the administration of each survey, the RA read its instructions aloud. Then 
the RA stepped away (usually into the hallway outside the exam room) to allow the patient 
to complete each survey on his/her own or with help from his/her proxy. However, the RA 
did ask each patient whether he/she needed assistance with reading and completing the 
surveys. If the participant had visual impairment or requested assistance, the RA read each 
survey item aloud, solicited a response, marked the patient’s response, and then repeated it 
aloud to ensure that it had been documented properly. All other participants read, answered, 
and marked their own responses. Only 4 participants needed assistance from the RA or 
proxies.   
Visit with the Clinical Pharmacist 
 Immediately after the baseline visit, each patient was interviewed by the clinical 
pharmacist, who collected information about income, health/disease conditions, number of 
medications, medication-taking behavior, and medication adherence, and entered this 
information onto the Baseline Comprehensive Medication Review Form that had been 
designed for the parent study. This transcription was preceded by a thorough review of each 
patient’s electronic medical record by the same pharmacist, using WebCIS. The information 
contained in these medical records, which included medical history, laboratory values, and 
other pertinent health history, helped the pharmacist to verify information given by the 
patients during their interviews and in and formulating her assessment of their medication 
use and medication-related problems. 
 All of the information gathered during the medication review was documented by the 
clinical pharmacist on the parent study’s Baseline Comprehensive Medication Review Form, 
which included the 4-item Morisky Compliance Assessment scale (Appendix 6). The parent 
study assessed adherence in three ways: 1) pharmacist clinical assessment, 2) the Morisky 
instrument, and 3) patient self-reports of adherence on each medication, from 0% to100% 
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(visual analog scale). However, for the purposes of the pilot study (Aim 1), the Morisky 
Compliance Assessment Scale was used to assess overall medication adherence. The 
Morisky Compliance Scale262 is a self-reported, 4-item measure of medication-taking 
behavior over the previous 4 weeks (Appendix 6).   
 The Morisky Compliance Scale was chosen over the other two measures of 
adherence used in the parent study after careful consideration. The clinical pharmacist’s 
assessment and self-reported adherence via visual analog was not judged to be ideal 
because both assessed adherence to each prescribed medication, which made it difficult to 
calculate a composite score of adherence. In the parent study, the clinical pharmacist 
marked whether a participant was adherent to a specific medication, based on the 
pharmacist’s clinical assessment, with ‘Yes’ or ‘No.’ For the visual analog scale, participants 
indicated the percentage (0% to 100%) that best reflected his/her compliance to each 
medication that had been prescribed during the previous 4 weeks. The focus of analysis for 
the pilot study (Aim 1) was the subset of hypertensive patients from the parent study rather 
than a specific hypertension medication type, in order to use as much of the sample as 
possible from the parent study (N = 73). Given the small sample size of the parent study and 
the inability to obtain an overall composite score for these measures, the 4-item Morisky 
scale was determined to be most efficient.  
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Description of Measures 
This section describes the measures that were administered and utilized for Aim 1. 
Table 1. Outline of Measures Administered at Baseline  
Measure 
Demographics 
Health literacy (s-TOFHLA) a,b               
Functional statusb 
Spirituality/Religiosity (DUREL; SHLCS; Self-
Ranking of Spirituality) 
Active coping (JHAC12) 
Social support (TIES) 
Comprehensive medication review 
Adherence  
Assessment of quality medication Useb 
Health services utilizationb 
Baseline 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Conducted by 
RA 
RA 
RA 
RA 
RA 
RA 
Pharmacist 
Pharmacist 
Pharmacist 
Pharmacist 
a This measure was given to the proxy if the participant had a documented diagnosis of cognitive impairment 
or dementia. 
bThese measures were used in the parent study but not the pilot study. 
 
Measures 
 Demographic Questionnaire: Age, race/ethnicity, gender, marital status and education 
were obtained for each patient during the baseline visit by the RA, using the parent 
study’s demographic questionnaire. Other patient information (e.g., number of 
medications and health conditions) was collected by the clinical pharmacist during the 
baseline assessment and was recorded on the parent study’s Baseline Comprehensive 
Medication Review Form.  
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 Duke University Religion Index (DUREL): The Duke University Religion Index 
(DUREL)257 (Appendix 3) is a widely used five-item measure, divided into three 
subscales, that assesses organized religious activity (frequency of attending religious 
services), non-organized religious activity (frequency of praying, meditating, or studying 
religious text) and intrinsic religiosity (internalization of and commitment to religious 
practices and beliefs). The five single items measure organizational and non-
organizational religiosity; the three-item subscale measures intrinsic religiosity. Items in 
the subscales are scored on a five-to-six-point Likert-type scale. The overall scale has 
been shown to have high test-retest reliability (intra-class correlation = 0.91), high 
internal consistency (Cronbach’s α = 0.78–0.91) and high convergent validity with other 
measures of religiosity (r’s = 0.71–0.86); DUREL’s factor structure has been 
demonstrated and confirmed in separate samples by different investigative teams.39,257   
 Spiritual Health Locus of Control (SHLCS): The Spiritual Health Locus of Control 
Scale (Appendix 2) is a 13-item, two-dimensional scale that assesses active and passive 
spiritual health locus of control beliefs. It was adopted from Holt and colleagues (2003, 
2007).160,258,263 Item responses are scored on a four-point Likert-type scale that ranges 
from strongly disagree (1) to strongly agree (4). The SHLCS is an expanded scale based 
largely on the concepts of Rotter’s (1966) social learning theory;264 previous work was 
done with other locus of control measures (the Health Locus of Control Scale,265 the 
Multidimensional Health Locus of Control Scale,266 and the God Locus of Control 
Scale267) of internal and external locus of control beliefs found to be predictive of health-
related behaviors and outcomes.258,263 On the SHLCS, Cronbach’s α for the active 
dimension (11 items) ranges from 0.78 to 0.89 and from 0.56 to 0.76 for the passive 
dimension (2 items).258,263,268 The active spiritual dimension was found to be positively 
correlated with the internal dimension of the Multidimensional Health Locus of Control 
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(MHLC) Scale266 and negatively associated with the external dimension, whereas the 
passive spiritual dimension was found to be positively associated with the external 
dimension.258,263 The SHLC subscales have demonstrated significant predictive validity, 
evidenced by negative correlations between the passive spiritual dimension and 
knowledge about mammography, breast cancer and breast cancer treatment, and 
mammography utilization.258 From a theoretical standpoint, spiritual health locus of 
control beliefs are thought to be predictive of health-related behaviors or outcomes. This 
measure is being further evaluated in various populations by the developers and for 
confirmation of its factor structure. 
 Self-Ranking of Spirituality: Overall self-ranking of spirituality (i.e., perceived level of 
spirituality) is a one-item assessment of spiritual intensity that asks participants to rate 
the extent that they consider themselves to be spiritual/religious. Responses range from 
4 (very spiritual/religious) to 1 (not spiritual/religious at all). This item was adopted from 
the Brief Multidimensional Measure of Religiousness/Spirituality (BMMRS) developed by 
a panel of experts on spirituality and health research at the Fetzer Institute and the 
National Institute on Aging259 and has been included on numerous spiritual surveys in 
combination with other spiritual measures; it has also been used as a single-item 
measure of spirituality.259,269 Self-ranking of spirituality has been correlated with other 
spiritual domains in health research, including daily spiritual experiences, 
spiritual/religious practices and beliefs, and positive spiritual coping.259,270 This item was 
administered along with a newly developed tool, which will be used for further 
development and future analysis (Appendix 3).    
 John Henryism Active Coping Scale (JHAC12): Active coping was assessed using 
the John Henryism Active Coping Scale (Appendix 4).260 This measure was used in the 
pilot study to describe the distribution of responses from the study sample about coping 
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and to assess feasibility of administration. The JHAC12 is a 12-item Likert-type scale 
consisting of statements that assesses a person’s behavioral or personality 
predisposition to persistently and actively cope with difficult psychosocial stressors and 
barriers; its active coping score is the sum of the values assigned to each of the 12 
responses, which range from 1 (completely false) to 5 (completely true). Possible total 
scores range from 12 to 60, with higher scores indicating a greater John Henryism trait 
(or predisposition to actively cope). Higher scores (i.e., those above the study’s sample 
median) predict mental and physical vigor, tenacity, and a strong sense of personal 
efficacy when confronted with stressors/barriers.260,271 The JHAC12 has been examined 
with other psychometrically validated coping and psychosocial measures. Evidence 
supports its validity and reliability among both Black and White Americans, and similar 
patterns of correlations have been found for these subgroups in other psychosocial 
measures.271,272 In these populations, the JHAC12 has been found to be correlated with 
the active coping and suppression of competing activities subscales of the COPE 
Inventory273 but negatively correlated with the Marlowe-Crowne Social Desirability 
Scale,274 which demonstrates support for convergent validity.271 In addition, the JHAC12 
has been shown to be positively correlated with the Life orientation Test (LOT),275 which 
assesses individual differences in generalized optimism versus pessimism.271 
Discriminant validity for the JHAC12 as an active coping scale has been demonstrated 
by its lack of correlation with the emotion-focused subscales of COPE, which are related 
to venting emotions and mental disengagement. Confirmatory factor analysis of JHAC12 
has suggested two similar and meaningful factors among Blacks and Whites that consist 
of two dominant themes: commitment to succeed through hard work, and personal 
efficacy.271  Reliability coefficients for the JHAC12 from community-based adult samples 
range from the low 0.70s to the low 0.80s. As discussed in Chapter 1, active coping 
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behaviors have been positively associated with spirituality and patient adherence across 
numerous chronic health conditions; moreover, the JHAC12 has been positively 
correlated with spirituality/religiosity, health behaviors, and life satisfaction.276,277 For 
aims 2 and 3, active coping was assessed in relation to spirituality, medication 
adherence, and blood pressure.  
 Social Support with Medications and Health: Social support was assessed using a 7-
item questionnaire (Appendix 5) to describe the distribution of responses from the study 
sample about social support for health issues and obtaining medications as well as to 
assess feasibility of administration. The questionnaire consisted of 6 questions adapted 
from the 16-item Tangible, Informational and Emotional Social Support Survey (TIES),261 
with one additional question (“Is there someone, other than your doctor, you could turn 
to for general advice regarding your medications?”). The six questions that were 
abstracted from the original 16-item TIES Survey (a reliable and valid social support 
survey) were items that specifically relate to support with medications and health; the 
original survey was developed to measure the types of social support that are necessary 
in cardiovascular disease prevention and management. For validation of the original 
TIES survey, researchers used the Medical Outcomes Study Social Support Survey 
(MOS)278 because it includes a broad range of items on tangible, information, and 
emotional support that are more specific to the social support needs of medically ill 
patients. Exploratory factor analysis revealed a four-factor solution that accounted for 
54% of total variance and correlated with the tangible (r = 0.77 and r = 0.51), the 
emotional/informational (r = 0.80), and positive social interaction (r = 0.60) subscales of 
the MOS. Scores on the original TIES have been correlated with the total scores on the 
MOS (r = 0.82).261 For the purposes of the pilot study, the adapted seven-item 
questionnaire was used to assess patients’ level of support with obtaining and taking 
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their medications. Item responses ranged from 0 (none of the time) to 2 (all or most of 
the time), with higher scores indicating more support with medications. Although this 
adapted version of TIES has not been validated, it was used in the pilot study (Aim 1) for 
descriptive purposes to report the distribution of responses and to help estimate the time 
of administration, taking into account the various questionnaires that were to be 
administered in the larger study (aims 2 and 3).  
 Baseline Comprehensive Medication Review (BCMR) was conducted by the clinical 
pharmacist during the baseline assessment and documented on the Medication Review 
Form used in the parent study. It consisted of the patient or proxy presenting all current 
medications (prescription, nonprescription, complementary, and alternative) to the 
clinical pharmacist and the clinical pharmacist reviewing each medication, inspecting 
their containers, and discussing/recording (1) medical conditions and related information, 
(2) information on all medications (e.g., strength, directions, indication, use), (3) 
medication-taking behaviors, (4) medication allergies and adverse drug events, (5) 
method of payment for medications, including prescription drug insurance or assistance, 
(6) the dispensing pharmacy, (7) use of medication adherence aids (e.g., pill boxes, 
medication calendars), (8) estimated out-of-pocket spending per month on medications, 
(9) number of prescribers, and 10) additional medication-related information provided by 
the older adult or his/her caregiver as per the protocol of the parent study. For Aim 1 of 
the present study, data were taken from the medication review form for descriptive 
purposes and included number of chronic medical conditions, number of current 
medications, prescription drug insurance coverage, and yes-or-no answers to “Was 
there a time in the past 6 months when you needed prescription medication but could 
not purchase it because of the cost?” 
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 Morisky Compliance Assessment Scale: For Aim 1, medication adherence 
(dependent variable) was evaluated using the Morisky instrument262 (Appendix 6), which 
assesses medication-taking behavior over the previous 4 weeks. Morisky is a four-item 
scale that asks: (1) Do you ever forget to take your medicine?, (2) Are you careless at 
times about taking your medicine?, (3) When you feel better do you sometimes stop 
taking your medicine?, and (4) Sometimes if you feel worse when you take the medicine, 
do you stop taking it? Its score is calculated by assigning one point for each answer of 
“no” and zero points for each answer of “yes.” Patients answering “yes” to one or more 
questions are viewed as possibly having problems with medication adherence.262 The 
Morisky scale has been shown to be reliable (Cronbach’s α = 0.61) and to demonstrate 
both concurrent and predictive validity,262 but it does not capture behavior for specific 
medications. This measure is a general assessment of adherence and is not disease or 
medication-specific. It was selected for its feasibility, considering that the data for Aim 1 
was collected in the context of a larger study. 
Data Collected and Variables 
  Data for Aim 1 was taken from the participants’ baseline visit with the RA and clinical 
pharmacist, using the measures described in the previous section. Table 2 presents the key 
variables, measures, sources, and their type or range. 
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Table 2. Variables Used in Aim 1  
Variable Measure Sourcea Type/Range Definition 
Dependent Variable 
Medication 
adherence 
Self-report Morisky 
(4-item) 
Scores range 
from 0 to 4 
1 = adherent 
0 = non-adherent 
(Scores < 4 
defined as 
nonadherent) 
Overall adherence to meds 
over past 4 weeks  
Nonadherence: Yes for > 1 
items on Morisky 
Compliance Scale. 
Key Independent Variables (Spirituality/Religiosity) 
Organized 
religious 
activity (ORA) 
Self-report DUREL 1 = High ORA 
0 = Low ORA 
Frequency of religious 
service attendance.  
High = (> few times/mth) 
Non-organized 
religious 
activity (NORA) 
Self-report  DUREL 1 = High NORA 
0 = Low NORA 
Frequency of private 
religious activity.  
High = (> two times/week) 
Intrinsic 
religiosity (IR) 
Self-report DUREL 1 = High Intrinsic 
0 = Low Intrinsic 
Internalization/commitment 
to beliefs. Scores at median 
or higher on the IR 
subscale will be ‘High IR.’ 
Scores below median will 
constitute low. 
Active spiritual Self-report SHLCS 
 
 
1 = High Active  
0 = Low Active  
Involves idea that God 
empowers self-care; both 
God and self are 
responsible for health. 
Responses: 4 (Strongly 
Agree) to 1 (Strongly 
Disagree) 
Passive 
spiritual 
Self-report SHLCS 
 
 
1 = High Passive 
0 = Low Passive 
Involves idea that God has 
control over one’s health. 
Responses: 4 (Strongly 
Agree) to 1 (Strongly 
Disagree) 
Self-ranking of 
spirituality 
Self-report 1-item measure 
 
 
Recoded: 
1 = High  
0 = Low/No  
Overall perceived 
spirituality via a 1-item 
measure asking “To what 
extent do you consider 
yourself a spiritual/religious 
person?” Responses: 4 
(very spiritual) to 1 (Not 
spiritual) 
Control Variable  
Race/ethnicity Self-report  0 = Black 
1 = White 
Collected at baseline 
assessment by the RA  
Patient Characteristics (variables used for descriptive purposes)  
Gender Self-report 
 
Demographic 
form of parent 
study 
0 = Male 
1 = Female 
Collected at baseline 
assessment by the 
Research Assistant  Age Continuous 
Education Categorical 
Difficulty paying 
for meds in 
past 6 months? 
Comprehensive 
Medication 
Review 
Categorical 
0 = No 
1 = Yes 
Collected at baseline 
assessment by the 
PharmD.  
No. of 
medications 
Chart/Med 
Record 
Comprehensive 
Medication 
Continuous Documented by PharmD 
and verified electronically 
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Review medical records review 
Social support 
 
 
Self-report TIES (adapted) 1 = High Support 
0 = Low Support 
Scores at median or higher 
on the adapted TIES 
measure will be ‘high social 
support’. Scores below 
median will constitute low. 
Active coping 
 
 
Self-report JHAC12 1 = High Active  
0 = Low Active  
Scores > median connotes 
‘high active coping’. Scores 
< median constitute low.  
aSource acronyms: Morisky (Morisky Compliance Assessment scale); DUREL (Duke University Religion Index); 
SHLCS (Spiritual Health Locus of Control scale); TIES (Tangible, Informational, Emotional, Social Support scale); 
JHAC12 (John Henryism Active Coping scale) 
 
Definition of Dependent Variable 
Medication Adherence: Adherence was measured using the Morisky self-report 
questionnaire that was administered during the baseline assessment with the clinical 
pharmacist. Response scores were recoded and dichotomized to “adherent” and “non-
adherent,” where a score < 4 was categorized as non-adherent to medication regimen(s). 
That is, nonadherence was defined as a “yes” answer to one or more of the four questions 
on the Morisky scale. Adherent to medications was defined as a “no” answer to every 
question (score = 4). Patients who answered “yes” to one or more of the Morisky items were 
viewed as possibly having problems with medication adherence.262  
Definition of Independent Variables  
Spirituality/Religiosity: To capture spirituality/religiosity, subscales from three different 
measures were used: the Duke University Religion Index (DUREL), the Spiritual Health 
Locus of Control Scale (SHLCS), and the one-item measure of overall self-ranking of 
spirituality. From the DUREL, organized religious activity (ORA), non-organized religious 
activity, (NORA), and intrinsic religiosity (IR) were measured. The ORA subscale asks 
participants to indicate how often they attend church or other religious meetings; responses 
range from “never” to “more than once/wk.” The ORA variable was dichotomized as high 
ORA (attendance > few times a month) and low ORA (< a few times a year). The NORA 
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subscale asks participants how often they spend time in private religious activities, such as 
prayer, meditation or Bible study. The NORA variable was dichotomized to high NORA (> 
two times/week) and low NORA (< once a week). The IR subscale is measured with three 
items on the DUREL that ask participants to mark the extent to which each of the following 
statements is true or not true: “In my life, I experience the presence of the Divine (i.e., God); 
“My religious beliefs are what really lie behind my whole approach to life”; and “I try hard to 
carry my religion over into all other dealings in life.” Item responses range from definitely 
true (4) to definitely not true (0). Total scores on the IR subscale were dichotomized at the 
sample’s median to categorize participants into high and low intrinsic religiosity groups. 
These subscales have previously been dichotomized in the literature.   
  The Spiritual Health Locus of Control Scale measures active spiritual (11 items) and 
passive spiritual beliefs (2 items). Item responses for these subscales range from 4 (strongly 
agree) to 1 (strongly disagree). Each of these variables was recoded to be dichotomous. 
Total scores for both the active and passive spiritual dimensions were dichotomized at the 
sample’s median to categorize participants into the high and low spiritual groups. Currently, 
there is no established cut-off score for the active and passive subscales; in previous work 
the scores have been both measured continuously and dichotomized at a median split 
(however, a median split in one sample does not necessarily correlate to another –thus, the 
scoring system was reevaluted for the main study for meaningful cut-offs).160,279,280 (Dr. 
Cheryl Holt, personal communication, February 16, 2011). This measure is being further 
evaluated by the developers for confirmation of its factor structure and for establishment of 
the scale’s scoring scheme. 
  Self-ranking of spirituality: A categorical variable measured from a one-item 
question that asks participants to what extent they consider themselves to be 
spiritual/religious. Responses range from 4 (very spiritual/religious) to 1 (not 
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spiritual/religious at all). This variable was recoded to be dichotomous: high spirituality (1) 
and low spirituality (0). High spirituality consisted of responses of either 4 (highly 
spiritual/religious) or 3 (moderately spiritual/religious) and low spirituality consisted of 
responses of either 2 (slightly spiritual) or 1 (not spiritual at all).   
 All of the following variables were collected by the research assistant on the 
demographic form during the baseline assessment, except where noted. 
Control Variable: (only one, due to small sample size of pilot study)  
Race: Two-category variable indicating the best description of the participant’s self-reported 
racial/ethnic background (either Black or White).  
Patient characteristics. The following patient characteristics were examined for descriptive 
purposes in the pilot study. These characteristics were considered as potential control 
variables to be used in analysis for the larger study (aims 2 and 3).  
Gender: This two-category variable (male or female) was taken from the demographic form 
of the parent study.  
Age: A continuous variable indicating the participant’s age in years at the time of the 
baseline assessment. 
Education: A seven-category variable ranging from the highest grade or year of school 
completed (postgraduate work) to “never attended school or only attended kindergarten.” An 
additional category included a response of “refuse to answer.”  
Total number of prescribed medications: Continuous variable measured on the BCMR 
(of parent study) by the clinical pharmacist. Total number of medications included any 
herbals, vitamins, and over-the-counter medications approved by the participants’ 
prescribing physician(s).  
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Difficulty paying for medication: Two-category variable (yes/no) indicating whether the 
participant needed prescription medication over the past six months but could afford it, taken 
from the BCMR completed by the clinical pharmacist. 
Social support with medications: Measured from items adapted from the TIES survey and 
consisting of three categories that indicate how often the participant has sufficient support 
with health and medication-taking. Support includes anyone other than the participant’s 
primary health care provider. Responses to the items include “all or most of the time,” “some 
of the time,” and “none of the time,” with corresponding item scores of 2, 1, and 0, 
respectively. Responses to all seven items were summed to create a total social support 
score ranging from 0 to 14 and were recoded as dichotomous (high or low support). Total 
scores for this adapted version of TIES were dichotomized at the sample’s median which 
was a score of 11.  The TIES measure has previously been dichotomized at a median split 
by the developers.281  However, this was an adapted version of the orginal TIES, and use of 
this unvalidated version and its scoring scheme was further considered for the main study 
(aims 2 & 3). 
Active coping: Dichotomous variable indicating high and low active coping, measured via 
the John Henryism Active Coping scale (JHAC12), a 12-item self-report measure. The active 
coping score is the sum of the values assigned to each of the 12 responses. In keeping with 
the methodology proposed by the developers and other researchers who have used the 
JHAC12 measure, scores were dichotomized at the sample median, which was a score of 
50 for the pilot study, to categorize respondents into “high” and “low” active coping 
groups.260,271,282-284   
  
50 
Aim 1 Analysis 
Overview  
 Results from Aim 1 helped determine the spiritual variable(s) that were used in aims 
2 and 3 (to test for the association between spirituality and medication adherence and 
spirituality and blood pressure, respectively). A cross-sectional analysis of data collected 
during the baseline visit (i.e., the spirituality/religiosity surveys, social support and active 
coping measures, patient demographics, and adherence behavior) was conducted. Prior to 
conducting analyses, three criteria were determined as the basis for selecting the primary 
spiritual measure to use in the larger study. It was also determined a priori that these criteria 
would be examined collectively. However, the ultimate decision for selection of the measure 
would be based on sample size efficiency. 
 Criteria for selecting the key spiritual variable(s) for hypothesis testing involved 
examining (1) the internal consistency of the different spiritual instruments and comparing 
these instruments to the one-item self-ranking of spirituality measure, (2) the odds ratios 
(effect sizes) of each spiritual variable on adherence, and (3) the required sample sizes for 
each spiritual variable, based on the effects observed in the pilot study. A threshold of 0.70 
was set for the internal consistency criterion. A Cronbach’s α value greater than 0.70 is 
generally desired and typically connotes acceptable overall scale reliability in the medical 
and social science fields.285,286 If all measures had acceptable reliability, the observed effect 
sizes (odds ratios) in relation to adherence would be the next determining factor. Given that 
this was an exploratory study, it was of interest to examine which spiritual measure 
produced the largest detectable effect in relation to adherence. Although a test of 
significance of the spiritual measures in relation to adherence was not of primary concern 
given the pilot’s small sample, it was considered an added benefit. Overall, sample size 
efficiency was of the upmost importance in the selection process. Due to the limited 
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resources for this project, a sample size that would yield adequate power and would be 
feasible for primary data collection was considered essential. 
Statistical Analyses  
For Aim 1, the outcome variable was medication adherence as measured by a 
validated self-report instrument.262 The independent spiritual variables were (1) organized 
religious activity, (2) non-organized religious activity, (3) intrinsic religiosity (all measured via 
DUREL); (4) the active spiritual and (5) passive spiritual dimensions of the SHLCS; and (6) 
the 1-item self-reported spiritual/religious measure (Table 2). Given the small size of the pilot 
study, race was the only control variable used in the logistic regression analyses. 
Racial/ethnic differences in medication adherence have been observed across various 
chronic conditions,84,85,287 where Blacks have been shown to be less adherent than Whites; 
accordingly race has been suggested as one of the strongest and most consistent predictors 
of adherence (even within elderly populations).82,84,90,288-290 Although race was used as the 
main control variable in the pilot study’s analyses, other patient characteristics (age, gender, 
education, number of medications, and difficulty obtaining medications due to cost) were 
examined for descriptive purposes and to explore as potential covariates for the larger 
study. These characteristics were selected a priori because they have been suggested to be 
correlates of medication adherence in older populations, although this suggestion has not 
been consistently verified.19,21,82,103,290-294 
All data were entered into the study database using Microsoft Access and cleaned 
for missing or nonsensical values prior to analyses. Next, data were converted to STATA 11 
(StataCorp LP, 2009) for analyses. Descriptive statistics were calculated for all variables.  
Bivariate relationships with medication adherence were examined using chi-square statistics 
for categorical variables and t-tests for continuous variables. Chi-square statistics were 
calculated for the cross-tabulation of adherent versus nonadherent patients and categorical 
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variables. Standard two-tailed t-tests were conducted to test the association between 
adherent versus nonadherent patients and the continuous variables. Because of the small 
sample size of the pilot study, no definitive conclusions about significance of these analyses 
were made. Bivariate relationships were not assessed to draw meaningful conclusions from 
the results themselves but rather to examine the trends and potential impact of the spiritual 
variables on medication adherence.  Results were examined to assess whether the 
adherence outcome differed across the spiritual variables. Logistic regression models were 
conducted to examine, after adjusting for race, how each spiritual variable was related to 
whether patients reported being adherent to their prescribed medications.   
In the multivariate analyses, five separate logistic regression models were 
constructed to examine the relationship between the spiritual variables and adherence while 
adjusting for race: three regressions for the DUREL subscales, one regression for the two 
SHLCS dimensions, and one model for the one-item overall self-ranking of spirituality 
measure. DUREL’s developers do not recommend summing all three subscales into a total 
overall religiosity score but instead suggest that investigators examine each subscale score 
independently in separate regression models to prevent subscale scores canceling out each 
other’s effects.257 The dimensions of the SHLCS have previously been run in the same 
model to control for the effects of each dimension (Dr. Cheryl Holt, personal communication, 
February 16 and March 8, 2011).160,258,263,268 The one-item overall self-ranking of spirituality 
variable was run as its own regression model while controlling for race.   
  After obtaining the logistic regression estimates of the spiritual variables on 
adherence while controlling for race, sample size estimations were generated from power 
analysis using SAS 9.2 (SAS Institute Inc, Cary, NC). To power the larger study, selection of 
the spiritual measure(s) that were used as the independent variables for hypothesis testing 
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in aims 2 and 3 was based on examination of the performance of each measure, the effects 
observed in relation to adherence, and the feasibility of the sample size.  
Aim 1 Results: Pilot Study 
Overview 
The pilot study was conducted to determine the spiritual variable(s) to be used in 
aims 2 and 3. Because Aim 1 helped inform the design of the larger study, the pilot study 
results (descriptive statistics, bivariate analyses, and logistic regression models predicting 
medication adherence) are presented prior to the description of method for aims 2 and 3. 
They are based upon the hypertensive patients enrolled in the parent study.  
Descriptive Data: Characteristics of Hypertensive Patients  
Because older adults with hypertension were the population of interest for hypothesis 
testing in aims 2 and 3, patient characteristics for the subset of hypertensive patients (N = 
62) for the pilot study are presented in Table 3. A total of 73 older adult participants enrolled 
in the parent study; of these, the majority (62, 85%) had hypertension. The mean age of this 
subset was 75.0 (SD = 6.4); 58% were women; and 29% identified themselves as 
Black/African American. The majority were married and highly educated, and most had had 
high active coping and social support scores. The mean number of chronic health conditions 
was 8 (median = 8.5) and the mean number of medications was 14 (median = 13). Only one 
(1.6%) hypertensive patient answered “yes” to the question “Was there a time in the past 6 
months when you needed prescription medication but could not purchase it because of the 
cost?”. In addition, only two patients reported lacking prescription drug coverage at the time 
of consent. Fifty-seven percent of patients were nonadherent to prescribed medications 
(score < 4 on Morisky four-item). The most common reasons for nonadherence were 
forgetting to take medicines (82.9%) and occasional carelessness (37.1%). 
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Spiritual characteristics of the study sample are presented in Table 4. When patients 
were asked to rank their spirituality, 46 (74%) reported being moderately to very 
spiritual/religious; 35 (56%) attended church (or other religious meeting) a few times a 
month or more; and 10 (16%) reported never attending church or religious meetings. Half of 
the patients reported spending time in private prayer or meditation two or more times a week 
and 21 (34%) patients reported rarely or never spending time in private religious activities. 
The majority of patients (37, 60%) had high intrinsic religiosity. On the intrinsic religiosity 
subscale, the majority (71%) reported that their religious beliefs underlie their whole 
approach to life and 73% reported carrying their beliefs over into all other dealings in life. 
Similarly, more than half (56%) had high active spiritual locus of control beliefs and only 
17% had high passive spiritual locus of control beliefs.
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Table 3. Characteristics of Hypertensive Patients (N = 62) in Aim 1 
 
 Characteristics     Characteristics 
Hypertensive sample (N = 62) 
No. (%) unless otherwise specified 
Age, mean (std. deviation), range 75.0 (+ 6.4), 66–92 
Women 36 (58.1)  
Race   
 Black 18 (29.0) 
 White 44 (71.0) 
Marital status   
 Never married 3   (4.8) 
 Married 39 (62.9) 
 Widowed 16 (25.8) 
 Divorced  3   (4.8) 
 Separated                         1   (1.7) 
Education  
 Grades 1-8 (Elementary) 4   (6.5) 
 Grades 9-11 (Some high school) 5   (8.1) 
 Grades 12 or GED (High school grad) 10 (16.1) 
 College 1 to 3 years (some college) 23 (37.1) 
 College 4 years (College graduate) 11 (17.7) 
 Postgraduate work 9 (14.5) 
No. of medications, mean (range) 14.1 (5–30) 
No. chronic conditions, mean (range) 8.3 (3–14) 
Could not purchase Rx b/c of cost                                                                 1   
(1.6) 
Chronic health conditions  
 Hyperlipidemia 46 (74.2) 
 Diabetes 30 (48.4) 
Active coping score, mean (std. deviation), range 49.3 (7.0), 23–60 
 Low active coping (< 50, median score) 27 (43.6) 
Social support, mean (std. deviation), range 10.4 (3.5), 1–14 
 Low social support (< 11, median score) 27 (43.5) 
aAdherence (score 4 = adherence)  
 Adherent (scored 4 on Morisky) 27 (43.6) 
 Non-adherent (scored < 4 on Morisky)   35 (56.5) 
  
aBecause this patient population had pre-existing medication-related issues,  adherence was coded  
strictly with a cutoff of 4 on the Morisky (score < 4 =nonadherent).  
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Table 4. Spiritual Characteristics of Patients (N = 62) in Aim 1  
  
Characteristic Frequency (%) 
  
Self-ranking of spiritualitya  
 High (moderately to very spiritual/religious) 74.2 
 Low (not at all to slightly spiritual/religious) 25.8 
  
ORA (frequency of church attendance)b  
 > a few times per month 56.5 
 < a few times per year 43.6 
  
NORA  (private religious activity, e.g., prayer, meditation)b  
 (> two times/week) 50.0 
 (< once/week) 50.0 
  
Intrinsic (internalization of and commitment to religious beliefs)b  
 High (> 10, sample median) 59.7 
 Low (< 10, sample median) 40.3 
  
Active spiritual (God empowers one to take healthy actions)c  
 High (> 28, sample median) 55.8 
 Low (<28, sample median) 44.2 
  
Passive spiritual (God or higher power is in control of health)c  
 High (> 4 score on 2 items) 17.3 
 Low (< 4 score on 2 items) 82.7 
  
aOne-item measure of the extent participants consider themselves spiritual/religious. bDUREL subscale.  
cSHLCS; sample totals (active and passive spiritual) are < 62 due to missing data. The SHLCS instrument was 
administered after the study had begun and 12 patients had been enrolled, so SHLCS was administered to only 
52 patients. 
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Bivariate Results 
Table 5 shows the differences in spiritual variables and patient characteristics by 
adherent and nonadherent patients.  Overall, no significant differences in adherence were 
found by whether patients had high or low scores across the spiritual variables (i.e., ORA, 
NORA, intrinsic religiosity, self-ranking of spirituality, active and passive spiritual locus of 
control beliefs).  The percentage of patients who had high intrinsic religiosity and reported 
being adherent was similar to the percentage who had low intrinsic religiosity and were 
adherent (43.2% vs. 44.4%). Notably, a higher percentage of patients who self-reported high 
spirituality were adherent compared to those who reported being slightly or not at all spiritual 
(50% vs. 25%). Similarly, 48% of the patients who had high active spiritual locus of control 
beliefs reported being adherent compared to 39% of patients who reported having low active 
spiritual health locus of control beliefs and being adherent. A higher percentage of patients 
with high passive spiritual locus of control beliefs reported being adherent than those with 
low passive spiritual beliefs who were adherent (56% vs. 42%).  
No significant differences across age, race, gender, or education were found in the 
pilot study in terms of patient adherence. However, those reporting being adherent were 
slightly older (mean age = 76.7 vs. 73.7 years). A higher percentage of females than males 
reported being adherent (47.2% vs. 38.5%) and a higher percentage of Whites than Blacks 
reported being adherent (50% vs. 27.8%). Furthermore, a higher percentage with less than 
a college education reported being adherent than those with some college or more (57.9% 
vs. 37.2%). 
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Table 5. Medication Adherence (Morisky Score of 4 = Adherent) by Spiritual Variables 
and Characteristics of Patients with Hypertension (N = 62) in Aim 1 
  Medication Adherencea 
 
 
Variables 
Adherent (n=27) 
Frequency (%) 
Nonadherent (n=35) 
Frequency (%) 
p 
value  
Spiritual independent variables    
DUREL (N=62)    
ORA (church attendance)    
 High (> few times/mth) 16 (45.7) 19 (54.3) 0.70 
 Low (< few times a year) 11 (40.7) 16 (59.3)  
NORA (private prayer)    
 High (> 2 times/week) 13 (41.9) 18 (58.1) 0.80 
 Low (< once a week) 14 (45.2) 17 (54.8)  
Intrinsic (commitment to beliefs)    
 High (> 10, sample median) 16 (43.2) 21 (56.8) 0.95 
 Low (< 10, sample median) 11 (44.4) 14 (56.0)  
    
1-Item measure of spirituality (N=62)    
Self-ranking of spirituality    
 High (moderately to very spiritual) 23 (50.0) 23 (50.0) 0.07b 
 Low (slightly to not spiritual at all)   4 (25.0) 12 (75.0)  
    
SHLCS (N=52)c (n=23)c (n=29)c  
Active spiritual locus of control  Spiritual Life & Faith    
 High (> 28, sample median)   High (SA or A to 2 of 3 items) 14 (48.3) 15 (51.7) 0.51 
 Low (< 28, sample median)    Low (SD or D to majority items)   9 (39.1) 14 (60.9)  
Passive spiritual locus of control    
 High (> 4 score of 2 items)   High (SA or A to 2 of 3 items)   5 (55.6)   4 (44.4) 0.45b 
 Low (< 4 score of 2 items)    Low (SD or D to majority items) 18 (41.9) 25 (58.1)  
    
Patient characteristics (N = 62)    
 Age, mean (std dev) 76.7 (6.3) 73.7 (6.3) 0.06 
 Race    
  Black   5 (27.8) 13 (72.2) 0.11 
  White 22 (50.0) 22 (50.0)  
 Gender    
 Male 10 (38.5) 16 (61.5) 0.49 
 Female 17 (47.2) 19 (52.8)  
 Education    
 Less than college 11 (57.9)   8 (42.1) 0.13 
 Some college or more 16 (37.2) 27 (62.8)  
 No. of medications, mean (std dev) 13.4 (5.6) 14.7 (4.8) 0.33 
aSignificance level of the chi-square statistic for categorical variables, two-tailed t-test for continuous 
variables: *p < 0.05. bFisher’s exact test was performed and p-value reported when the cells reached an 
expected frequency of ≤ 5. cTotals for the SHLCS variables are < 62 due to missing data; the SHLCS instrument 
was administered after the study had begun and 12 patients had been enrolled. 
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Internal Consistency of Spiritual Measures 
The internal consistencies (reliability) of the various spiritual instruments were 
examined using Cronbach’s α. This test statistic is used to examine whether several items 
that propose to measure the same general construct produce similar scores (i.e., how well 
the different items hang together). Internal consistency ranges between 0 and 1 and a 
coefficient of 0.70 or higher is acceptable in most social science research.286 Table 6 reveals 
the Cronbach’s α reported in the literature for the validated measures (DUREL and SHLCS) 
and also the Cronbach’s α that were calculated for the different measures (where 
applicable) in this pilot study sample.   
It is not recommended to obtain a single composite score for DUREL and SHLCS257 
(Cheryl Holt (developer), personal communication, February 16, 2011) but rather to explore 
the subscales independently. However, some researchers have used single composite 
scores for these instruments and have reported the Cronbach’s α (Table 6). The α reported 
in the literature for DUREL range from 0.78 to 0.91. For this study sample the DUREL (when 
examined as one scale) had a Cronbach’s α reliability of 0.87, which falls in the range 
reported in the literature.257 For the SHLCS, Cronbach’s α reported in the literature range 
from 0.66 to 0.78 for the active spiritual subscale and 0.51 to 0.76 for the passive 
subscale.258,268,279 The calculated Cronbach’s α for this study sample was a little higher than 
those reported for the active and passive subscales (0.90 and 0.82, respectively). Because 
Cronbach’s α cannot be calculated for individual items, it is not reported for the one-item 
measure assessing overall self-ranking of spirituality. 
 
 
 
 
  
60 
Table 6. Reliability of Spirituality Measures (Cronbach’s α) used in Aim 1 
Measurea Reported α in 
literature 
Calculated α for 
study sample 
DUREL   
 ORA (1 item) + NORA (1 item) 0.57–0.79 0.66 
 Intrinsic religiosity (3 items) 0.75–0.94 0.88 
 Single composite index 0.78–0.91 0.87 
SHLCS   
 Active spiritual (11 items) 0.66–0.78 0.90 
 Passive spiritual (2 items) 0.51–0.76 0.82 
 Single composite index   Blacks = 0.80 
     Whites = 0.89 
0.89 
   
Self-ranking of spiritualityb --- --- 
 Single item  --- --- 
aMeasure acronyms: DUREL (Duke University Religion index); SHLCS (Spiritual Health Locus of Control scale).  
bThe self-ranking of spirituality measure could not be examined for reliability because it is a 1-item measure.  
 
Logistic Regression Models  
Logistic regression was performed to determine the effect of each spiritual variable 
on medication adherence after controlling for race (Table 7). Five separate logistic 
regression models were constructed in order to assess the relationship between each 
spiritual variable and self-reported medication adherence. 
DUREL subscales (ORA, NORA and Intrinsic Religiosity)  
Three separate logistic regression models were performed to examine the 
relationships between (1) organized religious activity and adherence, (2) nonorganized 
religious activity and adherence, and (3) intrinsic religiosity and adherence. Consistent with 
the literature and the recommendations of by the developers of the DUREL instrument, each 
subscale was examined independently in separate regression models to inhibit subscale 
scores canceling out each other’s effects.257 After controlling for race, none of the DUREL 
subscales were significant at the p < 0.05 level. However, a positive relationship with 
adherence was seen for organized religiosity (OR = 1.79; 95% CI 0.58–5.46), non-organized 
religiosity (OR = 1.05; 95% CI 0.37–2.99), and for intrinsic religiosity (OR = 1.41; 95% CI, 
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0.46–4.34), where patients with high religiosity had higher odds of reporting adherence than 
those with low religiosity. 
Spiritual health locus of control subscales (active spiritual and passive spiritual) 
One logistic regression to evaluate the effects of SHLC (active spiritual and passive 
spiritual) on medication adherence included both dimensions while controlling for race; the 
dimensions of the SHLCS have previously been run in the same model to control for the 
effects of each dimension160,258,263,268 (Cheryl Holt, personal communication, February 16, 
2011). To ensure that there were no issues of collinearity when including these dimensions 
in the same regression model, the variance inflation factor (VIF) and tolerance (1/VIF) 
values were examined (a variable whose VIF values are > 10 may merit further investigation 
to rule out linear combination of other independent variables). The VIF and tolerance (1/VIF) 
values for active spiritual were 1.22 and 0.82 and for passive spiritual the VIF was 1.04 and 
the tolerance value was 0.96. These results suggest that no issues of collinearity arise from 
including these dimensions in the same model. 
After controlling for race, neither the active nor passive spiritual locus of control 
dimensions were significant at the p < 0.05 level. However, a positive relationship with 
adherence was seen for the active spiritual dimension (OR = 2.77; 95% CI 0.77–10.04), 
which suggests that patients with high active spiritual locus of control beliefs are more likely 
to report being adherent to their medications. Interestingly, the same trend was seen for the 
passive spiritual dimension, which suggests that patients who believe that a higher power is 
in control of their health are more likely to report being adherent (OR = 2.66; 95% CI, 0.52–
13.52). 
Self-ranking of spirituality   
A separate logistic regression (using the one-item measure of spirituality) was 
performed to evaluate the effect of patients’ self-ranking of their spirituality on medication 
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adherence. After controlling for race, self-ranking of spirituality was significant in relation to 
self-reported adherence (p = 0.04). Patients who rated themselves as highly spiritual had 
higher odds of reporting adherence to their medications than those with low spirituality (OR 
= 4.12; 95% CI 1.09–15.61). 
Estimated Sample Sizes 
Another purpose of the pilot study (Aim 1) was to determine the sample size to 
sufficiently power the study in Aim 2, which tested the hypothesis that hypertensive older 
adults who report being highly spiritual are more likely to report being adherent to their anti-
hypertensive medication(s) than those who report low spirituality. In order to calculate the 
necessary sample size, three values were required: (1) significance level (α), (2) desired 
power, and (3) effect size. The pilot data were used to estimate the population distribution of 
the variables used in the logistic regression models. The β coefficients (estimates) and 
standard errors for each spiritual variable (Table 7) were then used to determine the 
required sample size to test for the effect observed in the pilot study at 80% power and a 
0.05 significance level. It is generally accepted that power should be 0.80 or greater.295 That 
is, there is an 80% chance of finding a significant effect that actually exists. Also, an alpha 
level of less than 0.05 is commonly accepted in most social science fields as statistically 
significant.295 Sample calculations were based on the assumption that the sample in Aim 2 
would be similar to the population distribution of the variables observed in Aim 1 (the pilot 
study). The sample size calculations were performed in SAS 9.2 (SAS Institute, Cary, NC).  
Results of the sample size calculations for the DUREL subscales range from 472 to 
61,343; this is the number of subjects needed to test for the effects observed for organized, 
non-organized, and intrinsic religiosity with a power of 0.80 and an alpha of 0.05. The 
estimated sample sizes needed for the active and passive spiritual subscales from the 
SHLCS were calculated to be 170 and 295, respectively. For the self-ranking spirituality 
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measure, the sample size calculation estimated that a total of 113 subjects would be needed 
to test an odds ratio of 4.12 with a power of 0.80 and an α of 0.05. 
aDUREL: Duke University Religion index; SHLCS: Spiritual Health Locus of Control scale. The logistic models 
consisted of three separate models for the DUREL subscales and a model that contained the two SHLCS 
dimensions; the self-ranking of spirituality measure was run in its own model. bEach logistic regression model 
was adjusted for race. cSignificance level of odds ratio; p < 0.05 was significant. 
 
Table 7. Adjusted Logistic Regression Models for Medication Adherence and Sample Size  
   
Spiritual 
Variablesa 
 
ORb 
 
95% CI 
β  
Estimates (SE) 
 
p valuec 
Sample Size 
(power=0.80, 
α=0.05) 
 
DUREL 
     
 ORA  1.79 0.58–5.46 0.58 (0.57) 0.31    472 
 NORA  1.05 0.37–2.99 0.05 (0.53) 0.93 61343 
 IR   1.41 0.46–4.34 0.34 (0.57) 0.55   1358 
      
SHLCS      
 Active         2.77 0.77–10.04 1.02 (0.66) 0.12    170 
 Passive     2.66 0.52–13.52 0.98 (0.83) 0.24    295 
      
Self-ranking of 
spirituality  
  4.12 1.09–15.61 1.88 (0.84)  0.04    113 
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Selection of Spiritual Measure(s) for Aims 2 & 3 
Table 8 includes a summary of the selection criteria and results of Aim 1 that helped 
inform the design of the larger study. 
Table 8. Summary of Criteria for Selecting Spiritual Measure to Use in Aims 2 and 3 
 
   Criteria 
 
Cronbach’s α 
Calculated 
(literature) 
 
Effect on Adherence 
(odds ratios; 95% CI) 
 
Sample 
Size 
Efficiency 
Measuresa √   
DUREL    
 ORA (1 item) ----  1.79  (0.58–5.46) 472 
 NORA (1 item) ----  1.05  (0.37–2.99) 61343 
 Intrinsic (3 items) 0.88 (0.75–0.94)   1.41  (0.46–4.34) 1358 
 Composite index 0.87 (0.78–0.91)   
    
SHLCS  √ √ 
 Active spiritual (11 items) 0.90 (0.66–0.78)        2.77  (0.77–10.04) 170 
 Passive spiritual (2 Items) 0.82 (0.51–0.76)    2.66  (0.52–13.52) 295 
 Composite index 0.89 (0.80–0.89)   
    
Self-ranking of spirituality   √ √ 
 Spirituality (1-item) ----  4.12  (1.09–15.61) 113 
    
aDUREL: Duke University Religion index; SHLCS: Spiritual Health Locus of Control scale. 
 
The first criterion for selecting the key spiritual variable for hypothesis testing was the 
scales’ reliability. In addition to calculating the Cronbach’s α for the current study sample for 
each spiritual instrument, the literature was reviewed for reported Cronbach’s α for the 
validated measures (DUREL and SHLCS). When examining the internal consistency of each 
spiritual measure, the Cronbach’s α were all above 0.70 which connoted good reliability of 
the items on each scale (in addition to the Cronbach’s α reported in the literature for the 
DUREL and SHLCS subscales). Each measure showed good homogeneity with Cronbach’s 
α above 0.80 for this study sample. Although a Cronbach’s α could not be obtained for the 
one-item self-ranking of spirituality variable, it was examined in relation to the other 
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measures via cross-tabulation; results were comparable and consistent with participants’ 
responses on those measures.  
The second criterion for selecting the key spiritual variable was the observed effect 
of each spiritual variable on adherence in the logistic regression analysis. As 
conceptualized, the high spiritual characteristics (i.e., organized, non-organized, and 
intrinsic religiosity; active spiritual health locus of control beliefs, and self-ranking of 
spirituality) demonstrated a positive trend in relation to adherence for this study sample. The 
smallest effects in relation to adherence were observed for the DUREL subscale measures 
(ORA, NORA, and intrinsic religiosity) with odds ratios ranging from 1.05 to 1.79. This 
relationship may suggest that religious involvement or external expression of spirituality may 
not benefit or determine whether a patient decides to be adherent. Although the spiritual 
health locus of control beliefs were not significantly associated with adherence, they had 
greater observed effects than the DUREL subscales did in that patients who reported high 
spiritual health locus of control beliefs were on average twice as likely to report being 
adherent. These results suggest that the role of God or some Supreme Power in individuals’ 
health may be influential in their decisions to adhere to their prescribed regimens and to stay 
healthy by other means. The largest observed effect, and the only significant association, 
was seen with the one-item self-ranking of spirituality variable: the odds ratio was 4.12 (95% 
CI 1.09–15.61). The confidence interval, which was large for this variable, is most likely due 
to the small sample size. However, these results seem to indicate that the level of perceived 
spirituality is more associated than the other spiritual measures with self-reported 
adherence. 
Sample size efficiency was also a criterion for selection of the key spiritual measure 
used for aims 2 and 3. These sample sizes were calculated based on the effects and 
standard errors observed in the pilot at a significance level of 0.05 and a power of 0.80. The 
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DUREL subscales required the largest and least feasible sample sizes (range 472 to 
61,343) for the purposes of the present study. The most feasible sample size was calculated 
for the self-ranking of spirituality variable; results estimated that a total of 113 subjects would 
be needed to test for the effects observed in Aim 1 at a power of 0.80 and an α of 0.05. The 
next feasible sample size, for the active spiritual locus of control dimension, was 170 
(required). 
Considering these results collectively, the one-item self-ranking of spirituality 
measure was chosen as the key spiritual variable to examine in relation to adherence (Aim 
2) and blood pressure (Aim 3). This variable was chosen after careful consideration because 
it is a concise measure but also, as suggested by the Fetzer Institute and the National 
Institute on Aging, one of the important domains of spirituality for health research.259 In 
addition, the self-ranking of spirituality measure captures the broader phenomenon of 
spirituality in comparison to the other validated measures, allows inclusiveness of both the 
spiritual and religious context of individuals, and allows participants to frame the construct 
within their own experience and to the aspects of spirituality that are relevant for them. For 
example, although the DUREL is a brief instrument, it focuses on religiosity (i.e., outward 
expressions of spirituality). The population of interest for the present study (older adults) 
may be highly spiritual, even if they do not frequently participate in religious activities or 
consider themselves religious, this would inhibit the capture of their overall self-ratings of 
spirituality and its effect on their adherence. In other words, one’s personal awareness or 
perceived spiritual state may be more important to health and behaviors than outward 
expressions of spirituality or connections with a religious group are. Due to the broad and 
inclusive nature of this measure and its relevance to the study population, the one-item self-
ranking of spirituality was judged to be most suitable measure to use as the key spiritual 
variable. 
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Moreover, a basic cross-tabulation of the self-ranking of spirituality measure with 
each of the other spiritual measures showed that self-ranking of spirituality was highly 
related to spiritual practices and beliefs of the older adults in this study. For example, of the 
patients with high ORA, 89% also reported high spirituality. Similarly, patients with high 
NORA and high intrinsic religiosity, and those with high active spiritual locus of control 
beliefs, also reported themselves of high spirituality (94%, 95%, and 86%, respectively). This 
result suggests that perceived spiritual intensity may be a suitable indicator of other spiritual 
characteristics and beliefs or that it may provide a foundation marker for other domains of 
spirituality. 
Finally, the self-ranking of spirituality measure had the largest observed association 
with adherence and the most efficient required sample size. It is important to note, however, 
that the effect (OR = 4.12) observed for the self-ranked spirituality measure was large and 
may be imprecise (or an overestimation of the effect), as evidenced by the large confidence 
intervals. This result may be attributed to the small sample size in the pilot study. Therefore, 
to be conservative and to avoid overestimation, the observed effect size for the self-reported 
spirituality variable was arbitrarily decreased by 10% and 25%. At a decrease of 10%, an 
estimated sample of 133 subjects was needed to maintain a power of 0.80, whereas a 25% 
decrease resulted in a total of 142 subjects to maintain a power of 0.80.  
Although a conservative sample of 142 subjects would provide enough power to 
detect the relationship between the self-ranking of spirituality measure and adherence, 
further consideration was given to this estimated sample size. Because self-ranking of 
spirituality is only a 1-item measure and would provide limited information regarding the 
participants’ spiritual alignment and beliefs, it was believed that the sample size should be 
further increased to include a secondary measure of spirituality.  Inclusion of a secondary 
measure would provide support for the associations observed with the 1-item measure and 
  
68 
additional information regarding the participants’ spiritual beliefs.  Thus, the active SHLC 
subscale was selected as the secondary measure of spirituality to use in the main study, 
and the sample size needed to observe an effect on that instrument was estimated to be 
170.  Thus, the sample size of 142 was further increased to account for the inclusion of this 
second instrument. Furthermore, both the primary and secondary measures aligned with the 
definition of spirituality used for this study and did not solely focus on religiosity or worship 
service attendance as has been most often used in prior studies examining spirituality in 
relation to health and behaviors.         
Thus, it was determined that 170 community-dwelling older adults with hypertension 
would be surveyed for aims 2 and 3. These samples were estimated to provide sufficient 
power to test the association between the self-ranking of spirituality measure and self-
reported adherence and to allow for control variables other than race (e.g., social support 
and active coping) in the regression analyses. In addition, the active dimension of the 
validated SHLCS was chosen as a secondary measure of spirituality. Results from the 
power analysis revealed that 170 subjects were required to detect the effect observed for 
the active spiritual dimension of this scale; in addition, this measure yielded the second-
largest association with adherence in the pilot study. Therefore, a sample size of 170 
subjects was chosen to allow the inclusion of additional control variables and to include a 
secondary measure of spirituality while maintaining a power of 0.80.   
Summary of Other Study Findings  
 Several other findings from the pilot project (Aim 1) helped inform the design of the 
larger study (aims 2 and 3). Descriptive results indicated that the pilot sample was well 
educated and that only one patient had been unable to purchase medication. Nonetheless, 
approximately 57% of the patients reported being nonadherent to their prescribed 
medications—a result that suggests other patient-level factors than access or 
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socioeconomic status may have influenced the adherence of patients in this study 
population. Similar results have been seen in the work of other researchers who found 
differences in adherence even after access to care and cost of medications were 
minimized.90,287,290,296 It is important to note that the large percentage of patients who 
reported being non-adherent may be related to the type of patients who were enrolled in the 
parent study upon which Aim 1 (the pilot study) was based. The subjects of the parent study 
consisted of older patients who were referred to clinical pharmacists by their primary health 
providers for medication therapy management (MTM) services based on patient need and 
medication complexity. Furthermore, although the study sample consisted of patients with 
hypertension, the adherence measure (4-item Morisky instrument) was not specific to 
antihypertensive medications, which means that results may have been affected by patient 
reports of nonadherence to other medications (including acute therapies). Therefore, it was 
determined that a more specific and reliable measure of adherence should be used for aims 
2 and 3. 
With regard to the spiritual characteristics of the study sample, most of the patients 
(74%) reported being very to moderately spiritual and more than half (56%) believed that 
God empowers them to enact healthy behaviors or take an active role in their own health. 
The high spiritual culture found in this study sample is consistent with the distribution norms 
reported in the literature for the southern region of the United States and for patients who 
are chronically ill.25,39,162,168,257,297-299 Although no significant relationships were found 
between the spiritual variables and adherence in the bivariate analyses, a higher percentage 
of patients with high spiritual characteristics (organized, non-organized, and intrinsic 
religiosity; self-reported spirituality, and active spiritual locus of control) reported being 
adherent to their regimens than patients with low spiritual characteristics. This trend is 
consistent with the project hypothesis that spirituality is positively associated with 
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adherence. Although no definitive conclusions can be drawn, these results strongly suggest 
that certain aspects or benefits of spirituality positively impact adherence in some patients. 
For example, patients who are more spiritual may use their spirituality to manage and cope 
with the demands taking chronic medications—much as previous studies have associated 
positive spiritual coping strategies with better health outcomes and other health-promoting 
behaviors.241,242,269,300,301  
 Self-ranking of spirituality was the only spiritual variable associated with adherence in 
the logistic regression analyses. After adjusting for race, patients who reported being 
moderately to very spiritual were more likely to be adherent to their medications than those 
who reported being slightly or not at all spiritual (95% CI 1.09-15.61). This result is 
consistent with the study hypothesis and corroborates previous studies that have shown 
positive associations between higher levels of spirituality and health promoting-
behaviors.34,39,123,137,269 For example, Mellins and colleagues (2009) used a similar measure 
of spirituality in a study of HIV-infected adults with both psychiatric and substance abuse 
disorders, with the main objective of examining factors associated with adherence to 
antiretroviral medications. In that study, researchers asked participants to rate on a 4-point 
Likert-type scale their level of spirituality/religiosity and found that lower self-reported 
spirituality was one of the factors significantly and consistently associated with 
nonadherence. The HIV-infected adults who reported high spirituality had better adherence 
to their antiretroviral medications than those who reported low spirituality (OR range 1.47–
1.92; p < 0.01).269   
 Patient characteristics that would be used as control variables in the larger study were 
the last group of variables to be considered. The majority of the patients in the pilot study 
had high active coping and high social support scores (both are established 
attributes/benefits of spirituality). That most of the patients reported high spiritual 
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characteristics may explain the high perceptions of social support and positive coping 
strategies, and upholds the conceptual framework for the present study.26 In bivariate 
analyses, none of the demographic characteristics were significantly associated with self-
reported adherence; however, patients who reported being adherent were slightly older, 
female, and White—all characteristics that have been noted in the adherence 
literature82,103,290,292,302 and shown to be significantly related to spirituality.39,228,303,304 
Therefore, age, race, and gender were considered important demographic characteristics to 
include in the analysis of the larger study.  
Conclusion 
 The present study began with a limited examination of spiritual measures in relation to 
medication adherence among a sample of older adults with hypertension. The main purpose 
of this pilot study (Aim 1) was to select a suitable spiritual measure to use in examining the 
relationships between spirituality and adherence and the effect of spirituality on blood 
pressure (aims 2 and 3). The criteria for selecting the spiritual measure consisted of 
examining and comparing the reliability of the instruments, assessing which spiritual 
measure(s) had the largest detectable effect on adherence, and determining the sample 
size (using the effects observed in the pilot study) that would be feasible for conducting 
hypothesis testing.   
 Results revealed that each spiritual measure had fairly good homogeneity with a 
Cronbach’s α > 0.80. In addition, as conceptually hypothesized, each spiritual measure 
demonstrated a positive trend in relation to adherence. However, after adjusting for race in 
the logistic regression analysis, the one-item self-ranking of spirituality measure yielded the 
largest and only statistically significant effect on adherence and required the most feasible 
sample size that had been calculated in the power analysis (the next feasible sample size 
was calculated for the active SHLC measure). According to the results from this pilot study 
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and its relevance to the population of interest, it was determined that self-ranking of 
spirituality would be the key measure used in the larger study to examine in relation to 
adherence and blood pressure, and the active SHLC would function as a secondary 
measure. A conservative sample size of 170 community-dwelling older adults was 
calculated for the larger study to maintain a power of 0.80 as well as to allow for the 
inclusion of additional control variables and the second spiritual measure. The following 
sections describe the methods and results, and present a discussion of aims 2 and 3 (the 
second phase of the present study). 
Aims 2 & 3 Methods 
 Aim 2: To examine the relationship between spirituality and self-reported medication 
adherence among community-dwelling older adults with hypertension. 
Hypothesis 2:  
 Older adults who report high spirituality versus those who report low spirituality 
are more likely to report being adherent to their anti-hypertensive medication(s).  
 Older adults with high active spiritual health locus of control (SHLC) beliefs 
versus those with low active SHLC are more likely to report being adherent to 
their anti-hypertensive medication(s). 
Aim 2a: To examine the relationships among spirituality, social support, active 
coping, and self-reported medication adherence in community-dwelling older adults 
with hypertension.  
Hypotheses 2a: 
 Spirituality is positively associated with self-reported medication adherence, 
and this association is mediated through social support and active coping. 
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Aim 3:  To examine the relationship between spirituality and blood pressure among 
community-dwelling, older adults with hypertension. 
 Hypothesis 3: 
 Older adults who report high spirituality will have lower systolic and diastolic 
blood pressures compared to older adults who report low spirituality. 
Overview 
  The study hypotheses for aims 2 and 3 were tested by conducting a cross-sectional 
study of a sample of community-dwelling older adults with hypertension. This study involved 
administering surveys on spirituality, social support, active coping, and medication 
adherence behavior to a convenience sample of 170 older adults visiting senior community 
centers in the Triangle area of North Carolina.  Demographic characteristics and two blood 
pressure measurements were also collected from each participant. Data collection began in 
September 2011 and recruitment/enrollment of participants ended February 2012. The 
University of North Carolina Institutional Review Board (IRB) approved this study.  
Study Setting  
Participants were recruited from local senior community centers in the Research 
Triangle Park region of North Carolina. The center directors were contacted to obtain 
approval to solicit older adults who attend the center(s) for recruitment/enrollment. Four 
senior centers agreed to participate and they were located in the cities of Chapel Hill, 
Hillsborough (near Chapel Hill), Raleigh, and Garner (near Raleigh).   
These senior center settings were targeted because the centers serve older adults 
from diverse socioeconomic and racial/ethnic backgrounds and are open to the general, 
independently living, older adult population aged 55 years and older. These centers were 
deemed feasible and efficient for capturing older adults who would be able to spend 
approximately 45 minutes completing the questionnaires. Senior centers in North Carolina 
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are community facilities that provide services and activities that meet the skills, interests, 
and needs of the older adult population. These services range from fitness and health 
promotion to job training. The centers also provide engagement opportunities for older 
adults through regularly scheduled programs, volunteer opportunities, and other activities, 
which makes them focal points for their attendees. Most of the centers provide 
programs/activities at no cost or for a minimal fee, as well as scholarships. According to a 
report prepared for the Division of Aging and Adult Services by the N.C. Department of 
Health and Human Services: “The principal goals of senior centers are to improve seniors’ 
access to services that support independence in their later years, to provide a community 
setting for continuing engagement in meaningful activities, and to serve as a launch pad for 
advocacy about issues important to seniors.”305   
Targeting older adults at senior community centers rather than other settings such as 
medical clinics and/or hospitals was considered advantageous for several reasons. First, 
this population of older adults tend to live and function independently and are therefore more 
likely to be responsible for managing their own medications with minimal to no assistance. 
By contrast, clinics and/or hospitals may afford a sicker population of older adults who may 
already be receiving specialty care and assistance with their health and managing their 
prescribed medications. Second, targeting senior centers lessened recruitment challenges 
by eliminating the need to train and depend on medical staff to invite older adults to 
participate, and also because the reasons that older adults might be visiting medical clinics 
could include situations and/or conditions that could have influenced their survey responses. 
Finally, choosing senior centers throughout the Triangle area provided a racial, ethnic, and 
socioeconomically diverse sample because the site coordinators at the senior centers 
indicated that their clients are diverse in these areas.  
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Because the centers are open public spaces for seniors, actual demographic data is 
unavailable. However, the centers’ coordinators and resource directors for seniors provided 
general characteristics of the seniors who participated in several health and wellness 
programs in 2012. The two centers in Orange County served more than 9,000 seniors in 
2012. Approximately 69% were female, 71% were > 65 years, and about 81% reported 
having a high school diploma or more. Most of the attendees were White (74%), with 13% 
identifying as Black and 12% as Other. The two Wake County centers served approximately 
13,000 seniors in 2012. Of these, 84% were > 65 years, 74% female, 58% White, and 29% 
Black. About 69% reported a high school diploma or higher. Exact income demographics 
were not available for the four centers, but approximately 7% of each center’s clientele were 
below the 100% poverty level (based on the numbers of older adults who attended the free 
lunch programs). Overall, the centers’ older adult attendees were demographically similar to 
older adults across the state and in Orange and Wake counties. The seniors in Orange 
County, however, reported a higher average level of education.306  
Participant Eligibility and Recruitment/Enrollment   
 
Older adults were eligible for the study if they: (1) self-identified as being Black or 
White, (2) were age 65 years or older, (3) had been told by a health provider that s/he has 
hypertension, (4) reported taking at least one anti-hypertensive medication, (5) reported 
living independently in the community (not in a hospice, nursing and/or assisted housing 
facility), (6) were English-speaking and able to read or understand English, and (7) agreed 
to sign a consent form. Individuals were excluded if they had participated in the pilot phase 
(Aim 1), as were individuals who were unable to give consent without a proxy. Because the 
target population was older adults, pregnant women and children were also excluded. Older 
adults were actively and passively recruited from the four senior community centers. The 
study was consistently advertised and introduced as “a project conducted by UNC 
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Eshelman School of Pharmacy to understand what is important to older adults when it 
comes to their health and taking their blood pressure medicines.” Thus, all participants were 
blinded to the study questions and hypotheses. 
Upon approval from the IRB and the senior centers, flyers advertising the study and 
containing contact information for the principal investigator (PI) were given to center staff, 
placed in the centers’ newsletters, and posted in the centers’ common areas. Flyers 
(Appendix 11) were also distributed at the centers’ special events and health programs (e.g., 
health fairs, informational sessions, and health screenings). At these events the senior 
centers’ program coordinators distributed flyers, announced the study, and collected contact 
information from interested older adults for a referral list (Appendix 12) that was provided to 
the PI after each program or event. If the PI was not at the site when the program 
coordinator collected the contact information, the referral list was put in a sealed envelope 
and kept in the office of the site’s coordinator until the PI returned. After the PI obtained the 
contact information, she contacted each potential participant by phone to invite participation 
using a conversation flow detailed in the study’s telephone script (Appendix 13). Within two 
weeks of this contact, interested, eligible individuals met with the PI at a mutually agreed-
upon time at the senior center for consent and enrollment. If an older adult on the contact list 
was not interested, his/her name and telephone number was deleted with a black 
permanent marker. After all potential participants had been called, the list was shredded and 
discarded.   
A total of 76 potential participants were contacted via the referral lists from the four 
senior centers. Of these, 58 were eligible and agreed to participate. The exact participation 
rate cannot be determined, however, because it was difficult to track and account for the 
individuals who dropped by the study area for additional information as well as the groups 
who were approached and invited to participate but declined (during active recruitment, 
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many groups of three to six older adults approached the researcher and expressed interest 
in the study).   
In addition to these recruitment strategies, the main recruitment method involved the 
PI directly and actively recruiting older adults at the senior centers by waiting in the common 
areas and approaching attendees as they entered or exited. For this purpose, the PI 
arranged to be at the senior centers on alternating days and weeks. Eventually, 
appointments for enrollment were set for interested participants at each of the senior 
centers, which made recruitment and enrollment easier. The recruitment/enrollment 
schedule for the centers is shown in Table 9. 
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Table 9. Recruitment/Enrollment Schedule for the Senior Centers 
 Month 1 
 Days Time Senior Centers 
Weeks 2 & 3 Monday & Thursday 8 am–3 pm Center 1 (Orange County) 
Tuesday & Wednesday 
Friday 
9 am–5 pm 
 
9 am–3 pm 
Center 2 (Wake County) 
 
Center 3 (Wake County) 
Weeks 4 Monday & Tuesday 9 am–3 pm Center 4 (Orange County) 
 Monday & Thursday 
 
Wednesday 
 
Friday 
5:30 pm–7 pm 
 
9 am–5 pm 
 
9 am–5 pm 
Center 1 (Orange County) 
Center 2 (Wake County) 
 
Center 3 (Wake County) 
Month 2  
    
Weeks 1 & 2 Monday & Thursday 9 am–3 pm Center 1 (Orange County) 
Tuesday & Wednesday 9 am–3 pm Center 2 (Wake County) 
Saturday 10 am–1 pm Center 1 (Orange County) 
Weeks 3 & 4 Monday & Thursday 9 am–2 pm Center 3 (Wake County) 
 Tuesday & Wednesday 
 
Wednesday 
9 am–2 pm 
 
2:30 pm–5 pm 
Center 2 (Wake County) 
 
Center 3 (Wake County) 
 Saturday 8 am–12 pm Center 1 (Orange County) 
Month 3 
     
Weeks 1 & 2 Mon, Thurs & Friday 9 am–3 pm Center 3 (Wake County) 
 Tuesday & Wednesday 9 am–5 pm Center 4 (Orange County) 
Weeks 3, 4, 5 Monday  9 am–2 pm Center 1 (Orange County) 
 Tuesday & Wednesday 
 
Thursday & Friday 
9 am–5 pm 
 
9 am–5 pm 
Center 2 (Wake County) 
 
Center 3 (Wake County) 
 
Months 4 & 5: (Open for enrollment appointments. Revisited sites (i.e., Garner and 
Seymour) that had the most traffic. 
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  After an older adult was identified or demonstrated an interest in the study, the PI led 
him or her to the private study area within the center and confirmed eligibility with the first six 
questions on the Demographic Questionnaire (Appendix 7). Next, the PI provided the 
participant with the study objectives and the potential benefits of the research findings. After 
consent had been obtained, the PI immediately assigned the participant a subject number 
(1–170) and wrote it at the top of each study questionnaire. The study visit occurred on the 
same day consent was obtained and usually lasted 30–45 minutes. 
The study visit began with the PI obtaining two blood pressure readings, as per the 
procedures outlined in the Blood Pressure Measurement Protocol (Appendix 14), and the 
remaining demographic information. Prior to collecting the two blood pressure 
measurements, the PI had no knowledge of how participants would respond or perform on 
the study questionnaires because only demographic information had been collected at this 
point. This was to eliminate bias in the blood pressure measurements. 
After collecting the blood pressure and demographic information, participants were 
then provided with the study documents and instructions for completing the other 
questionnaires, which included self-reported assessments of medication adherence to their 
high blood pressure therapy, spirituality, social support, and active coping. To minimize 
social desirability issues and for privacy, a closed drop-box was hung in each study station 
for the participants’ completed questionnaires. For privacy reasons, the PI stepped away 
from the study station while each participant completed his or her questionnaires.  
The PI assessed whether each participant needed assistance with reading and 
completing the surveys by asking, “Are you able to complete this survey on your own, or do 
you need me to help you complete it?”. If the participant had vision impairment or literacy 
issues, the PI read each survey item aloud, solicited a response, marked the response, and 
then repeated it to ensure that it had been documented properly. The PI enacted this routine 
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only for participants with literacy issues or visual impairment. All other participants read, 
answered, and marked their responses independently for each of the survey measures and 
placed the completed documents in the drop-box. The PI documented when assistance was 
given, along with the reason, on those participants’ demographic questionnaires. 
At the end of the study visit, each participant was given a multipurpose, lightweight, 
recyclable tote bag and a pill box as tokens of appreciation. Copies of informational 
brochures from the NIA about cardiovascular health, hypertension, and the importance of 
medication adherence were available for the participants to take away in their tote bags. All 
study materials were removed daily from the senior center sites and taken to the Cecil G. 
Sheps Center at the University of North Carolina at Chapel Hill for entry into the secure 
study database. Hard-copy study files were secured in a locked file cabinet, in a secure 
private office at the center. 
Data Collected and Variables 
To maximize the response rate, each study questionnaire was given and collected by 
the PI on the same day the patient was enrolled into the research study and all data were 
collected from these questionnaires. The study questionnaires were self-report surveys of 
participants’ demographic background, spirituality, social support, active coping, and 
medication adherence. The PI collected information from the demographic questionnaire 
before asking the participant to complete the following questionnaires: 
1) 8-item Morisky Medication Adherence Scale (MMAS-8) (Appendix 8); 
2) Visual Analog Scale for Medication Adherence (VAS) (Appendix 9);  
3) Tangible, Informational, Emotional Social Support Survey (Appendix 10); 
4) Self-Ranking of Spirituality (Appendix 3); 
5) Spiritual Health Locus of Control Scale (SHLCS) (Appendix 2); 
6) John Henryism Active Coping Scale (JHAC12) (Appendix 4). 
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Table 4 lists the key variables, measures, and sources, along with their type or range 
for this study. Most measures are only briefly described here as they are revisited from Aim 
1 and are in the appendices). The only measures not repeated from Aim 1 are the 
demographic questionnaire and the original validated TIES instrument (social support 
measure); in addition, a medication adherence measure specific to hypertension 
medications was used for greater reliability. A visual analog scale was also administered as 
a global measure of adherence to hypertension medications (for future research). 
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Table 10. Variables Used in Aims 2 and 3 
Variable Sourcea Type/Range Definition 
Dependent Variable 
Medication 
Adherence 
8-item MMAS 
(Morisky) 
 
1 = High adherence  
0 = Low adherence  
Self-reported adherence to anti-
hypertensive meds; scores range from 0 to 
8. A score >6 connoted high adherence and 
low adherence consisted of scores <6. 
Blood Pressure  
  
Demographic 
Questionnaire  
Continuous 
 
Average of two blood pressures taken at 
the time of consent (systolic and diastolic).  
Key Independent Variables 
Self-ranking of 
spirituality 
(primary spiritual 
measure) 
 
Self-ranking of 
spirituality  
 
 
1 = High 
Spirituality 
 
0 = Low/No 
Spirituality    
Sspiritual intensity: 1 item  measure asking 
“To what extent do you consider yourself a 
spiritual/religious person?” Responses: 4 
(very spiritual) to 1 (not spiritual at all). 
Scores of moderately to very spiritual 
constituted high spirituality. 
Active Spiritual 
Health Locus of 
Control  
(secondary spiritual 
measure) 
SHLCS  
1 = High Active  
0 = Low Active  
Active spiritual health locus of control 
beliefs. Involves idea that God empowers 
one to take care of self; both God and self 
take a responsibility in health. Responses: 4 
(Strongly Agree) to 1 (Strongly Disagree). 
Scores > 28 connoted as high active SHLC. 
Social Support 
  
 
TIES  
(validated 
version) 
 
1 = High Support 
0 = Low Support 
How often participant had support s/he 
needed.  Support suggested as necessary in 
cardiovascular disease and prevention.  
Responses: 0 (none of the time) to 2 (most 
or all of the time). Scores > 15 connoted high 
social support. Score of 15 separated those 
with support at least some of the time from 
those with support none of the time. 
Active Coping 
  
 
JHAC12 1 = High Active 
 Coping 
0 = Low Active 
 Coping 
A person’s behavioral predisposition to 
actively cope with difficult psychosocial 
stressors.  Scores at the study sample’s 
median (score > 48) connote high active.  
Control Variables 
Gender  
 
 
Demographic 
Questionnaire  
1 = Male 
0 = Female 
 
Race/ethnicity 1 = Black 
0 = White 
 
Age Continuous  
Education Categorical  
Difficulty obtaining 
meds due to cost? 
1= Yes 
0 =No 
Participants were asked if they have had 
difficulty obtaining a prescription medication 
in the past 3 months due to cost. 
Income  Categorical  
 
aSource acronyms: MMAS (Morisky Medication Adherence Scale 8-item); SHLCS (Spiritual Health Locus of 
Control Scale); TIES (Tangible, Informational, Emotional, Social Support Scale); JHAC12 (John Henryism Active 
Coping Scale) 
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Measures Administered and Definition of Variables 
The specifics of the following measures can be found in the Methods section of Aim 1; the 
instruments are located in the appendices. 
 Demographic Questionnaire and Blood Pressure Measurement. Age, race/ethnicity, 
gender, marital status, education, and income were obtained for each participant, along 
with whether participants had a hypertension diagnosis, used anti-hypertensive 
medication, lived independently in the community, and had difficulty obtaining 
medications due to cost during the previous three months were recorded on the 
demographic questionnaire (Appendix 7). Two blood pressure measurements were 
recorded for each participant in Section II of the questionnaire. The PI also recorded 
whether the participant needed assistance completing the self-report questionnaires and 
the reason for assistance. Age, race, and gender were considered a priori as potential 
control variables. The other characteristics were collected for descriptive purposes. 
Age: Continuous variable indicating participant’s age in years at the time of consent. 
Race/ethnicity: Two-category variable indicating the best description of the 
participant’s racial background (i.e., Black or White). Participants also reported 
ethnicity status by indicating whether they were of Hispanic or Latino origin or 
ancestry. 
Gender: Two-category variable indicating male or female. 
Education: Seven-category variable indicating highest grade completed with 
minimum of never attended/only kindergarten and maximum of postgraduate. 
Variable was trichotomized as “less than high school,” “high school graduate,” and 
“college or more.” 
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Income: Five-category variable indicating household income for previous 12 months 
with minimum of less than $10,000 and maximum of $35,000 or more. Variable was 
dichotomized as “less than $35,000” and “35,000 and more.” 
Difficulty obtaining meds due to cost: Two-category variable (Yes/No) measuring 
whether there was a time in the previous 3 months that the individual needed 
prescription medication but could not purchase it due to cost.  
Outcome Variable: Adherence 
 8-item Morisky Medication Adherence Scale (MMAS-8): Medication adherence 
(dependent variable) was assessed using the 8-item Morisky Medication Adherence 
Scale (Appendix 8). This self-reported adherence scale was developed from the 4-item 
Morisky instrument used in Aim 1 (the pilot study) and supplemented with additional 
items to better capture barriers to adherence behavior.307 The new scale was determined 
to have higher reliability than the 4-item scale (α = 0.83 vs. α = 0.61) after its original 
validation in a sample of 1367 hypertensive patients; it was chosen in lieu of the 4-item 
scale used in Aim 1 because of its better reliability and because it is a disease-specific 
measure of adherence. Prior research has significantly associated the MMAS-8 with 
antihypertensive drug pharmacy refill adherence in seniors (concordance of 75% or 
higher).308 In addition, the MMAS has been significantly associated with blood pressure 
control in patients with hypertension (p < 0.05).307 MMAS-8 scores, which range from 0 
to 8, and has previously been dichotomized into two levels of adherence: high (score = > 
6) and low (score = < 6)307,309 (D.E. Morisky, personal communication, March 7, 2011). In 
a study307 that examined the validity of this instrument with the same cut-offs, the 
sensitivity of the measure identifying low versus high adherers was estimated to be 93% 
and the specificity was 53%. 
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 For the present study, the MMAS-8 was chosen over the 4-item scale because it is more 
reliable and was designed to facilitate the identification of barriers to and behaviors 
associated with adherence to antihypertensive medication.307 Although the sample size 
for the current study was based on effect estimates from the 4-item measure used in the 
pilot study, it was considered reasonable to believe that because the MMAS-8 is a more 
precise and reliable measure, the adherence scores would have less error variance. 
Thus, the observed effect sizes of the spiritual variables on adherence in the present 
study were expected to be no smaller than the effects observed in the pilot study. 
Rather, they were expected to be larger; even though switching from the generic to the 
disease-specific measure would limit the generalizability of results to other chronic 
diseases.21  
 Medication adherence: The self-report adherence measure (8-item MMAS), asked 
about medication-taking behavior specific to anti-hypertensive medication(s); its scores 
range from 0 to 8. The adherence outcome variable was dichotomized to low (MMAS-8 
score < 6) and high adherence (MMAS-8 score > 6).   
 Visual Analog Scale of Medication Adherence (VAS): This measure was included 
only as a secondary measure of adherence, for the purposes of future analysis. The 
VAS is a single item that asks, “On a scale of 0% to 100%, which of the following 
percentages best reflects your compliance with your high blood pressure medicine over 
the past 4 weeks?”. Subjects were instructed to indicate their adherence percentage on 
a horizontal line anchored by 0% and 100%, demarcated at every tenth percentile. This 
self-reported measure has been shown to be reliable and valid where it has been 
correlated with pill counts, pharmacy claims, and other electronic measures of 
adherence.310-314  
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Independent Variables 
Key Independent Variable: Self-Ranking of Spirituality 
Self-ranking of spirituality: As in Aim 1 (the pilot study), this variable was dichotomized  
indicating overall self-ranking of spirituality (i.e., spiritual intensity). Participants were 
asked to indicate their spirituality according to one item: “To what extent do you consider 
yourself to be a spiritual/religious person?”. Responses ranged from 4 (very 
spiritual/religious) to 1 (not spiritual/religious at all). Participants who indicated that they 
were moderately to very spiritual/religious were dichotomized to the high spiritual group 
and those who considered themselves slightly or not at all spiritual/religious were placed 
in the low spiritual group. The one-item self-ranking of spirituality was administered 
along with a newly developed survey (Appendix 3).  
Secondary Spiritual Variable: Active Spiritual Health Locus of Control 
The Spiritual Health Locus of Control Scale (SHLCS): As in the pilot study, active 
spiritual health locus of control was assessed using 11 items on the SHLCS (Appendix 
2). Responses range from 4 (strongly agree) to 1 (strongly disagree).  
Active SHLC: Dichotomous variable indicating high and low active spiritual health locus 
of control (SHLC). The total active SHLC score was the sum of values assigned to the 
responses of the 11 items. Total scores for active spiritual dimension were 
conservatively dichotomized at 28 points, which represents a scale split separating 
between those who disagreed or strongly disagreed to a majority of the 11 items and 
those who agreed or strongly agreed. Scores < 28 were categorized as low active SHLC 
and > 28 above were high (Appendix 2). This score was the same as the cut-off score in 
the pilot study. 
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Psychosocial Independent Variables 
Tangible, Informational and Emotional Social Support Survey (TIES): Differently 
than was administered in the Aim 1 pilot study, the original validated version of the TIES 
survey (Appendix 10) was administered to assess social support in aims 2 and 3. In Aim 
1, the pilot study, this measure was shortened to a 7-item survey of questions specific to 
support access and medication-taking for descriptive purposes and to assess 
administration feasibility. Because the adapted version was not validated and the 16-
item scale was found to be an acceptable time burden for study participants, the entire 
16-item TIES instrument was used with no alterations. The TIES measure was 
developed to measure the types of social support that are necessary in cardiovascular 
disease prevention and management; responses range from 0 (none of the time) to 2 (all 
or most of the time), with higher scores indicating more support. Its validation and 
description can be found in the Methods section of Aim 1.   
Social Support: The total social support score was the sum of the responses to the 
items on the TIES questionnaire. Total scores were dichotomized at a cut-off score of 
15, which separated participants who indicated that they had support at least some of 
the time from those who had support none of the time to a majority of the scale’s items. 
Scores of < 15 were categorized as low social support and > 15 were categorized as 
high social support. The TIES instrument is a fairly new measure and the developers 
have previously dichotomized the high and low groups at a median split.281 However, it 
was believed that a cut-off score of 15 was more meaningful and relevant, from a clinical 
perspective, for examining the proportion of older adults who had overall higher support 
from those who had lower support for the domains assessed. 
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John Henryism Active Coping Scale (JHAC12): As in the pilot study, active coping 
was assessed using the 12-item John Henryism Active Coping scale (Appendix 4).   
Active Coping: The total active coping score was the sum of the values assigned to the 
responses for the 12 items. In keeping with the methodology proposed by developers 
and other researchers who have used this measure,260,271,272,276 scores were 
dichotomized at the sample’s median (score=48) to categorize respondents into high 
and low active coping groups. Scores at and above the sample median were categorized 
as high active coping and scores below the median were categorized as low active 
coping. 
Aim 2 Analysis 
Aim 2: To examine the relationship between spirituality and self-reported medication 
adherence among community-dwelling older adults with hypertension. 
Hypothesis 2:  
 Older adults who report high spirituality versus those who report low spirituality 
are more likely to report being adherent to their anti-hypertensive medication(s).  
 Older adults with high active spiritual health locus of control (SHLC) beliefs 
versus those with low active SHLC are more likely to report being adherent to 
their anti-hypertensive medication(s).  
Overview 
 Prior to analyses, all data were entered into the study database using Microsoft 
Access and cleaned for missing or nonsensical values. Next, data were converted to STATA 
11 (StataCorp LP, 2009) for analysis, which was done in three stages. First, descriptive 
statistics were calculated for all variables and descriptive analysis was performed to 
describe participant, adherence, and spiritual characteristics in detail. Second, bivariate 
relationships to the medication adherence and spiritual variables were examined. Third, 
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multivariate logistic regression models were used to examine how each spiritual variable 
related to patient reports of adherence to anti-hypertensive medications, after controlling for 
the psychosocial and demographic variables.   
Descriptive Data and Bivariate Analysis 
Descriptive statistics were calculated for the entire study sample of 170 community-
dwelling older adults. These included age, gender, marital status, education, income, length 
of time with hypertension, difficulty purchasing prescriptions due to cost, average blood 
pressure, active coping, and social support. Frequencies and percentages were used to 
describe categorical and dichotomous variables (i.e., gender, race, marital status, education, 
income).  Means and standard deviations were used to describe continuous and counted 
variables (i.e., participant age, length of time with hypertension, average blood pressure, 
active coping, and social support). Distributions for the adherence and spiritual 
characteristics were also examined, and frequencies, percentages, means, and standard 
deviations of participant characteristics were calculated by race. Bivariate relationships were 
examined for all variables using chi-square statistics for categorical variables and t-tests for 
continuous variables. Fisher’s exact test was used for cell frequencies of ≤ 5. Participant 
characteristics were examined by high and low self-reported adherence, high and low self-
ranking of spirituality, and high and low active SHLC.       
Logistic Regression Analysis 
For Aim 2, separate logistic regressions were conducted to assess the bivariate and 
multivariate relationships between the spiritual variables and self-reported medication 
adherence. The outcome variable was self-reported medication adherence measured by the 
8-item MMAS.307 Self-ranking of spirituality, the primary independent variable, was 
measured by one item (“To what extent do you consider yourself a spiritual/religious 
person?”). Active SHLC, the second spiritual variable, was assessed using the SHLCS. The 
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independent spiritual variables and the adherence outcome variable were all dichotomized 
for analysis. Separate multivariate logistic regression models were used to examine how 
self-ranking of spirituality and active SHLC related to self-reported medication adherence, 
after adjusting for the psychosocial and demographic variables. For all analyses, the alpha 
level was 0.05 and analyses were performed with STATA 11 (StataCorp LP, 2009).  
Selection of the control variables used for the multivariate logistic regression was 
driven by several factors (the conceptual model, the bivariate analysis, and the relevance of 
variables mentioned in the literature to medication adherence). As in the conceptual model, 
social support and active coping were accounted for in the regression analysis because they 
are attributes/benefits of spirituality that are thought to facilitate health 
behaviors.26,119,221,224,315,316 As in the literature, age, race, and gender were found to be the 
stronger correlates of adherence in the older population than the other participant 
characteristics that were collected for the present study.19,21,82,103,290-294 Although these 
demographic characteristics were not significant in the pilot study, patients who reported 
being adherent to their medications were slightly older, female, and White. 
Initially, the variable “could not purchase prescription medication due to cost” was 
intended to be a control variable; however, this turned out to be the case for relatively few 
participants (N = 7). Moreover, this question was not specific to antihypertensive 
medications. The challenges posed to multivariate modeling were therefore considered 
sufficient to exclude this variable from the regression analysis.    
Statistical power was taken into account because the conservative sample size (N = 
170) would only permit a few variables other than race to be included in the logistic 
regression analysis. Using the 10:1 event-to-variable ratio and assuming that 35-40% of the 
participants would report low adherence, logistic regression analysis would allow for 
approximately five to six variables for reliable estimates and model fit.317,318 None of the 
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participant characteristics that were excluded from the multivariate logistic regressions were 
significantly related to either the adherence outcome variable or the independent spiritual 
variables in bivariate analysis. After these considerations, it was determined that social 
support, active coping, age, race, and gender would be the control variables used in the 
logistic regression models when examining the relationships of the spiritual variables to self-
reported adherence. 
Aim 2a Analysis: Secondary Aim 
Aim 2a: To examine the relationships among spirituality, social support, active 
coping, and self-reported medication adherence in community-dwelling older adults 
with hypertension.  
 Spirituality is positively associated with self-reported medication adherence, and 
this association is mediated through social support and active coping. 
Overview 
To address the secondary aim, separate logistic regression models were performed 
to examine the relationships between spirituality, social support, and adherence, as well as 
the relationships between spirituality, active coping, and adherence. As depicted in the 
conceptual model, it was thought that spirituality would affect adherence through its known 
attributes of social support and active coping. To examine whether social support and active 
coping were mediators in the relationship between spirituality and self-reported adherence 
for the subjects of the present study, an informal evaluation and the Sobel Test (a formal 
statistical method used to test for mediation) were conducted. The alpha level for all 
analyses was 0.05. The informal evaluation was performed with STATA 11 (StataCorp LP, 
2009). For the formal statistical mediation analysis, given the dichotomous nature of the 
variables, standardized coefficients and standardized errors were calculated for each 
variable using an Excel (Microsoft Office, 2010) spreadsheet. The standardized values were 
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then entered into an interactive calculator tool developed by Preacher and Leonardelli to 
conduct the Sobel Test.319  
Mediation Analysis 
Informal Evaluation 
 A secondary aim of the present study was to explore whether social support and 
active coping serve as mediators for the relationship between spirituality and self-reported 
adherence.  Mediators are defined as variables that account for all or part of the relationship 
between a predictor and an outcome variable.320-322 Before mediation analyses can be 
attempted, a certain pattern of relationships must exist.321-323 Generally speaking, mediation 
can be said to occur when the 
(1) Independent variable (IV) significantly affects the mediator variable(s) (MV);  
(2) IV significantly affects the dependent variable (DV) in the absence of the 
     mediator;  
(3) Mediator(s) has a significant unique effect on the DV; and  
 (4) The effect of the IV on the DV shrinks upon the addition of the mediator(s).  
The IV might influence the DV through several mechanisms, or it might have both direct and 
indirect effects. If the regression coefficient is largely reduced in the final criterion (step 4) 
but remains significant, partial mediation is believed to occur.321,322 In other words, a portion 
of the IV is mediated by the MV(s) but other parts of the IV’s effect are either direct or 
influenced by variables not included in the model for the present study. The above criteria 
are used to informally judge whether or not mediation is occurring,324 but the Sobel Test is a 
statistically  based way to formally test whether a mediator carries the influence of an IV to a 
DV.320,321,323  
 The first step of the informal evaluation was to determine whether the pattern of 
relationships for mediation was met between the variables. Using bivariate logistic 
regressions and the four criteria described above, social support and active coping were 
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examined in relation to the key independent variable (self-ranking of spirituality) and the 
dependent variable (self-reported medication adherence). When the four criteria were 
confirmed, the formal statistically based method for mediation was conducted.  
Sobel Test 
The Sobel Test for partial mediation was conducted to formally test whether social 
support and active coping are mediators in the relationship between spirituality and 
adherence.325 The Sobel Test is a statistical evaluation of whether “the indirect effect of the 
independent variable on the dependent variable through the mediator variable is 
significant.”320,321,324,326 When dichotomous variables are involved, the coefficients must be 
standardized prior to mediation analyses because the coefficients in the mediation analyses 
are placed on different scales.322,324,326-328 For this reason, the coefficients of the variables 
have to be made comparable across the regression equations by standardizing them and 
their standard errors. This is accomplished by multiplying each coefficient by the standard 
deviation (SD) of the predictor variable in the equation and then dividing by the SD of the 
outcome variable. The standardized coefficients and standard errors can then be used to 
run the Sobel Test.322,324 
After the pattern of relationships between the variables was confirmed, the 
coefficients and standard errors for the dichotomous variables were calculated and used to 
run the Sobel Test. For ease of calculation, the standardized coefficients and standardized 
errors were calculated for each variable using an Excel (Microsoft Office, 2010) 
spreadsheet. A diagram of the statistical mediation model is presented in Figure 3, and the 
main theoretical equation for the model and the equations used to standardize the 
coefficients for the predictor variables prior to statistical mediation analysis are presented in 
Table 11. Both the standardized coefficient values and their standard errors for the variable 
paths are needed to run the Sobel Test. The standardized standard errors are calculated 
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similarly to the standardized coefficients (Table 11). After calculating the standardized 
values for each variable, the values were then entered into an online, interactive calculator 
tool that was developed to conduct the Sobel Test using categorical variables.319,325 
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Figure 3. Diagram of Single-step Multiple Mediation Model 
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Table 11.  Standardizing Equations Used in the Sobel Test for Partial Mediation 
Model Equations  Equation Definition 
MA´   = cS + e1  Direct effect of spirituality on medication adherence 
   
SS΄   = a1S + e2  Direct effect of spirituality on social support 
   
AC´  = a2S + e3  Direct effect of spirituality on active coping 
   
MA΄΄  = b1SS + b2AC + c´S + e4  Direct effects of spirituality and social support and active coping 
medication adherence    
Standardizing Equations for 
Coefficients 
 Standard Errors for Standardized Coefficients 
Std a1  = a1 * SD(S)/SD (SS´)  SE (a1)  = SE(a1) * SD(S)/SD (SS´) 
   
Std a2  = a2 * SD(S)/SD (AC´)  SE (a2)  = SE(a2) * SD(S)/SD (AC´) 
   
Std b1  = b1 * SD(SS)/SD (MA´΄)  SE (b1)  = SE(b1) * SD(SS)/SD (MA´΄)  
   
Std b2  = b2 * SD(AC)/SD (MA´΄)  SE(b2) = SE(b2) * SD(AC)/SD (MA´΄) 
   
Std c  = c * SD(S)/SD (MA´)  SE(c)  = SE(c) * SD(S)/SD (MA´) 
   
Std c´  = c΄ * SD(S)/SD (MA´΄)  SE(c´) = SE(c΄) * SD(S)/SD (MA´΄) 
   
Formula for Testing Two Mediators (SS and AC) 
   
MA΄΄ = b1
2 VAR(SS) + b2
2VAR(AC) + 2b1b2cov(SS, AC) + 2b1c´cov(S, SS) + 2b2c´cov(S, AC) + c´
2VAR(S) + π2/3 
   
MA = medication adherence; S = spirituality; SS = social support; AC = active coping; Std = standardized coefficient; SD = standard 
deviation; SE = standard error; VAR = variance; cov = covariance 
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Aim 3 Analysis 
Aim 3:  To examine the relationship between spirituality and blood pressure among 
community-dwelling, older adults with hypertension. 
 Hypothesis 3: 
 Older adults who report high spirituality will have lower systolic and diastolic 
blood pressures compared to older adults who report low spirituality. 
To address this aim, the spiritual variables were examined in relation to systolic and 
diastolic blood pressure after adjusting for self-reported adherence, the psychosocial and 
demographic variables. Two blood pressure measurements were obtained from each 
participant at the time of consent. The average of the systolic and diastolic pressures was 
measured as continuous outcome variables in OLS regressions. The regressions were 
adjusted for adherence, the psychosocial and demographic variables. Self-reported 
adherence was a control variable because patient’s adherence to antihypertensive therapy 
can effect systolic and diastolic blood pressure. It was of interest in this study to understand 
whether spirituality had an effect on blood pressure beyond whether a participant was 
adherent to their prescribed therapy.  For all analyses in Aim 3, the alpha level was 0.05 and 
analyses were performed in STATA 11 (StataCorp LP, 2009). 
  
 
 
 
Chapter 4 
RESULTS OF AIMS 2 & 3 
 
Aim 2 Results 
Overview 
The following sections include the results of the descriptive statistics, bivariate 
analyses, and multivariate logistic regression models predicting medication adherence for 
Aim 2, based upon the 170 hypertensive older adults who were recruited from four local 
Senior Community Centers and enrolled in the present study.   
Participant Characteristics 
Participant characteristics for the full sample of 170 community-dwelling older adults 
are presented in Table 12. The mean participant age was 75.1 (SD = 7.6); 61% were 
women; 45% identified as Black/African American; and none (0%) identified as Spanish or 
Hispanic. Most of the participants reported being either currently married (58, 34.1%) or 
widowed (57, 33.5%). At the time of enrollment, 21 (12.4%) participants reported a 
household income of less than $10,000 in the previous 12 months. Only 29 (17.1%) 
reported having less than a high school education; 90 (52.9%) reported some college or 
more. The majority, 113 (66.5%), reported having had hypertension for at least 10 years, 
with a mean time of 14.6 years (SD = 11.0). Twelve (7.1%) reported that in the previous 
three months they could not purchase a prescribed medication due to cost; as a result of 
this inability, 7 (58.3%) went without their prescriptions. The mean systolic blood pressure 
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was 139.9 mmHg (SD = 19.1, ranging from 98 mmHg to 188 mmHg). The mean diastolic 
blood pressure was 74.2 mmHg (SD = 11.3, ranging from 45 mmHg to 95 mmHg). 
The mean score on the active (JHAC12) was 47.5 (SD = 6.5); scores ranged from 31 
to 60. The median score was 48 (95%, CI 46–50) and 6 participants scored at the median. 
When the scores were dichotomized at the sample’s median per the scales guidelines, 90 
(52.9%) participants were categorized as having high active coping. The median score for 
the current sample was slightly lower than was observed in the pilot study (i.e., score of 48 
vs. 50, respectively). However, these scores are consistent and overlap with previous coping 
scores found in the literature with similar populations.260,271,272,276  In addition, the cut-off 
score of 48 is believed to provide a meaningful difference between the high and low active 
coping groups as it separates those participants who responded positively (i.e., somewhat 
true=4 or completely true=5) to a majority of the measure’s 12 items from those who 
responded negatively to a majority of the items.  
Social support was assessed using the 16-item Tangible, Information, Emotional, 
Social Support Survey (TIES), a validated survey developed to measure dimensions of 
social support that are deemed necessary in cardiovascular disease and prevention. 
Question 16 (“If you smoke, is there someone to encourage you to quit smoking?”) was 
dropped from the analysis because some participants responded that they did not smoke 
and therefore did not know how to respond to this item; they left it blank or put an X through 
it. However, other participants who stated that they did not smoke circled a response 
anyway and wrote their nonsmoking status in the margins of the instrument. Survey results 
indicated that only two respondents neither said nor wrote that they did not smoke but 
circled a response anyway. Because these inconsistencies were considered to have 
rendered the item unreliable, the social support analysis was based upon items 1 through 15 
on the TIES instrument. (It should be noted that when this scale was originally validated, its 
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developers dropped this same smoking item from analysis because it did not significantly 
load on any of conceptual domains of social support261 and that the developers attributed 
this problem to a dearth of smokers among their subjects.) Without the smoking item, the 
remaining 15 TIES items still had very good reliability for this study sample (Cronbach’s α 
0.92).   
The mean social support score for the sample was 15.5 (SD = 7.6) in a range from 0 
to 30. The median score was 14 (95%, CI 13–17) with five participants scoring at the 
median. The social support variable was dichotomized at a cut-off score of 15 (a scale split), 
which separated participants who responded to a majority of the items that they had support 
at least some of the time from those who responded to a majority of the items that they had 
support none of the time. Those with a score of < 15 on this measure were categorized as 
having low social support. The social support groups were almost evenly distributed for this 
sample, where about half (84, 49.4%) were categorized as having high social support and 
the other half (86, 50.6%) had low social support.   
Of the 170 participants who completed the study questionnaires, only 7 (4.1%) 
requested or required assistance with completion. Of these, one (14.3%) had literacy issues 
and six (85.7%) had vision impairment. All other participants completed the materials without 
assistance. 
Characteristics by Race 
Because of the significance of racial identity in American society and because 
significant differences in adherence and hypertension outcomes by race have been reported 
in the literature (albeit these may be related to other factors), demographic characteristics 
were examined by race (Black versus White). Chi-square statistics were calculated for the 
cross-tabulation of race and the dichotomous or categorical variables; t-tests were 
conducted for race and the continuous variables. Characteristics that were found to 
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significantly differ by race were age, income, marital status, and active coping scores (Table 
13). The Blacks in this study were significantly younger than the Whites (p < 0.01), more 
likely to report a household income less than $35,000 in the previous year (p < 0.05), and 
also differed with respect to marital status (p < 0.05). Significant differences were also found 
between Blacks and Whites in the active coping scores, where Blacks had a higher average 
JHAC12 score (48.9 vs. 46.4, p = 0.01). No other characteristics differed significantly by 
race. 
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aSD = standard deviation 
Table 12. Participant Characteristics in Total Sample (N = 170). 
Characteristics     Characteristics No. (%) unless specified 
  Age, mean (SD)a, range 75.1 (+ 7.6), 65–93 
  Women 104 (61.2) 
  Black  76 (44.7) 
  Marital Status   
 Never married                              8 (4.7) 
 Married 58 (34.1) 
 Widowed 57 (33.5) 
 Divorced  43 (25.3) 
 Separated                               4 (2.4) 
  Education  
 Grades 1–8 (Elementary)                               5  (2.9) 
 Grades 9–11 (Some high school) 24 (14.1) 
 Grades 12 or GED (HS grad) 51 (30.0) 
 College 1–3 yrs (Some college) 43 (25.3) 
 College 4 yrs (College graduate) 23 (13.5) 
 Postgraduate work 24 (14.1) 
  Income  
 Less than $10,000 21 (12.4) 
 $10,000–$34,999  89 (52.4) 
 $35,000 or more 59 (34.7) 
 Don’t know 1 (0.6) 
  Length of time w/HTN, mean(range) 14.6 (0.2–50) 
 < 10 years 57 (33.5) 
 10–20 years 80 (47.1) 
 > 20 years 33 (19.4) 
  Could not purchase Rx b/c of cost 12 (7.1) 
 Went without it 7 (58.3) 
 Someone else bought it 1 (8.3) 
 Other action 4 (33.3) 
  Average Blood Pressure (mmHg)  
 Systolic (SD), range 139.9 (+19.1), 98–188 
 Diastolic (SD), range 74.2 (+11.3), 45–95 
  Active Coping, mean (SD), range 47.5 (+6.5), 31–60 
 Low active coping (< 48) 80 (47.1) 
 High active coping (> 48) 90 (52.9) 
  Social Support, mean (SD), range 15.5 (+7.6), 0–30 
 Low social support (< 15) 86 (50.6) 
 High social support (> 15) 84 (49.4) 
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Table 13. Characteristics of Participants by Racea in Total Sample (N = 170) 
 
Characteristics 
Blacks (N = 76) 
No. of participants (%) 
Whites (N = 94) 
No. of participants (%) 
Age, mean (SD)
b
, range 73.1 (+7.0), 65-90 76.7 (+7.7), 65-93** 
   Gender   
Female 47 (61.8) 57 (60.6) 
Male 29 (38.2) 37 (39.4) 
   Marital status    
Not Married 57 (75.0) 55 (58.5)* 
Married 19 (25.0) 39 (41.5) 
   Education   
Less than HS grad 19 (25.0) 10 (10.6) 
High school grad  21 (27.6) 30 (31.9) 
 College or more 36 (47.4) 54 (57.5) 
   Income
c 
  
 Less than $35,000 59 (77.6) 51 (54.8)** 
 $35,000 or more 17 (22.4) 42 (45.2) 
   HTN Years, mean (SD), range 14.7 (+10.5), 0.5-50 14.4 (+11.3), 0.2-45 
 < 10 years 22 (29.0) 35 (37.2) 
 10-20 years 40 (52.6) 40 (42.6) 
 >20 years 14 (18.4) 19 (20.2) 
   Not purchase Rx b/c of cost  6 (7.9) 6 (6.4) 
 Went without it 4 (66.6) 3 (50.0) 
 Someone else bought it 1 (16.7) 0 (0.0) 
 Other action 1 (16.7) 3 (50.0) 
   Avg. Blood Pressure (mmHg)   
 Systolic mean (SD), range 141.5 (+19.1), 98-186 138.7 (+19.2), 99-188 
 Diastolic mean (SD), range 75.3 (+10.0), 50-95  73.3 (+12.3), 46-95 
      
Active Coping, mean (SD), range 48.9 (+6.6), 31-60 46.4 (+6.1), 34-59* 
 Low active coping (< 48) 25 (32.9) 55 (58.5)** 
 High active coping (> 48) 51 (67.1) 39 (41.5) 
      
Social Support, mean (SD),range 15.5 (+7.4), 0-29 15.5 (+7.8), 1-30 
 Low social support (< 15) 38 (50.0) 48 (51.1) 
 High social support (> 15)  38 (50.0) 46 (48.9) 
   
aSignificance level of chi-square statistic for categorical variables and two-tailed t-test for continuous 
variables: *p < 0.05, **p< 0.01, ***p < 0.001 
bSD = standard deviation 
cTotal is less than N = 170 due to missing data. Missing data n = 1. 
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Adherence Characteristics 
Self-reported Adherence 
A histogram plot of the adherence scores is displayed in Figure 4. The mean score 
for the sample was 5.98 points with a median score of 6.75 points; scores ranged from 0.5 
to 8. Sixty-five (38%) of the participants were categorized as having low adherence and 105 
(62%) were categorized as having high adherence, which is similar to the distribution 
reported for the population in which the MMAS-8 was developed (32.1% low adherers); a 
population who also had hypertension.307 
The distribution of participants who were categorized as adherent in the present 
study (62%) was higher than the distribution in the pilot study (44%). This result was 
expected because the measure used in the pilot study (4-item Morisky) was a generic 
measure of adherence that did not specify medication type. Also, because participants in the 
pilot study had been referred to a MTM service due to their medication complexity, the 
higher percentage of non-adherers in the pilot study may have been due to these patients 
reporting nonadherence to other chronic and/or acute medications. Using the MMAS-8 in 
the present study, however, provided an assessment of adherence to anti-hypertensive 
therapy only. 
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Figure 4. Histogram of Self-Reported Medication Adherence Scores (N = 170). 
 
Adherence: Dichotomized Frequency Percent 
    Low adherence 65 38.24 
    High adherence 105 61.76 
   
Total 170 100.00 
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Bivariate Results (Self-Reported Adherence) 
 
Table 14 shows the differences in demographic, hypertension, active coping, and 
social support characteristics by high and low self-reported adherence. Chi-square statistics 
were calculated for the cross-tabulation of high versus low self-reported adherence with the 
dichotomous or categorical variables. T-tests were conducted for high versus low adherence 
and the continuous variables. Of the demographic characteristics, only one had a 
statistically significant association with self-reported adherence. Adherence was found to 
differ significantly by gender: a higher percentage of female participants were more likely to 
report being adherent to their anti-hypertensive medication(s) than male participants (71% 
vs. 29%, p < 0.001). No significant relationships were found between self-reported 
adherence and age, race, marital status, education, or income.  
No differences were found in the length of time participants reported living with 
hypertension between those who reported high adherence to their anti-hypertensive 
medication(s) and those with low adherence. However, significant differences were 
observed for blood pressure measurements between the two groups. As expected, the 
average systolic blood pressure for the low adherence group was significantly higher than 
for the adherent group (151.9 mmHg vs. 132.5 mmHg, p < 0.001). Similarly, the average 
diastolic blood pressure in the low adherence group was significantly higher than in the high 
adherent group (82.1 mmHg vs. 69.3 mmHg, p < 0.001). 
Differences were observed in both active coping and social support in the high and 
low adherence groups. Participants with high active coping were more likely to report high 
adherence to their anti-hypertensive medication(s) (p = 0.02). Sixty percent of the 
participants who reported high adherence also had high active coping and 40% had high  
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adherence but low active coping. Similarly, participants with high social support were more 
likely to report high adherence (p < 0.001); 61% had high adherence and high social support 
and 39% had high adherence but low social support. 
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Table 14. Self-Reported Medication Adherence Characteristics by Other Demographic, 
Hypertension, Active Coping, and Social Support Characteristics (N = 170) 
  Adherencea 
 
Characteristics 
High (N = 105) 
Frequency (%) 
Low (N = 65) 
Frequency (%) 
Age, mean (SD)b 75.7 (+ 7.3) 74.0 (+8.0) 
   Race   
 Black 43 (41.0)  33 (50.8) 
 White 62 (59.0) 32 (49.2) 
   Gender   
 Male 30 (28.6)  36 (55.4)*** 
 Female 75 (71.4) 29 (44.6) 
   Marital status    
 Married 36 (34.3)   22 (33.8) 
Not married  69 (65.7) 43 (66.2) 
   Education   
Less than high school grad 20 (19.1) 9 (13.8) 
High school grad  36 (34.3) 15 (23.1) 
 College or more 49 (46.6) 41 (63.1) 
   Incomec   
 Less than $35,000 68 (65.4) 42 (64.6) 
 $35,000 or more 36 (34.6) 23 (35.4) 
   Length of time w/ HTN, mean (SD) 15.3 (+11.6) 13.3 (+9.8) 
 < 10 years 33 (31.4) 24 (36.9) 
 10–20 years 48 (45.7) 32 (49.2) 
 >20 years 24 (22.9) 9 (13.9) 
   Could not purchase Rx b/c of cost   
 Yes 9 (8.6) 3 (4.6) 
 No 96 (91.4) 62 (95.4) 
   Average Blood Pressure (mmHg)   
 Systolic mean (SD) 132.5 (+16.6) 151.9 (+16.9)*** 
 Diastolic mean (SD) 69.3 (+10.5)  82.1 (+7.6)*** 
   Active Coping score, mean (SD) 48.8 (+5.6) 45.5 (+7.2)** 
 Low active coping (< 48) 42 (40.0) 38 (58.5)* 
 High active coping (> 48) 63 (60.0) 27 (41.5) 
   Social Support score, mean (SD) 17.6 (+7.1) 12.0 (+7.2)*** 
 Low social support (< 15) 41 (39.1) 20 (30.8)*** 
 High social support (> 15)  64 (60.9) 45 (69.2) 
aSignificance level of the chi-square statistic for categorical variables and two-tailed t-test for continuous 
variables: *p < 0.05, **p < 0.01, ***p < 0.001 
b SD = standard deviation 
cTotal number is less than N = 170 due to missing data. Missing data n = 1. 
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Spirituality Characteristics 
Self-ranking of spirituality 
Self-ranking of spirituality was the key independent variable in the present study. 
Participants responded to the question “To what extent do you consider yourself a 
spiritual/religious person?” (response distribution is shown in Figure 5). The spirituality 
variable was created by dichotomizing participants who reported moderately to very 
spiritual/religious (the high spiritual group) and participants who reported being slightly or not 
at all spiritual/religious (the low spiritual group). Most participants (84.7%) were at least 
slightly spiritual; 58.8% were moderately or very spiritual. 
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Figure 5. Self-Ranking of Spiritualitya Characteristics (N = 170) 
 
a
Responses to the question “To what extent do you consider yourself a spiritual/religious person?” 
 
 
 
 
Spirituality Frequency Percent 
    Low spiritual  70 41.18 
    High spiritual 100 58.82 
   
Total 170 100.00 
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Bivariate Results (Self-Ranking of Spirituality) 
In the bivariate analysis shown in Table 15, a few notable differences appear 
between the high spiritual and low spiritual groups. The spirituality variable differed 
significantly by race, in that a higher percentage of Blacks than Whites were categorized as 
high spiritual (52% vs. 48%, p = 0.02) and approximately 66% of the participants who 
reported low spirituality were White. Spirituality also differed significantly by gender, in that 
females were more likely than males to report being high spiritual (77% vs. 23%, p < 0.001); 
approximately 65% of the males reported low spirituality. No differences were observed for 
marital status, education, or income characteristics. The spiritual groups did differ with 
respect to whether participants needed a prescription in the previous three months but could 
not afford to purchase it (p = 0.02). Of the 12 participants who could not purchase 
medication they needed, 11 were characterized as high spiritual; only one was in the low 
spiritual group. It is important to note that this question on the demographic form was not 
specific to access to anti-hypertensive medications. Participants who responded 
affirmatively also indicated that the prescription they had gone without was not for their 
blood pressure.  
Although no significant differences were observed between the high and low spiritual 
groups in the length of time participants had been diagnosed with hypertension, it is notable 
that blood pressures for the low spiritual group were significantly higher than for the high 
spiritual group (p < 0.001). The average systolic blood pressure for the low spiritual group 
was 150.2 mmHg (SD=18.5). Similarly, the average diastolic blood pressure for the low 
spiritual group was significantly higher than for the high spiritual group (79.4 mmHg vs. 70.5 
mmHg, p <0.001). 
The spiritual groups differed with respect to active coping and social support. The 
high spiritual group had a higher active coping score on the JHAC12 measure than the low 
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spiritual group (49.5 vs. 44.8, p < 0.001). Thus, a higher percentage of the high spiritual 
group had high active coping than low active coping (65% vs. 35%, p < 0.001). Sixty-four 
percent of the low spiritual group was categorized as having low active coping. A similar 
significant trend (p < 0.001) was observed with respect to social support: more participants 
who were categorized as having low social support were in the low spiritual group (73%) 
than participants who had low social support but were in the highly spiritual group (27%).
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Table 15.  Self-Ranking of Spirituality Characteristics by Other Demographic, 
Hypertension, Active Coping, and Social Support Characteristics (N = 170) 
  Spiritualitya 
 
Characteristics 
High (N = 100) 
Frequency (%) 
Low/Not at all (N = 70) 
Frequency (%) 
Age, mean (SD)b 75.3 (+ 7.9) 75.3 (+7.9) 
   Race   
 Black 52 (52.0)  24 (34.3)* 
 White 48 (48.0) 46 (65.7) 
   Gender   
 Male 23 (23.0)  43 (61.4)*** 
 Female 77 (77.0) 27 (38.6) 
   Marital status    
 Married 32 (32.0)   26 (37.1) 
Not married  68 (68.0) 44 (62.9) 
   Education   
Less than high school grad 22 (22.0) 7 (10.0) 
High school grad  26 (26.0) 25 (35.7) 
 College or more 52 (52.0) 38 (54.3) 
   Incomec   
 Less than $35,000 70 (70.7) 40 (57.1) 
 $35,000 or more 29 (29.3) 30 (42.9) 
   Length of time w/ HTN, mean (SD) 14.9 (+11.6) 14.0 (+10.0) 
 < 10 years 33 (33.0) 24 (34.3) 
 10–20 years 47 (47.0) 33 (47.1) 
 >20 years 20 (20.0) 13 (18.6) 
   Could not purchase Rx b/c of cost   
 Yes 11 (11.0) 1 (1.4)* 
 No 89 (89.0) 69 (98.6) 
   Average Blood Pressure (mmHg)   
 Systolic mean (SD) 132.8 (+16.2) 150.2 (+18.5)*** 
 Diastolic mean (SD) 70.5 (+9.5)  79.4 (+11.8)*** 
   Active Coping score, mean (SD) 49.5 (+5.7) 44.8 (+6.5)*** 
 Low active coping (< 48) 35 (35.0) 45 (64.3)*** 
 High active coping (> 48) 65 (65.0) 25 (35.7) 
   Social Support score, mean (SD) 17.8 (+7.3) 12.2 (+7.0)*** 
 Low social support (< 15) 35 (35.0) 51 (72.9)*** 
 High social support (> 15)  65 (65.0) 19 (27.1) 
aSignificance level of the chi-square statistic for categorical variables and two-tailed t-test for continuous 
variables: *p < 0.05, **p < 0.01, ***p < 0.001 
b SD = standard deviation 
cTotal number is less than N = 170 due to missing data. Missing data n = 1. 
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Active Spiritual Health Locus of Control (SHLC) Characteristics 
 The secondary spiritual measure used in the present study was the active dimension 
of the Spiritual Health Locus of Control scale (SHLC). The measure, which consisted of 11 
items, involved the notion that God (or some higher power) and self are involved in the 
health of individuals. Responses to the items were on a 4-point Likert-type scale that ranged 
from “strongly agree” to “strongly disagree.” The histogram plot in Figure 6 shows the 
distribution of the sample’s active SHLC scores. The mean score on the active SHLC scale 
was 30.9 points (median score = 33). This active SHLC variable was conservatively 
dichotomized at 28 points to separate those who disagreed or strongly disagreed with a 
majority of the 11 items from those who agreed or strongly agreed. Thirty-four (20.0%) of the 
participants were categorized as having low active SHLC beliefs and 136 (80.0%) with high 
active SHLC beliefs.
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Figure 6. Histogram of Active Spiritual Health Locus of Control (SHLC) scores 
(N = 170) 
 
 
 
Active SHLC Frequency Percent 
    Low active SHLC 34 20.00 
    High active SHLC 136 80.00 
   
Total 170 100.00 
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Bivariate Results (Active SHLC) 
 The active spiritual health locus of control (SHLC) variable significantly differed by 
race (p = 0.002). Seventy-nine percent of White participants had low active SHLC compared 
to only 21% of Black participants. Active SHLC also significantly differed by gender, in that 
females were more likely than males to have high active SHLC (66% vs. 34%, p = 0.007). 
The active SHLC groups did not differ with respect marital status, education, or income. 
 Similar to the trend observed for the primary spiritual variable (self-ranking of 
spirituality), participants in the high and low active SHLC groups did not differ with respect to 
the length of time they had been diagnosed with hypertension. They did however, differ in 
average blood pressures. The blood pressures measured for the low active SHLC group 
were significantly higher than for the high active SHLC group (p < 0.001). The average 
systolic blood pressure for the low active SHLC group was 153.5 mmHg (SD = 20.8). 
Similarly, the average diastolic blood pressure for the low active SHLC group was 
significantly higher than for the high active SHLC spiritual group (82.7 mmHg vs. 72.1 
mmHg, p < 0.001). 
Another similarity to the key spiritual variable was the difference between the SHLC 
groups with respect to both active coping and social support. A higher percentage of 
participants in the high active SHLC group were categorized as having high active coping 
than those in the low active coping group (60% vs. 30%, p = 0.001). Seventy-four percent of 
the low active SHLC group was categorized as having low active coping. A similar significant 
trend (p < 0.001) was observed with respect to social support: more participants who were 
categorized as having low social support were in the low active SHLC group (79%) than 
participants who had low social support but were in the high active SHLC group (43%). 
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Table 16. Active Spiritual Health Locus of Control (SHLC) Characteristics by Other Demographic, 
Hypertension, Active Coping, and Social Support Characteristics (N = 170) 
  Active SHLCa 
 
Characteristics 
High (N = 136) 
Frequency (%) 
Low (N = 34) 
Frequency (%) 
Age, mean (SD)b 75.2 (+ 7.6) 74.3 (+7.8) 
   Race   
 Black 69 (50.7)  7 (20.6)** 
 White 67 (49.3) 27 (79.4) 
   Gender   
 Male 46 (33.8)  20 (58.8)** 
 Female 90 (66.2) 14 (41.2) 
   Marital status    
 Married 44 (32.4)   14 (41.2) 
Not married  92 (67.6) 20 (58.8) 
   Education   
Less than high school grad 27 (19.9) 2 (5.9) 
High school grad  39 (28.6) 12 (35.3) 
 College or more 70 (51.5) 20 (58.8) 
   Incomec   
 Less than $35,000 92 (68.2) 18 (52.9) 
 $35,000 or more 43 (31.8) 16 (47.1) 
   Length of time w/ HTN, mean (SD) 14.9 (+11.4) 12.9 (+9.0) 
 < 10 years 45 (33.1) 12 (35.3) 
 10–20 years 62 (45.6) 18 (52.9) 
 >20 years 29 (21.3) 4 (11.8) 
   Could not purchase Rx b/c of cost   
 Yes 11 (8.1) 1 (2.9) 
 No 125 (91.9) 33 (97.1) 
   Average Blood Pressure (mmHg)   
 Systolic mean (SD) 136.6 (+17.2) 153.5 (+20.8)*** 
 Diastolic mean (SD) 72.1 (+10.8)  82.7 (+9.5)*** 
   Active Coping score, mean (SD) 48.6 (+5.8) 43.2 (+7.1)*** 
 Low active coping (< 48) 55 (40.4) 25 (73.5)** 
 High active coping (> 48) 81 (59.6) 9 (26.5) 
   Social Support score, mean (SD) 16.7 (+7.4) 10.8 (+7.0)*** 
 Low social support (< 15) 59 (43.4) 27 (79.4)*** 
 High social support (> 15)  77 (56.6) 7 (20.6) 
aSignificance level of the chi-square statistic for categorical variables and two-tailed t-test for continuous 
variables: *p < 0.05, **p < 0.01, ***p < 0.001. 
b SD = standard deviation. 
cTotal number is less than N = 170 due to missing data. Missing data n = 1. 
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Correlation Matrix of Independent Variables Used in Analyses 
 Table 17 presents the Pearson correlation coefficients and statistical significance of 
the independent variables used in the logistic regression analyses, which are described in 
the next section. These include the spiritual variables (self-ranking of spirituality and active 
SHLC), social support, active coping, age, race, and gender. Because the bivariate 
relationships between all the participant characteristics, spirituality, and self-reported 
adherence are presented above, this section focuses on the statistically significant 
interrelationships among the participant characteristics and spirituality variables used in the 
analyses. 
 The high spiritual participants were more likely to have a high active spiritual health 
locus of control (SHLC) than the low spiritual participants (r = 0.57, p <0.001). They were 
also more likely to have high social support (r = 0.37, p < 0.001) and high active coping (r = 
0.29, p < 0.001) compared to the low spiritual group. The high spiritual participants were 
more likely to self-identify as Black (r = 0.18, p < 0.05) than the low spiritual participants. 
Males were less likely to report being high spiritual (r = -0.39, p < 0.001) than females. 
Participants with high active SHLC were more likely to have high social support (r = 0.29, p 
< 0.001) and high active coping (r = 0.27, p < 0.001) compared to participants with low 
active SHLC. In addition, the high active SHLC participants were more likely to self-identify 
as Black (r = 0.24, p < 0.01) and less likely to be male (r = -0.21, p < 0.01) compared to 
participants with low active SHLC. 
 Participants with high social support were more likely to have high active coping (r = 
0.18, p < 0.001) and were less likely to be male (r = -0.23, p < 0.01) than participants with 
low social support. Participants with high active coping were more likely to be Black (r = 
0.26, p < 0.001) and less likely to be male (r =-0.24, p < 0.01) compared to participants with 
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low active coping. Black participants were more likely to be younger compared to the White 
participants (r = -0.24, p < 0.01).  
 Although statistically significant correlations were observed between the independent 
variables, the strength of these relationships were relatively weak to moderate. The largest 
correlation was between the two spiritual variables (r = 0.56, p < 0.001), which was 
expected and the reason these spiritual domains were selected a priori to be examined in 
separate regression models. Nonetheless, the trends seem to support the proposed 
conceptualization of these constructs (i.e., that spirituality is positively related to social 
support and active coping). 
 
Table 17. Correlation Matrix Assessing Relationships Among Independent Variables 
Predicting Self-Reported Medication Adherence to Anti-Hypertensive(s)a    
        
 Spirituality Active 
SHLC 
Social  
support 
Active 
coping 
Age Black Male 
        
Spirituality 1.00       
        
Active SHLC 0.56*** 1.00      
        
Social support 0.37*** 0.29*** 1.00     
        
Active coping 0.29*** 0.27*** 0.18* 1.00    
        
Age -0.03 0.05 -0.03 -0.09 1.00   
        
Black 0.18* 0.24** 0.01 0.26*** -0.24** 1.00  
        
Male -0.39*** -0.20** -0.23** -0.24** 0.06 -0.01 1.00 
        
aBased on two-tailed tests: *p < 0.05, **p < 0.01, ***p < 0.001 
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Checking for Multicollinearity of independent variables 
 To ensure that there were no multicollinearity issues with the independent variables 
used in the regression analyses, the variance inflation factor (VIF) and tolerance (1/VIF) 
values were examined. A variable with VIF values greater than 10, or a tolerance value 
lower than 0.1, may merit further investigation to rule out linear combinations of other 
independent variables. The VIF and tolerance (1/VIF) values for the explanatory variables 
that had been expected to predict adherence are shown in Table 18. These were not 
worrisome with respect to multicollinearity because the VIF values were all < 10 and the 
tolerance values were all > 0.1 (e.g., the variables were not redundant or were measuring 
the same thing).329-331 
Table 18. Variance Inflation Factor (VIF) and Tolerance (1/VIF) Values for 
Independent Variables Used in Regression Analyses Predicting Adherence. 
Variable VIF 1/VIF 
Spirituality 1.77 0.563735 
Active SHLC 1.58 0.632066 
Male 1.23 0.813885 
Black 1.20 0.831760 
Social support 1.20 0.832975 
Active coping 1.19 0.837600 
Age 1.09 0.921459 
Mean VIF 1.32  
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Aim 2 Logistic Regression Results  
Overview 
In the next step of the analysis, separate logistic regressions were conducted to 
assess the bivariate and multivariate relationships between the spiritual variables and self-
reported medication adherence while adjusting for social support, active coping, and the 
demographic variables (tables 19 and 20). Bivariate logistic models were examined for each 
of the spiritual variables and the other covariates in relation to self-reported adherence. The 
multivariate models were adjusted for the psychosocial (i.e., social support and active 
coping) and demographic variables (age, race and gender). 
Effects of Self-ranking of Spirituality on Adherence 
Table 19 presents the bivariate and multivariate effects of self-ranking of spirituality 
on self-reported medication adherence. The models produced large estimates and wide 
confidence intervals, but significant positive relationships were observed between spirituality 
and adherence. A significant positive relationship was observed where participants reporting 
high spirituality had greater odds of reporting high adherence to their antihypertensive 
medication(s) compared to the low spiritual group (OR = 7.2; 95% CI 3.6–14.4). Social 
support and active coping were both positively and significantly related to self-reported 
adherence in bivariate analysis (95% CI 1.8-6.8 and 1.1–4.0, respectively) where 
participants with high social support and high active coping had greater odds of reporting 
high adherence than participants with low social support and low active coping. The only 
demographic variable significantly related to self-reported adherence in bivariate logistic 
analysis was gender: males had 70% lower odds of reporting adherence than females (OR 
= 0.3, 95% CI 0.2–0.6). Gender did not remain significant in the multivariate models, 
however. 
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The multivariate logistic model examined the effect of spirituality on self-reported 
adherence while adjusting for social support, active coping, and the demographic variables. 
Again, a significant positive relationship between spirituality and adherence was observed. 
The high spiritual group had greater odds of reporting high adherence to their blood 
pressure medications than the low spiritual group (OR = 6.2, 95% CI 2.7–14.5). The only 
other significant variable in the multivariate model was race. Blacks had 60% odds of 
reporting higher adherence than Whites when the other variables were held constant—a 
notable finding, considering that race was not a significant bivariate predictor of high 
adherence.  
For further analysis, a logistic regression model was conducted to examine whether 
there was a significant interaction between the race and self-ranking of spirituality variables 
(not shown in table). Because race was significantly associated with spirituality in bivariate 
analysis, it was thought that an interaction might have been occurring between spirituality 
and race, which in turn affected the adherence outcome. Thus, an interaction term was 
created and entered in the regression model along with the other covariates to see if the 
combined effect of the spirituality and race variables was significant. The interaction was not 
significant (OR = 0.84, 95% CI 0.17 – 4.19) so the interaction term was dropped from the 
model for parsimony reasons. In addition, a regression model was conducted omitting the 
race variable and the odds ratio and confidence interval for the spirituality variable slightly 
decreased compared to the full model (OR = 6.2, 95% CI 2.6 – 14.5 vs. OR = 4.9, 95% CI 
2.3 – 10.9). This result suggested that race may be functioning as a suppressor variable. In 
general, suppressor variables improve the prediction of a dependent variable.332,333 When 
suppression occurs in regression analysis, an addition of a suppressor is frequently 
associated with a sizable increase in the regression coefficient of the suppressed 
predictor.332,334 In this case, race may be suppressing some of the “outcome-irrelevant 
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variation or errors” in the spirituality variable, and improving or enhancing the overall 
predictive power of the model.333 
To summarize the logistic regression results, self-reported high adherence seemed 
to be favorable for those who considered themselves more spiritual. This finding held true 
even after controlling for the effect of the psychosocial and demographic variables in the 
regression model. Therefore, there is support for the first hypothesis of Aim 2. 
Effects of Active Spiritual Health Locus of Control on Adherence 
The secondary spiritual variable used in this study was the active spiritual health 
locus of control (SHLC) dimension, which involves the notion that God or a higher power 
gives individuals the strength to improve their health. The bivariate and multivariate effects 
of the active SHLC variable on self-reported medication adherence appear in Table 20. 
Similar to the key spiritual variable, the models examined produced large estimates and 
wide confidence intervals, but significant positive relationships were observed. In the 
bivariate model, active SHLC was significantly associated with self-reported adherence 
where those participants with high active SHLC had greater odds of reporting high 
adherence than participants with low active SHLC (OR = 6.7, 95% CI 2.86–15.54). 
In multivariate regression, the psychosocial and demographic variables were 
adjusted for and active SHLC remained positively significant in relation to adherence (OR = 
6.19, 95% CI 2.3–16.7). Active coping was not significant in the multivariate model, but 
social support remained significant (OR = 2.21, 95% CI 1.1–4.6), which suggests that 
participants’ perceptions of their social support positively affects their adherence beyond 
their SHLC beliefs and coping strategies. Gender was also significant in the multivariate 
model. Males had 55% lower odds of reporting adherence than females (OR = 0.45, 95% CI 
0.21–0.95). Similar to the analysis with the key spiritual variable, race became significant in 
the multivariate model. Blacks’ odds of reporting high adherence were approximately 62% 
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lower than Whites’ when the other variables were held constant (OR = 0.38, 95% CI 0.17–
0.86). This finding was also notable because the same effect was observed with the self-
ranking of spirituality variable wherein race was not a significant bivariate predictor of high 
adherence. Again, an interaction term was created and entered in the multivariate model to 
see if the combined effect of the active SHLC and race variables was significant (not shown 
in table). The results revealed that the interaction was not significant (OR = 3.6, 95% CI 
0.37–34.86) and was therefore dropped. Also, as had happened with the key spiritual 
variable, the odds ratio for active SHLC in the full model decreased when the race variable 
was omitted (OR = 6.2, 95% CI 2.3–16.7 vs. OR = 4.3, 95% CI 1.7–10.8). Thus, suppressor 
effects may also be a possible explanation for this finding.332,335    
To summarize the logistic regression results, self-reported high adherence also 
appears to be favorable for the second spiritual variable. Participants with high active SHLC 
beliefs had greater odds of reporting high adherence than those with low active SHLC, and 
this effect held true even after controlling for the psychosocial and demographics variables. 
These results support the secondary hypothesis for Aim 2.  
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aMultivariate Model: Adjusted for social support, active coping, age, race, and gender. 
bAn interaction term (race x spirituality) was entered in the multivariate model and was not significant (95% CI 0.2-4.2). 
cWhen the race variable was omitted from the model, the odds ratio for the spirituality variable decreased (OR = 4.9, 95 CI 2.3–10.9). 
 
Table 19.  Bivariate and Multivariate Effects of Spirituality on Self-Reported Medication Adherence in Hypertensive Older 
Adults (N = 170) 
Variable     Bivariate Models      Multivariate Modela  
        Key Variable  OR [95% CI]      p OR [95% CI] p   
Spirituality      
 High  7.20 [3.60–14.39] <0.001 6.21 [2.66–14.52]  <0.001 
 Low  Reference    
      
Psychosocial Variables      
Social Support      
 High  3.51 [1.82–6.77] <0.001 1.91 [0.90–4.09]  0.09 
 Low  Reference    
      
Active Coping      
 High  2.11 [1.13–3.96] 0.02 1.49 [0.68–3.30]  0.32 
 Low  Reference    
      
Demographics      
Age  1.03 [0.99–1.08] 0.14 1.03 [0.98–1.09]  0.19 
Black  0.67 [0.36–1.25] 0.21 0.40 [0.17–0.92]  0.03b,c 
Male  0.32 [0.170.62] <0.01 0.67 [0.30–1.47]  0.31 
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Table 20.  Bivariate and Multivariate Effects of Active Spiritual Health Locus of Control (SHLC) on Self-Reported Medication 
Adherence in Hypertensive Older Adults (N = 170) 
Variable     Bivariate Models      Multivariate Modela  
        Key Variable  OR [95% CI]      p OR [95% CI] p   
Active SHLC      
 High  6.67 [2.86–15.54] <0.001 6.19 [2.29–16.74]  <0.001 
 Low  Reference    
      
Psychosocial Variables      
Social Support      
 High  3.51 [1.82–6.77] <0.001 2.21 [1.06–4.60]  0.03 
 Low  Reference    
      
Active Coping      
 High  2.11 [1.133.96] 0.02 1.58 [0.73–3.40]  0.25 
 Low  Reference    
      
Demographics      
Age  1.03 [0.99–1.08] 0.14 1.03 [0.98–1.08]  0.26 
Black  0.67 [0.36–1.25] 0.21 0.38 [0.170.86]  0.02b,c 
Male  0.32 [0.17–0.62] <0.01 0.45 [0.21–0.95]  0.04 
      
aMultivariate Model: Adjusted for social support, active coping, age, race, gender. 
bAn interaction term (race x active SHLC) was entered in the multivariate model and was not significant (95% CI 0.4–34.9). 
cWhen the race variable was omitted from the model, the odds ratio for the active SHLC variable decreased (OR = 4.3, 95 CI 1.7–10.8). 
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Aim 2a: Mediation Analysis Results 
Overview 
For exploratory analysis, social support and active coping were examined as 
mediators in the relationship between spirituality and medication adherence. First, an 
informal evaluation was conducted to determine if the pattern of relationships between the 
variables (spirituality, social support, active coping, and adherence) existed for mediation, as 
described in the Methods section. Next, a formal statistical method (the Sobel Test) was 
conducted to determine whether social support and active coping significantly carried the 
influence of spirituality to medication adherence. Results from these evaluations are 
discussed below. 
Analysis of Social Support and Active Coping as Mediators of Self-ranking of 
Spirituality  
Informal evaluation 
Using bivariate logistic regressions and the four criteria described in the Methods 
section, social support and active coping were examined in relation to the key independent 
variable (self-ranking of spirituality) and the adherence outcome (Figure 7). The independent 
effects of spirituality on the two potential mediators were examined first; both regressions 
revealed significant effects in that spirituality was significantly related to social support and 
active coping (95% CI 2.6–9.7 and 1.8–6.3). Thus, the first criterion was satisfied in that the 
IV significantly affected the mediator(s). As revealed in the bivariate analysis, spirituality was 
significantly related to self-reported medication adherence (95% CI 3.6–14.4), which 
satisfied the second criterion in that the IV significantly affected the DV in the absence of the 
mediator. Next, the potential mediators were examined for unique effects on medication 
adherence: both social support and active coping had significant effects on the outcome 
(95% CI 1.8–6.8 and 1.1–4.0), which satisfied the third criterion. Finally, when social support 
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and active coping were added to the logistic regression model that examined the effect of 
spirituality on adherence, the effect of spirituality decreased from an odds ratio of 7.2 to 5.4 
but remained significant (95% CI 2.5–11.4); this satisfied the fourth criterion in that the effect 
of the IV on the DV shrank upon the addition of the mediator(s). In spite of this shrinkage the 
effect remained significant, however, which suggests that full mediation was not 
demonstrated although results from the informal evaluation indicate that the social support 
and active coping variables may function as partial mediators in the relationship between 
spirituality and adherence. A formal statistical test was conducted to further examine this 
assumption. 
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Figure 7.  Informal Test of Social Support and Active Coping as Mediators  
 
Criteria 
 (1)  Spirituality       Social Support (SS) 
 
 
 
  Spirituality       Active Coping (AC) 
 
 
 
 (2)  Spirituality        Adherence 
 
 
 
 (3)  Social Support        Adherence 
 
 
 
  Active Coping        Adherence 
 
 
 
 (4)   Spirituality + SS + AC            Adherence 
   
OR = 4.98 (p <0.001) 
OR = 3.34 (p <0.001) 
OR = 7.20 (p <0.001) 
OR = 3.51 (p <0.001) 
OR = 2.11 (p =0.02) 
OR = 5.44 (p <0.001) 
  
 
130 
Formal Statistical Evaluation: Sobel Test 
The Sobel Test was used to formally test whether social support and active coping 
functioned as partial mediators between spirituality and self-reported medication adherence. 
(As discussed in the Methods section, the coefficients in mediation analyses end up being in 
different scales when the outcome variables are dichotomous in a logistic regression; 
therefore, the coefficients and standard errors of the variables must be standardized prior to 
conducting the Sobel Test for mediation.) For this analysis, both the mediator and outcome 
variables were dichotomous, which required standardization of the coefficients and standard 
errors of the variables involved. The calculations were performed using the equations in the 
Methods section. 
After the standardized coefficients and errors were calculated, the values were used 
to run the Sobel Test for mediation analysis (Figure 8). Results showed that neither social 
support nor active coping mediated the relationship between spirituality and adherence; 
moreover, the Sobel Test showed only a significant direct effect of spirituality on self-
reported adherence (OR = 1.49, p < 0.001). That is, the indirect paths of spirituality to 
adherence were not significant. In the logistic regression models that examined social 
support as a mediator of the relationship between spirituality and adherence, the estimate 
for the indirect effect (a1 * b1) was OR = 1.07 (p = 0.08), which suggests that the association 
between spirituality and adherence is not mediated by social support. The same pattern 
emerged with active coping, where the logistic regression models produced an odds ratio 
estimate for the indirect effect (a2 * b2) of 1.02 (p = 0.58). Therefore, the present study does 
not show the relationship between spirituality and adherence to be mediated by social 
support or active coping. 
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Figure 8. Model of Sobel Test of Mediation 
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It must be noted that the present study was not specifically powered to examine the 
mediation effects of social support and active coping; and the analysis was conducted for 
exploratory purposes. Therefore, the results of the mediation analysis should be interpreted 
with caution because a larger sample might have produced different results. Although the 
informal evaluation of mediation posed social support and active coping as partial mediating 
variables between spirituality and medication adherence, the Sobel Test of partial mediation 
revealed no significant indirect effects. Instead, only significant direct effects were observed 
between spirituality and medication adherence, which suggests that spirituality influences 
adherence when controlling for social support and active coping.  
Aim 3 Results 
Overview  
The purpose of Aim 3 was to examine the relationship between spirituality and blood 
pressure among community-dwelling, older adults with hypertension. Linear regression 
models were conducted to assess the bivariate and multivariate relationships between the 
spiritual variables and blood pressure. Average systolic and diastolic blood pressures were 
the outcome variables and were measured continuously using OLS regression methods. 
Self-ranking of spirituality and active SHLC beliefs were the independent variables of 
interest. The spirituality, adherence and blood pressure characteristics of the study sample 
have previously been discussed. Thus, this section focuses on the linear regression results 
predicting blood pressure. 
OLS Regression Results 
Table 21 presents the bivariate and multivariate effects of self-ranking of spirituality 
on systolic and diastolic blood pressures. In both the bivariate and multivariate models, 
participants who reported being more spiritual had significantly lower blood pressures than 
participants in the low spiritual group. As mentioned previously (Table 15), the average 
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blood pressures were significantly different between the participants who reported being 
more spiritual than those in the low spiritual group (132.8 vs. 150.2 mmHg systolic and 70.5 
vs. 79.4 mmHg diastolic, respectively). In the adjusted regression model (Table 21), the 
average systolic blood pressure was 12 points lower for the high spiritual group than the low 
spiritual group (95% CI -18.40, -6.04). Age and self-reported adherence were the only other 
covariates that remained significant in the adjusted model. On average, the systolic blood 
pressure of participants who reported high adherence was 14 points lower than participants 
who reported low adherence (β = -14.24; 95% CI -20.04, -8.43). Participants’ systolic blood 
pressure reduced slightly as their age increased. Diastolic blood pressure was 
approximately 4 points lower for those who reported being more spiritual and was also 
slightly lower with increasing age and for participants who reported high adherence. The 
adjusted models explain about 34% of the variance in systolic blood pressure and 37% of 
the variance in diastolic blood pressure. 
Similar to the aforementioned analyses, active SHLC was examined in relation to 
systolic and diastolic blood pressures (Table 22). In both the bivariate and multivariate 
models, participants who reported high active SHLC beliefs had significantly lower blood 
pressures compared to participants with low active SHLC. In the adjusted regression model 
(Table 22), systolic blood pressure was, on average, 11 points lower for the high spiritual 
group versus the low spiritual group (95% CI -18.16, -3.85). Consistent with the primary 
spiritual variable, age and self-reported adherence also remained statistically significant in 
the adjusted model for the systolic and diastolic outcomes. For this analysis, the adjusted 
models explain about 31% of the variance in systolic blood pressure and 38% of the 
variance in diastolic blood pressure. 
To summarize the linear regression results, both systolic and diastolic blood 
pressure seemed to be favorable for those who considered themselves more spiritual and 
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for those with active SHLC beliefs. These findings held true even after adjusting for the 
effects of adherence, the psychosocial and demographic variables in the models. Results 
indicate that there is support for the hypothesis of Aim 3, in that, older adults who report high 
spirituality are more likely to have lower blood pressure compared to those who report low 
spirituality. As in previous analyses, the confidence intervals around the estimates were 
large and imprecise making it difficult to determine a precise magnitude of the effect of the 
spiritual variables on blood pressure. The wide confidence intervals are likely due to the 
study’s modest sample size and the variability in the participants’ blood pressures. 
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Table 21.  Bivariate and Multivariate Effects of Self-ranking of Spirituality on Systolic and Diastolic Blood Pressure in Hypertensive Older Adults 
(N = 170) 
                            Systolic               Diastolic  
Variable  Bivariate     Multivariatea       Bivariate              Multivariatea  
          
          
Key Variable b [95% CI] p  b [95% CI] p b [95% CI] p b [95% CI] p 
Spirituality          
 High -17.44 [-22.71, -12.16] <0.001  -12.22 [-18.40, -6.04] <0.001 -8.84 [-12.07, -5.61] <0.001 -3.73 [0.07, 0.48] 0.04 
 Low Reference         
          
Adherence          
 High -19.42 [-24.62, -14.22] <0.001  -14.24 [-20.04, -8.43] <0.001 -12.85 [-15.81, -9.90] <0.001 -9.87 [-13.2, -6.52] <0.001 
 Low Reference         
          
Psychosocial 
Variables 
         
Social Support          
 High -9.03 [-14.68, -3.38] <0.01  -0.77 [-6.07, 4.53] 0.78 -5.28 [-8.63, -1.94] <0.01 -0.85 [-3.91, 2.21] 0.58 
 Low Reference         
          
Active Coping          
 High -5.22 [-10.99, 0.55] 0.08  -0.37 [-5.65, 4.91] 0.89 -2.97 [-6.39, 0.45] 0.09 -0.21 [-3.25, 2.84] 0.89 
 Low Reference         
          
Demographics          
Age 0.18 [-0.20, 0.56] 0.36  0.34 [0.01, 0.67] 0.04 -0.35 [-0.57, -0.13] <0.01 -0.28 [-0.48, -0.09] <0.01 
Black 2.75 [-3.08, 8.59] 0.35  4.87 [-0.44, 10.18] 0.07 1.93 [-1.53, 5.38] 0.27 0.69 [-2.37, 3.76] 0.65 
Male 7.14 [1.27, 13.00] 0.02  -1.98 [-7.48, 3.53] 0.48 5.62 [2.19, 9.05] <0.01 1.54 [-1.64, 4.72] 0.34 
          
R2    0.34    0.37  
aMultivariate Model: Adjusted for adherence, social support, active coping, age, race, and gender. 
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Multivariate Model: Adjusted for adherence, social support, active coping, age, race, and gender. 
Table 22.  Bivariate and Multivariate Effects of Active Spiritual Health Locus of Control on Systolic and Diastolic Blood Pressure in Hypertensive 
Older Adults (N = 170) 
                  Systolic           Diastolic  
Variable  Bivariate       Multivariatea        Bivariate       Multivariatea  
         
 
          
Key Variable b [95% CI] p  b [95% CI] p  b [95% CI] p b [95% CI] p 
Active SHLC          
 High -16.91[-23.71, -10.11] <0.001  -11.01 [-18.16, -3.85] <0.01 -10.67 [-14.66, -6.68] <0.001 -5.65 [-9.67,-1.64] <0.01 
 Low Reference         
          
Adherence          
 High -19.42 [-24.62, -14.22] <0.001  -15.64 [-21.43, -9.85] <0.001 -12.85 [-15.81, -9.90] <0.001 -9.75 [-13.0, -6.50] <0.001 
 Low Reference         
          
Psychosocial 
Variables 
         
Social Support          
 High -9.03 [-14.68, -3.38] <0.01  -1.76 [-7.09, 3.57] 0.52 -5.28 [-8.63, -1.94] <0.01 -0.84 [-3.83, 2.15] 0.58 
 Low Reference         
          
Active Coping          
 High -5.22 [-10.99, 0.55] 0.08  -0.54 [-5.92, 4.84] 0.84 -2.97 [-6.39, 0.45] 0.09 -0.06 [-3.08, 2.96] 0.97 
 Low Reference         
          
Demographics          
Age 0.18 [-0.20, 0.56] 0.36  0.39 [0.05, 0.73] 0.02 -0. [-0.57, -0.13] <0.01 -0.26 [-0.45, -0.07] <0.01 
Black 2.75 [-3.08, 8.59] 0.35  5.02 [-0.48, 10.52] 0.07 1.93 [-1.53, 5.38] 0.27 1.23 [-1.86, 4.31] 0.43 
Male 7.14 [1.27, 13.00] 0.02  0.26 [-5.16, 5.69] 0.92 5.62 [2.19, 9.05] <0.01 2.10 [-0.94, 5.14] 0.18 
          
R2    0.31    0.38  
  
 
 
Chapter 5 
DISCUSSION 
 
Although the spirituality and health literature has emphasized the positive 
relationship between some spiritual characteristics and various health domains, to our 
knowledge the present study is one of the first quantitative studies to examine the effects of 
spirituality on antihypertensive medication adherence and blood pressure in community-
dwelling older adults with hypertension. As such, it contributes to both the adherence and 
the spirituality and health literature. Because the conclusions of Aim 1 (the pilot study) have 
been previously discussed, the following sections summarize the prominent findings from 
the main study (aims 2 and 3), possible explanations for the findings, the limitations and 
strengths of the study, and possible directions for future research. 
Summary of Findings 
Spirituality and Medication Adherence (Aim 2) 
 This study was informed by a conceptual model (Figure 1) that suggests three 
dimensions of spirituality (i.e., faith in a transcendent force, relationship with God and 
others, and transformation and consolation) which may directly and indirectly affect 
adherence behavior and may also be useful in decreasing blood pressure and maintaining 
control.26 Because this model has never been tested, nor have the indirect pathways which 
mediate the relations of spirituality to medication adherence been empirically evaluated, this 
dissertation provides important contributions to the literature. This exploratory study 
examined self-ranking of spirituality and active SHLC beliefs in relation to self-reported 
 138 
 
medication adherence. These two spiritual measures represent the three dimensions of 
spirituality in the conceptual model. 
Supporting the hypothesis for Aim 2, the logistic regression models indicated that 
both self-ranking of spirituality and active SHLC beliefs are significantly and positively 
related to self-reported medication adherence. The positive relationships held true even 
after adjusting for the psychosocial (social support and active coping) and demographic 
variables (age, race, and gender) in multivariate analyses. These results are supportive of 
earlier studies that evaluated the associations between spiritual characteristics and other 
positive health behaviors (e.g., diet, exercise, lower alcohol/smoking 
prevalence).34,121,122,130,336,337 Furthermore, these results support previous qualitative studies 
in which informants indicated that their spirituality is a positive resource for coping with and 
managing their chronic illness.43,59-61,338  
Most of the previous quantitative studies have examined only one, concrete measure 
of spirituality, religious service attendance, without considering the broader aspects of 
spirituality. Most importantly, these previous studies did not evaluate spirituality in relation to 
medication adherence, which is a crucial health behavior for chronic disease maintenance 
and longevity. The majority of past qualitative studies, moreover, were conducted in 
overwhelmingly homogeneous racial minority populations, which limits the generalizability of 
their findings. Therefore, the current study supplied new information that contributes to the 
literature on the role of spirituality in adherence behavior in a racially diverse sample of older 
adults. 
Possible Explanations of Findings 
The cross-sectional design of the present study limits its ability to definitively unravel 
the mechanisms by which spirituality affects adherence behavior beyond the associations 
observed. However, by building on the insights of previous researchers—and taking into 
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account the key strengths of the present study (i.e., diverse hypertensive sample, use of 
different measures of spirituality) when viewed in the context of the extant literature, some 
possible reasons for the findings can be provided. The most descriptive studies to date 
reside in the HIV and cancer literature, where researchers report that higher spirituality 
predicts adherence to antiretroviral therapy33,269,339,340 and that patients often become 
spiritual after diagnosis, rely on their spirituality for coping, and try to deal with the 
challenges of their illnesses both purposefully and positively.240,301,341 It is believed that the 
nature of these diseases (HIV and cancer) may influence why and how these patients 
incorporate their spirituality in disease management.339,342 
The stressors and challenges of hypertension, a disease even more prevalent in the 
United States than HIV or cancer, may also catalyze patients to rely on their spirituality for 
meaning of their illness and disease management—responses that have been particularly 
noted in qualitative studies involving older Black women.59,151,343 Informants have articulated 
that they use their faith in God and spiritual practices (e.g., meditation, prayer, scripture 
reading) to specifically guide their self-care management, including taking their 
medications.43,59,158,159,343 Our findings suggest that spirituality may function as a positive 
resource for White older adults as well. The older adult population, regardless of race, is 
known to regard spirituality as not only a significant personal experience involving intimate 
relationship with a transcendent, divine force,344 but also as a source of guidance about how 
to behave in the context of life events, including health crises.344-347 Some reports have 
specifically found that spirituality offers support, enhances self-empowerment, and provides 
strength for individuals to cope with chronic illness.39,59,348,349 These effects may be at play in 
our study, in that supportive guidance and the power to cope are inherent to participants’ 
spiritual identity and beliefs. As seen in the bivariate analyses, both spiritual variables were 
 140 
 
positively associated with social support and active coping as well as with adherence 
behavior. 
For some patients, spirituality is a source for transformation (i.e., personal growth) 
and consolation, which in turn provide strength to proactively cope with chronic 
illness.39,342,350 These effects have been documented in cancer,351 HIV/AIDS,339 and in the 
management of diabetes159 as well as hypertension.151 In the present study, elements of the 
participants’ spiritual alignment or faith may have enabled them to come to terms with their 
hypertension and also provided them with the strength and self-empowerment to take 
control of their situation by adhering to their medication. These effects have been observed 
in previous studies of older adults.59,338,346  
Because of the common perception that patients (especially minorities and older 
adults) who are highly spiritual/religious tend to relinquish control or adopt a passive 
orientation toward their health,352,353 the spiritual variable of active SHLC was specifically 
chosen for the current study.263,279,280 As hypothesized, participants with high active SHLC 
reported better adherence than those with low active SHLC, perhaps because the former 
group considers health maintenance to be a partnership with God in which they must fulfill 
certain responsibilities (e.g., take their medications). Evidence for this effect has been found 
in qualitative studies in which informants viewed management of their hypertension as a 
collaborative relationship between God and an individual59,151 and in studies in which active 
SHLC beliefs were positively associated with health-promoting behaviors and inversely 
related to health risk behaviors.160,279,283,299 However, findings from these studies and others 
like them are limited as they have mostly involved examining these factors in minority 
women. Because of the lack of cross-racial and studies involving men, future research 
should examine the similarities and differences of spirituality in relation to adherence by race 
and gender.   
 141 
 
 
Mediation Analysis: Social Support & Active Coping (Aim 2a) 
Aim 2a addressed the indirect pathways by which spirituality may be linked to self-
reported adherence behavior, with social support and active coping as putative mediators. 
The expectation was that the benefits of spirituality would provide increased social support 
and active coping, which function as resources to overcome barriers associated with 
medication adherence.26 Contrary to the conceptual model, however, neither of the 
psychosocial variables (social support and active coping) were found to be significant 
mediators in the relationship between spirituality and self-reported adherence. Although the 
present study did not produce evidence in support of Hypothesis 2a, this may be because 
the study was under-powered for mediational analysis. Another possible explanation for the 
insignificant results may be the lack of data on study participants’ level of self-efficacy. 
Increased self-efficacy has been linked to spiritual practices and beliefs across different 
populations;43,111,136,354 in fact, some researchers have noted that the relational aspect of 
spirituality may increase ones capability or self-efficacy to manage different health situations 
and decrease the barriers to health-promoting activities.26,345,352 Although self-efficacy was 
not measured in the present study, it may have some bearing on how social support and 
active coping functioned in this sample of older adults. In addition, other mediating and/or 
moderating relationships may have been operating between the spirituality and adherence 
variables that were not measured in the present study.  
The literature contains insufficient evidence to show how social support functions as 
a mediator between spirituality and other health domains and behaviors. Some researchers 
report significant mediational effects226,355-358 whereas others have found marginal or no 
effect.194,359-362 Although associations between spirituality and active (or positive adaptive) 
coping have been found,39,224,229,358,363 and active coping has been linked to improved 
medication adherence,244,283,316,364 knowledge of whether active coping mediates the 
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relationship between spirituality and adherence behavior has been speculative.26,167,194,352 
Due to this lack of evidence and the limitations of the current study’s findings, further 
investigation of social support and active coping as mediators in this relationship is 
warranted.  
Spirituality and Blood Pressure (Aim 3) 
The objective of Aim 3 was to examine the relationship between the spiritual 
variables and blood pressure. As with the results of Aim 2, spirituality was significantly and 
positively related to blood pressure. These findings support Hypothesis 3 (i.e., that 
spirituality has positive effects on blood pressure). In adjusted analysis, participants who 
reported high spirituality were found to have lower systolic and diastolic blood pressures 
than participants with low spirituality. This trend was also supported in the analysis with the 
second spiritual variable; those with high active SHLC had significantly lower systolic and 
diastolic blood pressures. While these findings support previous reports that aspects of 
spirituality positively impacts blood pressure and hypertension,34,37,39,53,174,186,365-368 this study 
is one of the first to control for medication adherence, which is a major predictor of blood 
pressure control in hypertension. Past studies have focused mainly on the relationship 
between religious involvement and blood pressure but have not considered the older adult 
population, in which individualized aspects of spirituality (as opposed to organized religious 
expression) have been shown to positively influence health.  
Overall, findings from this study strongly indicate that spirituality has positive 
influences on blood pressure in older adults with hypertension, beyond their adherence to 
anti-hypertensive therapy. These results may have been influenced by over- or 
underreporting of spiritual magnitude, active SHLC, or adherence behavior by study 
participants. Although modest overreporting of spirituality/religiosity is likely,39 the 
operationalization of the spiritual variables in this study should have separated the more 
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spiritual from the less spiritual individuals. Because the current study did not adjust for other 
behavioral (e.g., diet, exercise, alcohol consumption) and psychological (e.g., stress, 
anxiety) factors that may affect blood pressure, further investigation is warranted of how 
spirituality impacts blood pressure (e.g., through behavioral and psychological mechanisms) 
in hypertensive patients. 
Limitations 
 Several limitations must be recognized when interpreting the results of the present 
study. First, its results may not be generalizable to other chronic diseases, younger adults, 
or populations outside the geographical region of central North Carolina. Similarly, older 
adults who visit senior centers may differ from older adults who do not go to such social 
gathering places in terms of their resources and/or other salient characteristics that may 
influence adherence behavior and health. Therefore, the results of this project may not be 
generalizable to older adults outside of those who visit senior centers. 
Second, the cross-sectional design of the present study did not permit 
determinations of causal relationships among the variables. This design is considered 
appropriate, however, given that (1) little other examination of the relationship between 
spirituality and adherence has been made, especially in community-dwelling older adults 
with hypertension; and (2) a deeper understanding (i.e., the mechanism) itself was 
examined. For these reasons, the study results should be considered exploratory. Given 
that the full range of potential variables were beyond the scope of the present study, it is 
possible that unobserved heterogeneity or unmeasured confounding affected the findings 
(as there may be other mediating variables that affect the relationships between spirituality, 
adherence behavior, and blood pressure). In addition, the current study may have been 
heavily biased toward the Christian faith due to its population and the geographical region in 
which it was conducted. Different faiths and belief systems (e.g., Christian Science, 
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Judaism, Islam, Hinduism, Buddhism) may have inherent factors that affect medication-
taking behavior and blood pressure quite differently. 
Other factors that may influence medication adherence that were not incorporated 
into the present study include: (1) health literacy, (2) number of health conditions, (3) the 
number of medications prescribed, and (4) the extent to which participants were burdened 
by the number of hypertension medications prescribed to them. These factors, which have 
been associated with adherence outcomes, could have been mediating variables in the 
relationships observed in this study.64,82,103,106,369 However, the absence of these factors is 
not assumed to have skewed the results because the logistic regressions in the present 
study were adjusted for some predictors known to be correlated with spirituality and blood 
pressure (i.e., age, race, gender, social support, active coping). 
This study relied on participant reports of hypertension diagnosis without access to 
medical charts or physician diagnosis for confirmation; in addition, one of its primary 
instruments, the MMAS-8, measures hypertensive medication adherence by relying on 
participants’ memories and self-assessments. Given that some older adults may not 
remember or know which medications they are prescribed or take for their hypertension, 
adherence may have been over- or underreported. In addition, some older adults may over-
report adherence for reasons of social desirability or to please their health care providers. 
To reduce the possibility that these factors would function as limitations, the present study 
was conducted outside of clinic or hospital settings. Although there is evidence in the 
literature that self-reported adherence measures such as the MMAS-8 have moderate to 
high concordance with pharmacy refill records and electronic monitoring devices,370-372 
including additional and more objective measures of adherence would be ideal. The MMAS-
8 was used because it is a disease-specific adherence measure, was originally validated in 
hypertensive older adults, and has been shown to have high concordance with pharmacy 
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refill records.307,308 Nevertheless, the possibility of bias in participants’ ability to accurately 
and truthfully report their adherence behavior must be acknowledged.  
Another consideration for the current study has to deal with the measurement of the 
active coping variable used in analysis.  The JHAC12 was used to assess this construct, 
and following the developers methodology of scoring, a median split was used to categorize 
participants into the high and low active coping groups.  There are a couple of issues that 
must be recognized with the use of this categorization scheme.  First, dichotomization of the 
participants’ continuous active coping scores (ranging from 12 to 60), may have resulted in a 
loss of power and residul confounding.202  Also, it is unclear whether using the median split 
score is an optimal and meaningful cutpoint with regards to the assessment of the active 
coping concept.  Finally, using the median split as a cutpoint limits the ability to compare 
active coping scores across different studies because the median score will most likely be 
different for different sample populations.    
In a sensitivity analysis of the current study data, when comparing active coping as a 
continuous measure versus as a dichotomized median split measure, the results did not 
change with regards to the significance, magnitude and the study’s conclusions.  However, it 
is best-practice that researchcers not dichotomize continuous data unless it clearly makes 
meaningful sense to do so, and in particular, dichotomization should not be applied to 
explanatory variables in regression models.200,202  It is suggested that dichotomization of a 
continuous variable only be when the distribution of the the variable of interest is hghly 
skewed or its relation with another variable is nonlinear.200  Although the developers suggest 
that JHAC12 scores are expected to be skewed with scores on the higher end, they provide 
no firm justification for the scoring scheme that they have used.  Moreover, the median 
scores for the populations have varied, making it difficult to compare active coping across 
studies.  Thus, further investigation into the proper cutpoint for this active coping measure is 
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warranted, or it is probably more appropriate to measure this concept as a continuous 
variable.  Future analysis will provide more insight into the scoring scheme of this measure. 
Finally, although the results of the present study revealed positive and significant 
relationships among the spirituality, adherence and blood pressure constructs, the 
confidence intervals around these estimates were quite large. Therefore, it is difficult to 
make precise estimates for the magnitude of the associations found. A larger sample size is 
required for more precise estimates of spirituality’s effect on adherence behavior and blood 
pressure.  
Strengths 
The present study addresses a persistent gap in the adherence literature and sets 
the stage for identifying potential mediators and mechanisms by which spirituality may affect 
adherence behavior in hypertensive patients. It advances the adherence and medical 
literature as its findings provide evidence that spirituality may be an important factor that has 
been largely overlooked, but should be considered for some hypertensive patients (i.e., for 
those who identify as spiritual). Findings from this study also illuminate that patients who 
have low or no spiritual alignment may be at risk for nonadherence and higher blood 
pressure. Thus, this study has presented another construct that should be considered in 
understanding predictors of medication adherence and health outcomes. 
   As one of the first studies to examine spirituality and medication adherence in a 
community-dwelling, hypertensive older adult population, the present study extends the 
design of the majority of past studies, which have focused mostly on terminally ill or hospital 
inpatients in the terminal stages of illnesses such as cancer and HIV. Although whether the 
latter group(s) rely upon their spirituality in the same ways and for the same reasons as 
hypertensive patients remains unknown, it is reasonable to assume that the findings of the 
 147 
 
present study are linked to different types of bias, or influences from hypertension itself, on 
the participants’ perspectives or spiritual intensity.  
Another strength of the present study is that it broadly defined and measured 
spirituality, whereas past studies almost routinely narrowed the definition and measurement 
of spirituality to frequency of religious service attendance or to religiosity (i.e., outward 
expressions of faith).167,338,349,373 Because the present study’s use of a broad measure of 
spirituality was more inclusive, it may have more accurately captured participants who 
identify as spiritual; clearly, the active SHLC measure captured some religious aspects (e.g., 
the use of the term “God” or “Lord” in some question items) that are relevant to the study’s 
population and geographical location. Although two different domains of spirituality were 
examined, both were significantly and positively associated with adherence and blood 
pressure; these associations provide affirmation that the relationships of the variables are 
valid.  
Several other components of the present study contribute to its robustness as well. 
These include its systematic and careful planning, which involved a pilot study (Aim 1) of the 
spiritual measures that are relevant to older adults. In addition, a power analysis of an 
appropriate and sufficient sample size for exploring the possible relationship between 
spirituality and adherence was conducted—an ideal method that is not available or feasible 
for many researchers. The fact that this was a multi-center study conducted in a diverse 
sample of older adults was also advantageous in that the study sample was heterogeneous 
by race/ethnicity (more than 40% Black/African American). This mix was impressive, given 
the difficulty of recruiting and enrolling Blacks into research studies, especially in the South. 
The enrollment of a fairly even distribution of both racial identifications was also 
advantageous because Blacks have been shown to have poorer adherence and blood 
pressure control than Whites.  
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Implications for Future Research and Practice 
The findings of the present study may serve as a useful starting point for the design 
of future studies on additional domains of spirituality in relation to hypertension self-care 
management and outcomes. Future research should examine these domains across and 
within other populations. Such studies would provide necessary insight into whether the 
concepts are consistent across different cultures, in different geographical regions, and 
among different racial/ethnic backgrounds, spiritual faiths, and age groups. To extend the 
present study in these ways will be clinically important because hypertension is just not an 
older adults’ disease, nor can its presence be classified as homogeneous in terms of 
location, ethnicity, and so forth. Hypertension affects all ages, diverse communities and a 
large proportion of the population in the United States.374 
Clearly, the variables of interest must be examined in larger and more diverse 
samples. Although the logistic regression results of the present study revealed significantly 
strong associations between spirituality, self-reported adherence, and blood pressure, the 
confidence intervals around the estimates were large and imprecise. Therefore, a precise 
calculation of the magnitude of the effect of spirituality on these outcomes cannot be made; 
the large estimates may merely be a function of the modest sample size. A larger sample, 
as well as use of additional and more objective measures of adherence (e.g., pharmacy 
refills) may generate more precise results.26,167,194,352 Use of additional and more objective 
measures of medication adherence will help to minimize the influence of cognitive 
functionality within the sample and to confirm accuracy of self-reported adherence behavior.  
Next, because the use of a cross-sectional study design in the present study 
provides evidence for an association between the spiritual variables and the outcomes, a 
prospective study design would permit the assessment of adherence behavior and blood 
pressure over time and improve the ability to make causal inferences among the variables. 
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Due to the current findings and inconsistent reports in the literature, future research should 
attempt to further examine the mechanisms by which spirituality affect health behavior and 
health outcomes. In particular, social support and active coping should be further examined 
as mediators in the relationship between spirituality and medication adherence. Future 
studies should also attempt to identify other important mediators of spirituality and 
adherence and the impact of these variables on cardiovascular outcomes. Such 
mechanisms and factors may include: (1) subjects’ level of spiritual engagement; (2) 
subjects’ spiritual practices, beliefs, or faiths; (3) subjects’ levels of self-efficacy and 
strength; and (4) the effect of spiritual variables upon other determinants of subjects’ 
medication adherence (e.g., spiritual concordance with health providers). Such research 
would help resolve certain unknowns that have been consistently noted in the literature, 
which would subsequently help researchers and clinicians better develop appropriate 
adherence and hypertension interventions. 
That spirituality may assist in healthy lifestyle behaviors and in improving health 
outcomes, such as decreasing blood pressure,190,349 is evidenced in the literature and 
supported by the current findings. However, how health care professionals can use this 
information to help improve adherence behavior and hypertension outcomes will remain 
unclear until the research needs mentioned above are addressed. Nevertheless, health care 
providers should increase their sensitivity to patients’ spiritual orientation, understand the 
prevalent beliefs (or lack thereof) in the communities they serve, and refer patients to 
chaplains or ministers when appropriate (e.g., when patients have spiritual struggle that 
conflicts with disease management).25,375 These approaches are important for patient-
centered and culturally appropriate care. 
Of course it would be grossly inappropriate to prescribe or try to change a patient’s 
spirituality; however, the attributes and benefits of spirituality in patients’ lives are subjects 
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that researchers and clinicians should actively consider in order to help inform the 
development of interventions that are appropriate and effective for individuals who do not 
identify as spiritual. For example, activities that may or may not be necessarily spiritual in 
nature have been shown to positively impact health; these include meditation (or 
mindfulness techniques), acts of compassion, and participation in strong social support 
networks.376,377 Capitalizing on these activities may cultivate adherence behavior and 
ameliorate outcomes in older adults who are at high risk for nonadherence but lack spiritual 
alignment. From a public health standpoint, researchers may explore the use of faith-based 
organizations and community support groups as platforms for health education about 
hypertension and the importance of medication adherence.  
Conclusion 
The literature emphasizes the importance of spirituality in overall health and some 
behaviors of chronically ill persons; however, spirituality has been largely overlooked in the 
study of medication adherence. The present study addresses a pertinent gap in the 
literature regarding the association between spirituality and medication adherence in 
hypertensive older adults. It is one of the first studies to examine spirituality, adherence and 
blood pressure outcomes from a conceptual framework and to explore the mechanism from 
both psychosocial and cultural contexts. Study results indicate that spirituality is significantly 
and positively associated with both medication adherence and significantly related to lower 
blood pressure. The discovery of these associations provides direction for future studies that 
will aid in understanding how health professionals can use this information to provide 
culturally sensitive and patient-centered care that will improve medication adherence and 
cardiovascular outcomes. 
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Appendix 2. Spiritual Health Locus of Control Scale (SHLCS) 
Subject #: _____________________                              Date of Visit __________________ 
 
 
 
 
 
SHLCS 
 
 
 
 
 
 
 
Please think about the following statements regarding your spiritual 
beliefs and your health in general.  The following questions use the 
word “God” which refers to whatever form of higher power you 
believe in.  For each statement, circle the one number (1, 2, 3, 4) that 
comes closest to how much you agree with that statement. 
 
 
***There are no right or wrong answers to your responses.  We 
just want to know your opinions to these statements*** 
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1.  Through my faith in God, I can stay healthy. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
2.  If I lead a good spiritual life, I will stay 
 healthy. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
3.  If I stay healthy, it’s because I am right with 
 God. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
4.  Living the way the Lord says I’m supposed 
 to live means I have to take care of myself. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
5.  Even though I trust God will take care of me, 
 I still need to take care of myself. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
6.  God gives me the strength to take care of 
 myself. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
7.  I rely on God to keep me in good health. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
8.  God works through doctors to heal us. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
9.  Prayer is the most important thing I do to 
 stay healthy.  
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
10. If I stay well, it is because of the grace of the 
 good Lord. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
11. It’s ok not to seek medical attention because 
 I feel that God will heal me. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
12. There is no point in taking care of myself 
 when it’s all up to God anyway. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
13. God and I share responsibility for my health. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
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Appendix 3.  Self-ranking of Spirituality and SMAS 
 
 
Self-ranking of Spirituality and SMAS 
 
 
Please think about the following statements regarding your 
spiritual/religious beliefs and how you take your medications.  The 
following questions use the word “God” which refers to whatever 
form of higher power you believe in.  For each statement, circle the 
one number (1, 2, 3, 4) that comes closest to how much you agree 
with that statement. 
 
 
***There are no right or wrong answers to your responses.  We 
just want to know your opinions to these statements*** 
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Self-Ranking of Spirituality 
To what extent do you consider yourself a spiritual/religious person? 
 
4 Very spiritual/religious 3 Moderately spiritual/religious 2 Slightly spiritual/religious    1 Not at all  
  
SMAS 
 
1. God works through health providers (doctors, 
nurses, pharmacists) to keep me in good 
health. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
2. My spiritual/religious beliefs influence the way 
I take my medications. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
3. I have faith that God is healing me through my 
medications. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
4. God wants me to take my medications the way 
my doctor prescribed them for me. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
5. I can get better without taking medications, by 
relying on my spiritual/religious beliefs. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
6. I use my spiritual beliefs as a guide for how to 
take my medications. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
7. I have faith that taking medications is part of 
God’s plan to heal me. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
8. I consult with (or pray to) God on whether or 
not I should take my medications.  
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
9. My spiritual/religious beliefs help me to take 
my medications like I am supposed to. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
10. I would stop taking my medications if God 
revealed to me to trust in Him, only. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
11. Sometimes I feel better by just praying, rather 
than taking my medications. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
12. If I take medications, it means that I am not 
relying on God to heal me. 
4 
Strongly 
Agree 
3 
Agree 
2 
Disagree 
1 
Strongly 
Disagree 
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Appendix 4. John Henryism Active Coping Scale (JHAC12) 
 
JHAC12 
 
We would like to ask you some questions about how you see yourself right now, today, as a 
man/woman living and doing things in the real world.  Please read each statement and then circle the 
one number that comes closest to how TRUE or FALSE each statement is for you, personally.  For 
each statement, circle only one number (1, 2, 3, 4 or 5). 
***There are no right or wrong answers to your responses about these statements*** 
 
1. I’ve always felt that I could make of my life pretty 
much what I wanted to make of it.  
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
2. Once I make up my mind to do something, I stay 
with it until the job is completely done. 
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
3.  I like doing things that other people thought 
could not be done. 
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
4. When things don’t go the way I want them to, 
that just makes me work even harder. 
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
5. Sometimes I feel that if anything is going to be 
done right, I have to do it myself. 
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
6. It’s not always easy, but I manage to find a way 
to do the things I really need to get done. 
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
7. Very seldom have I been disappointed by the 
results of my hard work. 
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
8.  I feel that I am the kind of individual who stands 
up for what he/she believes in, regardless of the 
consequences. 
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
9. In the past, even when things got really 
 tough, I never lost sight of my goals. 
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
10. It’s important for me to be able to do 
 things the way I want to do them rather  than 
the way other people want me to  do them. 
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
11. I don’t let my personal feelings get in  the 
way of doing a job.  
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
12. Hard work has really helped me to get 
 ahead in life. 
1 
Completely 
False 
2 
Somewhat 
False 
3 
Don’t 
Know 
4 
Somewhat 
True 
5 
Completely 
True 
James S.A., Strogatz D.S., Wing S.B., Ramsey D.L.  Socioeconomic Status, John Henryism, and Hypertension in Blacks and Whites.American Journal of 
Epidemiology, 1987, vol. 126, pp. 664-673 
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Appendix 5. Tangible, Informational and Emotional Social Support  (adapted TIES) 
 
Please think about the following questions regarding the support you have with your 
health and taking your medications. For each question, circle the one number (2, 1, 
or 0) that comes closest to how often you have the support you need. 
HOW OFTEN IS THERE…. 
 
1. Someone to encourage you to take your 
medications? 
2 
All or Most 
of the time 
1 
Some of 
the time 
0 
None of 
the time 
2. Someone available to help you get access to your 
medications (getting your prescriptions filled? 
2 
All or Most 
of the time 
1 
Some of 
the time 
0 
None of 
the time 
3. Someone available to actually take you or go with 
you to the hospital/doctor when you are sick? 
2 
All or Most 
of the time 
1 
Some of 
the time 
0 
None of 
the time 
4. Someone who could discuss your condition or 
health concerns with your doctor? 
2 
All or Most 
of the time 
1 
Some of 
the time 
0 
None of 
the time 
5. Someone who could visit you or check up on you 
while you are in the hospital or at home? 
 
2 
All or Most 
of the time 
1 
Some of 
the time 
0 
None of 
the time 
6. Someone (other than your doctor) you could turn to 
for general advice regarding your health? 
2 
All or Most 
of the time 
1 
Some of 
the time 
0 
None of 
the time 
7. Someone (other than your doctor) you could turn to 
for general advice regarding your medications?* 
2 
All or Most 
of the time 
1 
Some of 
the time 
0 
None of 
the time 
 
Adapted from: Boutin-Foster C; Alexander J. Development and Validation of the Tangible, Informational, and Emotional Social Support 
Survey. Journal of Cardiopulmonary Rehabilitation 2006; 26:307-313. 
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Appendix 6. Morisky Compliance Assessment Scale (4-item) 
Subject #:            ____              Visit:    Baseline          3 months          6 months              Date of Visit:  
MORISKY INSTRUMENT 
SELF-REPORT MEASURE OF ADHERENCE  
 
Interviewer:  I am going to ask you four questions.   
Think about how you have taken your medications during the past 4 weeks. 
 Yes No 
1.  Did you ever forget to take your medicines? 
 
 
  
2.  Are you careless at times about taking your 
medicines? 
 
  
3.  When you feel better, did you sometimes 
stop taking your medicines? 
 
  
4.  Sometimes if you felt worse when you took 
your medicines, did you stop taking them? 
 
  
Scoring: A response of “Yes” is equal to 0 and a response of “No” is equal to 1. 
Range:   0-4 
Total Score: ____________________________ 
  
1
6
0
 
Appendix 7.  Demographic Questionnaire 
 
Subject #: ___________    Date of Visit: ___________    Study site: ___________ 
Section I. 
 
1.  Age                              2. Date of Birth (e.g., 01/01/1920) 
 
 
3.  Has your doctor (or other health provider) ever told you that you have high blood pressure (or hypertension)?   
  
 Yes          No  If yes, how long have you had high blood pressure?    
 
4.  Do you take a high blood pressure medicine(s)?   Yes          No 
 
5.  Do you live independently in the community (not in an assisted living or long term care facility)?   Yes          No 
  
6.  Race                     Black/African American                 White              Other (specify)               
 
7.  Ethnicity                Hispanic or Latino      Not Hispanic or Latino 
 
8.  Gender                   Female               Male 
 
9.  Marital Status         Never married   Married         Widowed        Divorced       Separated 
 
10.   What is the highest grade or year of school you completed? 
 
 Never attended school or only attended kindergarten  College 1 year to 3 years (Some college or tech.l school) 
 Grades 1 through 8 (Elementary)                           College 4 years (College graduate)   
 Grades 9 through 11 (Some high school)    Postgraduate work 
 Grade 12 or GED (High school graduate)              Refused to answer 
 
 / /   
  
1
6
1
 
Subject #: ___________    Date of Visit: ___________    Study site: ___________ 
 
11.   “Was there a time in the past 3 months when you needed prescription medication but could not purchase it due to cost?”  
    Yes    No    Don’t know/Not sure   
If “Yes,” what did you do?     Went without it    Someone else bought it for me?   Other__________ 
 
12.  Without talking about exact dollars, how would you describe your household’s financial situation right now?   
Would you say that….           
    After paying the bills, you still have enough money for special things that you want. 
   You have enough money to pay the bills, but little spare money to buy extra or special things. 
   You have money to pay the bills, but only because you have to cut back on things. 
   You are having difficulty paying the bills, no matter what you do. 
   Don’t know 
   Refused 
13.  Can you tell me if your household income was more or less than $10,000 in the past 12 months?                                 
   Less than $10,000 (Go to Section II) 
   $10,000 or more 
   Don’t know 
   Refused 
14.  Can you tell me if your household income was more or less than $35,000 in the past 12 months?              
   Less than $35,000 
   $35,000 or more 
   Don’t know 
           Refused 
  
1
6
2
 
Subject #: ___________    Date of Visit: ___________    Study site: ___________ 
 
Section II. 
Blood Pressure Measurement   
First digital blood pressure  
SBP / DBP  
Time: ____________    _____________/_________mmHg 
 
**Wait at least 5 minutes seated ** 
Second digital blood pressure  
SBP / DBP  
Time: ____________    _____________/_________mmHg 
 
*Ask participant if s/he will need assistance with completing the remaining study surveys ** 
 
Did participant request or require assistance with completing study surveys (i.e., reading each survey item)?  
        Yes   No 
 
If yes, what was the reason for assistance (e.g., literacy, vision):    Literacy    Vision Impairment  
 
            Do not know   Other (specify) __________
 163 
 
Appendix 8.  Morisky Medication Adherence Scale (MMAS 8-item)©  
Subject #: ____________________    Date of Visit: _____________________ 
 
You indicated that you are taking medication for your high blood pressure. Individuals have 
identified several issues regarding their medication-taking behavior and we are interested in 
your experiences.  There is no right or wrong answer.  Please answer each question based on 
your personal experience with your high blood pressure medication.   
                                                                                
(Please circle the correct number) 
1. Do you sometimes forget to take your high blood pressure pills? 
 
No=1 Yes=0 
2.  People sometimes miss taking their medications for reasons other than 
forgetting. Thinking over the past two weeks, were there any days when you 
did not take your high blood pressure medicine? 
 
 
 
No=1 
 
 
Yes=0 
3. Have you ever cut back or stopped taking your medication without telling your 
doctor, because you felt worse when you took it? 
 
 
No=1 
 
Yes=0 
4. When you travel or leave home, do you sometimes forget to bring along your 
high blood pressure medication? 
 
 
No=1 
 
Yes=0 
5. Did you take your high blood pressure medicine yesterday? 
 
No=1 Yes=0 
6. When you feel like your high blood pressure is under control, do you 
sometimes stop taking your medicine? 
 
 
No=1 
 
Yes=0 
7. Taking medication every day is a real inconvenience for some people. Do you 
ever feel hassled about sticking to your high blood pressure treatment plan? 
 
 
No=1 
 
 
Yes=0 
8.  How often do you have difficulty remembering to take all your medications?  
(Please circle the correct number) 
   Never/Rarely…………………………………….. 4 
   Once in a while………………………………….. 3 
   Sometimes………………………………………... 2 
   Usually…………………………………………….. 1 
   All the time ..………………………………… 0 
Use of the 
©
Morisky Medication Adherence Scale (MMAS-8) is protected by US copyright laws. Permission for use is 
required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of 
Community Health Sciences, UCLA School of Public Health, 650 Charles E. Young Drive South, Los Angeles, CA 
90095-1772. E-mail: dmorisky@ucla.edu; Phone: (310) 825-8508
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Appendix 9.  Visual Analog Scale for Medication Adherence 
 
Subject #: ____________________    Date of Visit: _____________________ 
Instructions to participant: 
 
On a scale of 0% to 100%, which of the following percentages best reflects your compliance with your 
high blood pressure medicine over the past 4 weeks? 
 
                   __ 
 
0%       10%       20%     30%            40%          50%      60%   70%  80%      90%  100% 
            
Have taken none of the     Have taken about half the    Have taken all of the  
recommended doses over     recommended doses over   recommended doses 
the past 4 weeks      the past 4 weeks    over the past 4 weeks 
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Appendix 10. Tangible, Informational and Emotional Social Support Survey 
 
 
Subject #: _________________                                                                   Date of Visit:____________ 
 
 
Please think about the following questions regarding the support 
you have with your health and taking your medications. For each 
question, circle the one number (2, 1, or 0) that comes closest to 
how often you have the support you need. 
 
***There are no right or wrong answers. We just want to know your opinion to 
these questions. 
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HOW OFTEN IS THERE…. 
 
1. Someone to encourage you to follow a healthy diet? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
2. Someone available to help you to prepare healthy meals? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
3. Someone to encourage you to take your medications? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
4. Someone available to help you get access to your 
medications (getting your prescriptions filled)? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
 
5. Someone available to actually take you or go with you to the 
hospital/doctor when you are sick? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
6. Someone to encourage you to exercise? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
7. Someone who could participate in exercise with you? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
 
8. Someone who could discuss your condition or health 
concerns with your doctor? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
9. Someone you can talk to about important things in your life? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
10. Someone who could visit you or check up on you while you 
are in the hospital or at home? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
11. Someone who makes you laugh? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
12. Someone you can go out with just for fun (like going to the 
movies)?   
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
13. Someone who could make sure you get enough rest and 
relaxation? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
14. Someone to encourage you, tell you  “things will be okay,” 
or reassure you? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
15. Someone (other than your doctor) you could turn to for 
general advice regarding your health (eating, dieting, 
exercise, medications)? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
16. If you smoke, is there someone to encourage you to quit 
smoking? 
2 
All or Most of the 
time 
1 
Some of the 
time 
0 
None of the 
time 
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 Appendix 12. Referral List Form. 
 
Factors Influencing Medication-taking Behavior in Older Adults with Hypertension Study 
 
REFERRAL FORM 
If you would like to learn more about this study, your name and contact information will be 
forwarded to the researcher and she will contact you by phone.  This information will not be shared 
for any other purpose. If you are interested in participating in this study, please keep in mind that 
you must meet the following eligibility criteria: 
 Must self-identify as black or white  
 65 years of age or older 
 On at least 1 high blood pressure medication  
 Living independently (i.e., cannot reside in assisted living facility or nursing home) 
 Be English-speaking 
Patient Name Contact Telephone Number 
 
1. 
 
 
2. 
 
 
3. 
 
 
4. 
 
 
5. 
 
 
6. 
 
 
7. 
 
 
8. 
 
 
9. 
 
 
10. 
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Appendix 13.  Telephone Script Used For Recruitment 
Script 
 
1. Hello, may I please speak with Mr/Mrs_________________. My name is 
___________________ and I am a graduate student researcher with the UNC Eshelman 
School of Pharmacy. How are you today?  Your name was forwarded to me by 
Mrs______________ at the __________________(Senior Center).  You provided your name 
on a list at the center so that someone could follow up with you to describe the study we 
are conducting and invite your participation.  
 
2. I am the principal investigator for this study and I am calling today to see if you are 
interested in learning more about our research study. My call today will take less than 10 
minutes. Is this an O.K. time to talk?  
 
If not, see if individual is interested in setting aside a time to talk when it is more convenient 
for him/her. 
 
If the individual is not interested, please thank them for their time. 
      
3. The purpose of this research study is to learn about different factors that older adults 
consider important when it comes to their medication-taking behavior and blood pressure 
control.  We want to learn about your personal experiences with taking your high blood 
pressure medication, and understand your personal beliefs/attitudes, learn about the 
support you have, and how you cope with having to take your medicine and manage your 
high blood pressure.  If you decide to be in this study your participation will only be for 1 
day, and will take about 30 minutes to complete.  You will be asked to come to your local 
senior center for this 30 minute visit at a time that is convenient for you.  This can be a day 
that you have already planned to come to the center.  At the study visit you will be 
interviewed by me (or the research assistant).  During this visit, I (or the research assistant) 
will explain the study in more detail, obtain your consent and signature to participate and 
then ask you to complete a few questionnaires. For this study, we will also be checking 
blood pressure (similar to how you get your blood pressure checked at your doctor’s office).  
So, the entire study process will take about 30 minutes and there will be no additional 
follow-up for this study.   In appreciation for your time we will give you a multi-purpose tote 
bag, a medication pill box, and informational health brochures.  Does this sound like 
something you would be interested in doing? Again, I will explain the study in much greater 
detail at the first visit. 
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If not, please thank them for their time and end the call. 
 
4. Great! I really appreciate your interest and willingness in helping us. Before we schedule the 
study visit, would you be willing to answer a few questions to help me determine if you are 
eligible for this study?   
 
If yes, proceed; if no thank them for their time and end the call. 
 
5. Good.  I will read off a list of questions.  If your answer to any of them is no, wait until I am 
all done and tell me that when I am finished.  I do not want you to answer each question, 
individually.  Here are the questions: 
 
Are 65 years or older? 
Has your doctor ever told you that you have high blood pressure? 
Do you take a medicine to help control your blood pressure? 
Do your self-identify your race as being either black or white? 
Do you live independently in the community (not in an assisted living or long-term 
care center)? 
 
Would your response to any of these questions be “no?”   
(If person says yes, thank them for their time and that they are not eligible for the study.  If 
they answer no, proceed) 
 
6. OK, let’s go ahead and schedule the study visit?   
 
What day is best for you?_________________  
What time is best for you?________________ 
 
7. That is great. I will call you a day before your visit to remind you of this appointment time. 
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8. Do you have any questions for me at this time? 
 
9. Thank you so much Mr./Mrs._________________. We look forward to meeting you soon. 
Here is our phone number in case you have to reschedule the appointment or in case you 
have any questions: 919-843-8757. 
 
10. Have a nice day! And, again thank you for your time! 
 
If a message has to be left for potential subjects on telephone answering machines or with 
people other than the potential subject, leave the reason for the call and contact information 
to minimize the risk of breach of confidentiality.  Follow the script as outlined below: 
 
11. Voicemail/Answering Machine Script: 
 
“Greetings! This message is for Mr./Mrs.______________(potential subject’s name).  It is 
(say the date) at (say the time).  My name is ____________________ (name) from the UNC 
Eshelman School of Pharmacy.  I am calling in reference to the study that you requested to 
learn more about when you were at the ________________(Senior Center Name).   I would 
like to briefly describe the study with you and see if you would be interested in 
participating.  Please contact me, _________________(say name again) at 919-843-8757 if 
you are still interested in learning more about the study.  I hope to hear from you soon.  
Thank you and have a wonderful day.” 
 
12. Leaving Message with People other than potential subject: 
 
“Hello, may I please speak with Mr/Mrs_________________.”  
 
When notified that potential subject is unavailable, proceed with… 
“Ok.  Is there a better time that I can contact him/her?” (note day/time if given) May I also 
please leave my contact information?  
  
Great! My name is ___________________ from the UNC Eshelman School of Pharmacy. I 
am calling in reference to a study that Mr./Mrs._____________(potential subject’s name) 
requested to learn more about.  S/he can contact me at 919-843-8757 and I will describe the 
study to him/her.  Again, my name is _____________ and s/he can contact me at 919-843-
8757. Thank you for your time and I hope you have a nice day.” 
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Appendix 14.  Blood Pressure Measurement Protocol 
 
 
Blood Pressure Measurement Protocol 
 
 
 
Study personnel will be trained and certified to conduct BP measurements according to 
this study protocol.  
 
 
 
 
 
Version: 7/22/2011 
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Blood Pressure Overview  
 
Correct measurement of blood pressure (BP) is of importance in this study. It is essential that the 
procedures described for measuring BP be followed exactly. Precision is essential for valid 
comparisons of blood pressure between groups of people. 
 
  
Equipment Required  
 
OMRON® HEM-907XL digital automated non-invasive blood pressure monitor is used to obtain the 
outcome blood pressure reading.  
 
Cuffs  
 
Proper cuff size is essential for accurate BP measurement. OMRON® HEM-907XL is equipped with 
four different cuff sizes (small, medium, large and extra large), and each cuff is labeled with the arm 
circumference INDEX and has specific RANGE markings for proper fitting.  The range markings are 
located on the inside of each cuff.  The following corresponds to the arm circumference ranges and 
size for each cuff: 
  
Arm Circumference   Name of the Cuff (Size)   
 (7" - 9") 17-22 cm  HEM-907-CS19   (Small)  
(9" - 13") 22-32 cm  HEM-907-CR19   (Medium)  
(13" - 17") 32-42 cm  HEM-907-CL19   (Large)  
(17" - 20") 42-50 cm  HEM-907-CX19   (Extra Large) 
 
 
Preparation for Blood Pressure Measurement  
The setting in which BP readings are taken must be a quiet area. No other activity should be taking 
place there and temperature fluctuations are minimal. It is recommended that the room 
temperature be 65-75o F.  
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Measurement Procedures  
BP will be measured 2 times for each participant during the study visit.  It will take approximately 10 
minutes to take the readings, including an initial five-minute rest period.  
 
Once the participant has had the procedures explained and the equipment has been checked, BP 
measurement begins. The following steps must be followed precisely.  
 
The right arm should always be used for the measurements. If the participant indicates that there is 
a medical reason for not having BP measured on his or her right arm (such as surgery, or if the right 
arm is missing), reverse chairs and proceed with the left arm. Write a note on the form where BP 
will be recorded indicating that the left arm has been used. If the participant seems particularly 
apprehensive about the procedure, delay wrapping the cuff until after the five-minute wait. 
Measure the arm circumference using the following procedure.  
 
Have participant relax their arm. With the participant’s arm relaxed at their side, measure the arm 
circumference at the midpoint using a measuring tape in metric units.  The midpoint of the arm is 
measured from the acromion or bony extremity of the shoulder girdle to the olecranon or tip of 
elbow.  Select the appropriate cuff size to use for BP measurement based on the arm circumference. 
 
Have the participant put his/her right arm on the table with the palm of hand facing forward. The 
bend at the elbow (antecubital fossa) should be at heart level. Legs should be uncrossed and feet 
comfortably flat on the floor with back against the back of the chair. If necessary, place a book, 
footstool, or other flat object beneath the participant’s feet so that they do not dangle. 
 
Align the Artery Position Mark (ART.) on the cuff with the brachial artery.  Wrap the cuff snugly using 
both hands and securely fasten it with the Velcro™ tape. At this time, the lower edge of the cuff 
must be placed 1/2" to 1" above the inner side of elbow joint. As a second measure of proper cuff 
size, make sure that the INDEX marking located on the cuff is positioned within the RANGE mark, 
once the cuff is wrapped on the participant.  
 If the INDEX is positioned outside the RANGE, select the cuff suitable for the patient’s arm 
circumference and wrap it again. 
 Wrap the cuff so that you can insert only one finger between the cuff and arm.   
Keep the level of the cuff at the same level as the heart during the measurement. 
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Allow a five-minute wait before taking the BP. Conversation should be limited during this period. 
However, a brief explanation of the procedure can be repeated, if necessary, and the next steps of 
the study process can be described.  
After five minutes:  
1. Turn on the power button of the monitor by pressing the ON/OFF Button.  
2. Connect the cuff to the standard digital monitor.  
3. Push the “Start” button to start the measurement. 
 Do not push the START Button without wrapping the cuff. 
 If you want to stop measurement, push the STOP Button. The cuff will rapidly deflate.  
4. Record reading of Blood Pressure (systolic and diastolic).  The measurement results are 
displayed by the top to numbers on the monitor. 
5. Hit the “Clear” button to clear first reading.  
6. Wait 30 seconds having participant raise arm for 5 seconds/ level for 25 seconds 
*note – you may need to disconnect monitor from cuff when participant raises arm.  
7. Allow for a rest period before second reading (~5 minutes) 
8. Hit the “Start” Button for second reading. 
9. Record the second reading of Blood Pressure. 
10. Hit the “Clear “button to clear second reading.  
11. Disconnect the cuff from the monitor.  
12. Remove the cuff from the participant’s arm. 
13. Push the ON/OFF (power) Button to turn off the power. 
14. Wipe the cuff and monitor with a disinfectant wipe after use on every participant. 
 
If for any reason, you are unable to get a valid reading of the blood pressure on the participant, ask 
permission from the participant to retry the BP measurements. Take off the cuff, rewrap it on the 
arm, and retake BP measurements. 
If the participant expresses discomfort during BP measurement, push the STOP Button and the cuff 
will rapidly deflate.  Ask the participant if s/he would like to continue with the assessment.  If not, 
discontinue BP measurement and proceed with study questionnaires. 
BP control is considered to be SBP <140mmHg and DBP <90 mmHg.  If BP readings for a participant 
are concerning, for the participants safety the research personnel should instruct the participant to 
contact his/her physician to have further BP evaluation. 
 
BP safety levels based upon JNC7 & VA Hypertension Guidelines 
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* Mean of 2 Outcome Blood Pressure measurements at study visit 
 
Equipment Maintenance and Safety 
 The condition of the instrument for blood pressure measurement is too often ignored in common 
practice and should be a special responsibility of the principal investigator (PI), who understands the 
construction and function of the blood pressure equipment. The cleanliness and general working 
order of the cuffs and monitor display unit can usually be determined by simple inspection.  Each 
week the principal investigator will inspect the OMRON® HEM-907XL blood pressure unit.  Upon 
inspection, the air tubes for each cuff will be checked to assure that they are not clogged or cracked 
(free of leaks).  In addition, the entire monitor unit and cuffs will be wiped with a soft, damp cloth 
diluted with disinfectant alcohol.  Cleaning will be completed by wiping the monitor with a soft, dry 
cloth.   If the BP monitor is not functioning properly, the PI will contact Omron Healthcare’s 
Customer Service at 1-877-216-1336 and the monitor will be removed from service until issues are 
resolved. 
 
Training  
Introduction  
In order to standardize the previously described methods of the BP outcome measurement and to 
ensure that a high level of performance is attained, a training protocol has been developed. Before 
study personnel begin collecting standardized BP measurements, a training and certification of 
proper BP measurement will be provided for study personnel.  
BP Outcomes  Action  
Symptomatic:  
High: Stroke symptoms, CHF, headache 
 
Low: Dizziness, shortness of breath, chest pain  
Study personnel instructs subject to contact 
MD as soon as possible w/in 24 hours  
 
Study personnel asks subject would s/he like 
for personnel to call for medical assistance 
(911) 
 
Asymptomatic:  
SBP > 180 and/or DBP >110*  
 
 
Study personnel tells subject to contact MD 
w/in 1 week and to check blood regularly 
(every 24 hrs) until MD is contacted.  
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The principal investigator (Amica Yon, PharmD) will be the trainer. The training protocol will be 
presented at this time. Documentation of study personnel’s training performance from the trainer 
includes the successful understanding of the equipment, ability to place manual cuff on patient, and 
correct ascertainment of BP measurement. 
  
Steps Needed for Certification  
 
1. Before starting the certification process, study personnel should read/review the outcome 
information outlined in the previous pages. 
 
2. All study personnel taking BP measurements must receive training from the study trainer.  
 
3. All study personnel must demonstrate proper technique for BP measurement using the 
OMRON® HEM-907XL digital blood pressure monitor.   
 
4. Successful completion of the Checklist for Monitoring Form is the final step. All study personnel 
must be checked to ensure that they are following procedures correctly and utilizing proper 
measurement techniques. This is necessary and will be assessed prior to performing BP 
measurements on participants in this study.  The trainer will use the Checklist for Monitoring 
Form to grade the study personnel while s/he follows the entire outcome protocol to obtain two 
BP readings on a non-study individual. When carried out without procedural errors, this record 
should be completed, signed, and maintained in a file within the office where other study 
materials are kept. Errors of procedure should be reviewed, discussed, and corrected until one 
completed determination is accomplished without error.  
 
Study Forms Required for Certification Procedures  
 
1. Outcome Checklist for Monitoring Form (see enclosed).  
2. Outcome Certification Form (see enclosed).  
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Checklist for Monitoring BP Outcome Form  
 
Study personnel’s name ___________________________________  
Date Observed _____/______/_______  
Instructions: Check if procedure step is carried out correctly.  
 
Procedure          Comments  
1.  ____ Check BP equipment        _____________ 
2.  ____ Give participant explanation of BP procedures     _____________  
3.  ____ Measure arm for correct cuff size; choose correct size   _____________  
4.  ____ Mark brachial artery point       _____________  
8.  ____ Align the Artery Position Mark on cuff with brachial artery  _____________  
9.  ____ Wrap HEM-907XL BP cuff correctly     _____________  
10.____ Keep level of cuff at same level as the heart during measure  _____________  
11.____ Leave subject for 5 min. rest, instruct on posture   _____________  
12.____ Press start button        _____________ 
13.____ Record first BP reading (SysBP/DiaBP)      _____________  
14.____ Clear the monitor of first reading       _____________   
15.____ Instruct participant to raise arm for 5 sec and allow rest period  _____________  
16.____ Begin steps for next reading; press start button    _____________  
17.____ Record second BP reading (SysBP/DiaBP)    _____________  
18.____ Clear monitor of second reading and remove cuff   _____________  
19.____Wipe the cuff and monitor with disinfectant wipe   _____________  
 
Trainer:  _______________  
 
Pass/Fail:  _______________ 
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BP Outcome Measure 
 
Certification Form  
Name: __________________  
Date: ___________________ 
Arm Circumference ____ ____/cm  
Cuff Size  
1) Small (< 22 cm) _______   2) Medium (22 – 32 cm) _________  
3) Large (32 - 42cm) _______   4) Extra Large (42 - 50cm) _______  
Blood Pressure Measurement **Wait 5 minutes seated **  
First digital blood pressure  
 SBP / DBP  
Time:____________    _____________/_________mmHg  
**Raise arm for 5 seconds / level for 25 seconds**  
 
Second digital blood pressure  **Wait 5 minutes seated ** 
 SBP / DBP  
Time:____________    _____________/_________mmHg  
Pass/ Fail _________________________  
 
Trainer Signature_____________________      
 
Trainee Signature_____________________ 
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